METAL COMPLEXES

Abstract
The present invention relates to metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these metal complexes.
Description

The present invention relates to metal complexes which are suitable for use as emitters in organic electroluminescent devices.


The structure of organic electroluminescent devices (OLEDs) in which organic semiconductors are employed as functional materials is described, for example, in U.S. Pat. No. 4,539,507, U.S. Pat. No. 5,151,629, EP 0676461 and WO 98/27136. The emitting materials employed here are increasingly organometallic complexes which exhibit phosphorescence instead of fluorescence. For quantum-mechanical reasons, an up to four-fold increase in energy and power efficiency is possible using organometallic compounds as phosphorescence emitters. In general, there is still a need for improvement, in particular with respect to efficiency, operating voltage and lifetime, in the case of OLEDs which exhibit triplet emission.


According to the prior art, the triplet emitters employed in phosphorescent OLEDs are, in particular, iridium and platinum complexes. The iridium complexes employed are, in particular, bis- and tris-ortho-metallated complexes with aromatic ligands, where the ligands are bonded to the metal via a negatively charged carbon atom and a neutral nitrogen atom or via a negatively charged carbon atom and a neutral carbene carbon atom. Examples of such complexes are tris(phenylpyridyl)iridium(III) and derivatives thereof (for example in accordance with US 2002/0034656 or WO 2010/027583). The literature discloses a multiplicity of related ligands and iridium or platinum complexes, such as, for example, complexes with 1- or 3-phenylisoquinoline ligands (for example in accordance with EP 1348711 or WO 2011/028473), with 2-phenylquinolines (for example in accordance with WO 2002/064700 or WO 2006/095943), with phenylquinoxalines (for example in accordance with US 2005/0191527), with phenylimidazoles (for example in accordance with JP 2003/109758), with phenylbenzimidazoles (for example in accordance with US 2005/0008895) or with phenylcarbenes (for example in accordance with WO 2005/019373). Platinum complexes are known, for example, from WO 2003/040257. Although good results have already been achieved with metal complexes of this type, further improvements are still desirable here, in particular with respect to the efficiency and the lifetime of the complexes.


A further problem which some of the metal complexes in accordance with the prior art have is low solubility in organic solvents. Thus, for example, tris(benzo[h]quinoline)iridium(III) is virtually insoluble in a multiplicity of common organic solvents, for example in aromatic hydrocarbons or chlorobenzene. Besides the consequently considerably more difficult purification in the preparation of the complexes, the low solubility also makes the use of these complexes more difficult or prevents it entirely in the solution-processed production of OLEDs. Access to derivatives having higher solubility would therefore be desirable here, where the derivatisation should not impair their electronic properties. For processing from solution, improved oxidation stability would furthermore be advantageous.


There is furthermore a need for improvement in the case of the sublimation properties of some metal complexes in accordance with the prior art. Thus, these have a high sublimation temperature, which in turn means high thermal stress for these materials both during sublimation for purification after the synthesis and also during the production of OLEDs in vacuum-processed processes. Access to derivatives having a lower sublimation temperature would be desirable here, where the derivatisation should not impair their electronic properties.


The object of the present invention is therefore the provision of novel metal complexes which are suitable as emitters for use in OLEDs. In particular, the object is to provide emitters which exhibit improved properties with respect to efficiency, operating voltage, lifetime, colour coordinates, colour purity, i.e. width of the emission band, solubility and/or oxidation stability.


Surprisingly, it has been found that certain metal chelate complexes described in greater detail below achieve this object and are very highly suitable for use in an organic electroluminescent device. The present invention therefore relates to these metal complexes and to organic electroluminescent devices which comprise these complexes.


The invention thus relates to a compound of the formula (1),





M(L)n(L′)m  formula (1)


which contains a moiety M(L)n of the formula (2):




embedded image


where the following applies to the symbols and indices used:

  • M is iridium or platinum;
  • CyC is an aryl or heteroaryl group having 5 to 18 aromatic ring atoms or a fluorene or azafluorene group, each of which is coordinated to M via a carbon atom and each of which may be substituted by one or more radicals R and each of which is connected to CyD via a covalent bond;
  • CyD is a heteroaryl group having 5 to 18 aromatic ring atoms, which is coordinated to M via a neutral nitrogen atom or via a carbene carbon atom and which may be substituted by one or more radicals R and which is connected to CyC via a covalent bond;
  • R is on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(R1)2, CN, NO2, OH, COOR1, C(═O)N(R1)2, Si(R1)3, B(OR1)2, C(═O)R1, P(═O)(R1)2, S(═O)R1, S(═O)2R1, OSO2R1, a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 20 C atoms or an alkenyl or alkynyl group having 2 to 20 C atoms or a branched or cyclic alkyl, alkoxy or thioalkoxy group having 3 to 20 C atoms, each of which may be substituted by one or more radicals R1, where one or more non-adjacent CH2 groups may be replaced by R1C═CR1, C≡C, Si(R1)2, C═O, NR1, O, S or CONR1 and where one or more H atoms may be replaced by D, F, Cl, Br, I or CN, or an aromatic or heteroaromatic ring system having 5 to 40 aromatic ring atoms, which may in each case be substituted by one or more radicals R1, or an aryloxy or heteroaryloxy group having 5 to 40 aromatic ring atoms, which may be substituted by one or more radicals R1, or an aralkyl or heteroaralkyl group having 5 to 40 aromatic ring atoms, which may be substituted by one or more radicals R1, or a diarylamino group, diheteroarylamino group or arylheteroarylamino group having 10 to 40 aromatic ring atoms, which may be substituted by one or more radicals R1; two adjacent radicals R here may also form a mono- or polycyclic, aliphatic, aromatic or heteroaromatic ring system with one another; furthermore, two radicals R, one of which is bonded to CyD and the other of which is bonded to CyC, may form a mono- or polycyclic, aliphatic, aromatic or heteroaromatic ring system with one another; or CyC and CyD contain two adjacent carbon atoms, which are substituted by radicals R in such a way that the two carbon atoms, together with the substituents R, form a structure of the following formula (3):




embedded image




    • where the dashed bonds indicate the linking of the two carbon atoms in the ligand; the two carbon atoms explicitly drawn in are thus part of CyC and CyD;



  • A1, A2 are, identically or differently on each occurrence, CR2 or N;

  • A3, A4 are, identically or differently on each occurrence, an alkylene group having 2 or 3 C atoms, in which one carbon atom may be replaced by oxygen and which may be substituted by one or more radicals R3;


    with the proviso that no two heteroatoms in A1-A3-A2 and A1-A4-A2 are bonded directly to one another;
    • R1, R2, R3 are on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(R4)2, CN, NO2, Si(R4)3, B(OR4)2, C(═O)R4, P(═O)(R4)2, S(═O)R4, S(═O)2R4, OSO2R4, a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 20 C atoms or an alkenyl or alkynyl group having 2 to 20 C atoms or a branched or cyclic alkyl, alkoxy or thioalkoxy group having 3 to 20 C atoms, each of which may be substituted by one or more radicals R4, where one or more non-adjacent CH2 groups may be replaced by R4C═CR4, C≡C, Si(R4)2, C═O, NR4, O, S or CONR4 and where one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2, or an aromatic or heteroaromatic ring system having 5 to 40 aromatic ring atoms, which may in each case be substituted by one or more radicals R4, or an aryloxy or heteroaryloxy group having 5 to 40 aromatic ring atoms, which may be substituted by one or more radicals R4, or an aralkyl or heteroaralkyl group having 5 to 40 aromatic ring atoms, which may be substituted by one or more radicals R4, or a diarylamino group, diheteroarylamino group or arylheteroarylamino group having 10 to 40 aromatic ring atoms, which may be substituted by one or more radicals R4; two or more adjacent radicals R1 here may form a mono- or polycyclic, aliphatic, aromatic or heteroaromatic ring system with one another, and/or two radicals R3 may form a mono- or polycyclic, aliphatic ring system with one another, where ring formation between two radicals R3 which are bonded to A3 and A4 is also possible;
    • R4 is on each occurrence, identically or differently, H, D, F or an aliphatic, aromatic and/or heteroaromatic hydrocarbon radical having 1 to 20 C atoms, in which, in addition, one or more H atoms may be replaced by F; two or more substituents R4 here may also form a mono- or polycyclic ring system with one another;
    • L′ is, identically or differently on each occurrence, a ligand;
    • n is 1, 2 or 3;
    • m is 0, 1, 2, 3 or 4;


      a plurality of ligands L here may also be linked to one another or L may be linked to L′ via a single bond or a divalent or trivalent bridge and thus form a tridentate, tetradentate, pentadentate or hexadentate ligand system;


      a substituent R here may also additionally be coordinated to M;


      characterised in that the moiety of the formula (2) contains at least one structural unit of the above-mentioned formula (3).



The presence of a moiety of the formula (3), i.e. a condensed-on aliphatic bicyclic group, is essential to the invention. In the structure of the formula (3) depicted above and the further embodiments of this structure mentioned as preferred, a double bond is formally depicted between the two carbon atoms which are part of CyC and CyD. This represents a simplification of the chemical structure, since these two carbon atoms are bonded into an aromatic or heteroaromatic system of the ligand and the bond between these two carbon atoms is thus formally between the bond order of a single bond and that of a double bond. The drawing-in of the formal double bond should thus not be interpreted as limiting for the structure, but instead it is apparent to the person skilled in the art that this means an aromatic bond.


“Adjacent carbon atoms” here means that the carbon atoms are bonded directly to one another. Furthermore, “adjacent radicals” in the definition of the radicals means that these radicals are either bonded to the same carbon atom or to adjacent carbon atoms. In the above-mentioned moieties of the formula (2), CyC and CyD may furthermore also be linked to one another by ring formation of the substituents R. This may also result in CyC and CyD no longer representing independent aromatic systems, but instead forming an entire larger aromatic system through the ring formation. This is the case, for example, if CyC and CyD are bridged to one another by a group —CR1═CR1— or by an ortho-phenylene group, which is optionally substituted by R1. This is explained diagrammatically below with reference to a phenylpyridine ligand:




embedded image


An aryl group in the sense of this invention contains 6 to 40 C atoms; a heteroaryl group in the sense of this invention contains 2 to 40 C atoms and at least one heteroatom, with the proviso that the sum of C atoms and heteroatoms is at least 5. The heteroatoms are preferably selected from N, O and/or S. An aryl group or heteroaryl group here is taken to mean either a simple aromatic ring, i.e. benzene, or a simple heteroaromatic ring, for example pyridine, pyrimidine, thiophene, etc., or a condensed aryl or heteroaryl group, for example naphthalene, anthracene, phenanthrene, quinoline, isoquinoline, etc.


An aromatic ring system in the sense of this invention contains 6 to 60 C atoms in the ring system. A heteroaromatic ring system in the sense of this invention contains 1 to 60 C atoms and at least one heteroatom in the ring system, with the proviso that the sum of C atoms and heteroatoms is at least 5. The heteroatoms are preferably selected from N, O and/or S. An aromatic or heteroaromatic ring system in the sense of this invention is intended to be taken to mean a system which does not necessarily contain only aryl or heteroaryl groups, but instead in which, in addition, a plurality of aryl or heteroaryl groups may be interrupted by a non-aromatic unit (preferably less than 10% of the atoms other than H), such as, for example, a C, N or O atom or a carbonyl group. Thus, for example, systems such as 9,9′-spirobifluorene, 9,9-diarylifluorene, triarylamine, diaryl ether, stilbene, etc., are also intended to be taken to be aromatic ring systems in the sense of this invention, as are systems in which two or more aryl groups are interrupted, for example, by a linear or cyclic alkyl group or by a silyl group. Furthermore, systems in which two or more aryl or heteroaryl groups are bonded directly to one another, such as, for example, biphenyl or terphenyl, are likewise intended to be taken to be an aromatic or heteroaromatic ring system.


A cyclic alkyl, alkoxy or thioalkoxy group in the sense of this invention is taken to mean a monocyclic, bicyclic or polycyclic group.


For the purposes of the present invention, a C1- to C40-alkyl group, in which, in addition, individual H atoms or CH2 groups may be substituted by the above-mentioned groups, is taken to mean, for example, the radicals methyl, ethyl, n-propyl, i-propyl, cyclopropyl, n-butyl, i-butyl, s-butyl, t-butyl, cyclobutyl, 2-methylbutyl, n-pentyl, s-pentyl, tert-pentyl, 2-pentyl, neopentyl, cyclopentyl, n-hexyl, s-hexyl, tert-hexyl, 2-hexyl, 3-hexyl, neohexyl, cyclohexyl, 1-methylcyclopentyl, 2-methylpentyl, n-heptyl, 2-heptyl, 3-heptyl, 4-heptyl, cycloheptyl, 1-methylcyclohexyl, n-octyl, 2-ethylhexyl, cyclooctyl, 1-bicyclo[2.2.2]octyl, 2-bicyclo[2.2.2]octyl, 2-(2,6-dimethyl)octyl, 3-(3,7-dimethyl)octyl, adamantyl, trifluoromethyl, pentafluoroethyl, 2,2,2-trifluoroethyl, 1,1-dimethyl-n-hex-1-yl, 1,1-dimethyl-n-hept-1-yl, 1,1-dimethyl-n-oct-1-yl, 1,1-dimethyl-n-dec-1-yl, 1,1-dimethyl-n-dodec-1-yl, 1,1-dimethyl-n-tetradec-1-yl, 1,1-dimethyl-n-hexadec-1-yl, 1,1-dimethyl-n-octadec-1-yl, 1,1-diethyl-n-hex-1-yl, 1,1-diethyl-n-hept-1-yl, 1,1-diethyl-n-oct-1-yl, 1,1-diethyl-n-dec-1-yl, 1,1-diethyl-n-dodec-1-yl, 1,1-diethyl-n-tetradec-1-yl, 1,1-diethyl-n-hexadec-1-yl, 1,1-diethyl-n-octadec-1-yl, 1-(n-propyl)cyclohex-1-yl, 1-(n-butyl)cyclohex-1-yl, 1-(n-hexyl)cyclohex-1-yl, 1-(n-octyl)-cyclohex-1-yl and 1-(n-decyl)cyclohex-1-yl. An alkenyl group is taken to mean, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl or cyclooctadienyl. An alkynyl group is taken to mean, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl or octynyl. A C1- to C40-alkoxy group is taken to mean, for example, methoxy, trifluoromethoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy or 2-methylbutoxy.


An aromatic or heteroaromatic ring system having 5-60 aromatic ring atoms, which may also in each case be substituted by the radicals mentioned above and which may be linked to the aromatic or heteroaromatic ring system via any desired positions, is taken to mean, for example, groups derived from benzene, naphthalene, anthracene, benzanthracene, phenanthrene, benzophenanthrene, pyrene, chrysene, perylene, fluoranthene, benzofluoranthene, naphthacene, pentacene, benzopyrene, biphenyl, biphenylene, terphenyl, terphenylene, fluorene, spirobifluorene, dihydrophenanthrene, dihydropyrene, tetrahydropyrene, cis- or transindenofluorene, cis- or trans-monobenzoindenofluorene, cis- or trans-dibenzoindenofluorene, truxene, isotruxene, spirotruxene, spiroisotruxene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, indolocarbazole, indenocarbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazole, naphthimidazole, phenanthrimidazole, pyridimidazole, pyrazinimidazole, quinoxalinimidazole, oxazole, benzoxazole, naphthoxazole, anthroxazole, phenanthroxazole, isoxazole, 1,2-thiazole, 1,3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, quinoxaline, 1,5-diazaanthracene, 2,7-diazapyrene, 2,3-diazapyrene, 1,6-diazapyrene, 1,8-diazapyrene, 4,5-diazapyrene, 4,5,9,10-tetraazaperylene, pyrazine, phenazine, phenoxazine, phenothiazine, fluorubin, naphthyridine, azacarbazole, benzocarboline, phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, tetrazole, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine, purine, pteridine, indolizine and benzothiadiazole.


Preference is given to compounds of the formula (1), characterised in that they are uncharged, i.e. are electrically neutral. This is achieved in a simple manner by selecting the charge of the ligands L and L′ in such a way that they compensate for the charge of the complexed metal atom M.


In the complexes of the formula (1), the indices n and m are selected so that the coordination number at the metal M corresponds in total, depending on the metal, to the usual coordination number for this metal. For iridium(III) this is the coordination number 6 and for platinum(II) this is the coordination number 4.


In a preferred embodiment of the invention, M is iridium(III), and the index n stands for 1, 2 or 3, preferably for 2 or 3. If the index n=1, four monodentate or two bidentate or one bidentate and two monodentate or one tridentate and one monodentate or one tetradentate ligand L′, preferably two bidentate ligands L′, are also coordinated to the metal. If the index n=2, one bidentate or two monodentate ligands L′, preferably one bidentate ligand L′, are also coordinated to the metal. If the index n=3, the index m=0.


In a further preferred embodiment of the invention, M is platinum(II), and the index n stands for 1 or 2. If the index n=1, one bidentate or two monodentate ligands L′, preferably one bidentate ligand L′, are also coordinated to the metal M. If the index n=2, the index m=0.


In a preferred embodiment of the present invention, CyC is an aryl or heteroaryl group having 6 to 14 aromatic ring atoms, particularly preferably having 6 to 10 aromatic ring atoms, very particularly preferably having 6 aromatic ring atoms, or a fluorene or azafluorene group, which is in each case coordinated to M via a carbon atom and which may be substituted by one or more radicals R and which is bonded to CyD via a covalent bond.


Preferred embodiments of the group CyC are the structures of the following formulae (CyC-1) to (CyC-19), where the group CyC is in each case bonded to CyD at the position denoted by # and is coordinated to M at the position denoted by *,




embedded image


embedded image


embedded image


where R has the meanings given above and the following applies to the other symbols used:

  • X is on each occurrence, identically or differently, CR or N;
  • W is on each occurrence, identically or differently, NR, O, S or CR2.


If the group of the formula (3) is bonded to CyC, two adjacent groups X in CyC stand for CR and these two carbon atoms, together with the radicals R which are bonded to these carbon atoms, form a group of the formula (3) mentioned above or described in greater detail below.


Preferably a maximum of three symbols X in (CyC-1) to (CyC-19) stand for N, particularly preferably a maximum of two symbols X in (CyC-1) to (CyC-19) stand for N, very particularly preferably a maximum of one symbol X in (CyC-1) to (CyC-19) stands for N. Especially preferably all symbols X stand for CR.


Particularly preferred groups CyC are therefore the groups of the following formulae (CyC-1a) to (CyC-19a),




embedded image


embedded image


embedded image


embedded image


where the symbols used have the meanings given above. If the group of the formula (3) is bonded to (CyC-1) to (CyC-19), two adjacent radicals R, together with the carbon atoms to which they are bonded, form a group of the formula (3) mentioned above or described in greater detail below.


Preferred groups amongst the groups (CyC-1) to (CyC-19) are the groups (CyC-1), (CyC-3), (CyC-8), (CyC-10), (CyC-12), (CyC-13) and (CyC-16), and particular preference is given to the groups (CyC-1a), (CyC-3a), (CyC-8a), (CyC-10a), (CyC-12a), (CyC-13a) and (CyC-16a).


In a further preferred embodiment of the invention, CyD is a heteroaryl group having 5 to 13 aromatic ring atoms, particularly preferably having 5 to 10 aromatic ring atoms, which is coordinated to M via a neutral nitrogen atom or via a carbene carbon atom, which may be substituted by one or more radicals R and which is bonded to CyC via a covalent bond. The group CyD is preferably coordinated to M via a nitrogen atom.


Preferred embodiments of the group CyD are the structures of the following formulae (CyD-1) to (CyD-10), where the group CyD is in each case bonded to CyC at the position denoted by # and is coordinated to M at the position denoted by *,




embedded image


where X, W and R have the meanings given above.


If the group of the formula (3) is bonded to CyD, two adjacent groups X in CyD stand for CR and the two carbon atoms, together with the radicals R which are bonded to these carbon atoms, form a group of the formula (3) mentioned above or described in greater detail below.


Preferably a maximum of three symbols X in (CyD-1) to (CyD-10) stand for N, particularly preferably a maximum of two symbols X in (CyD-1) to (CyD-10) stand for N, very particularly preferably a maximum of one symbol X in (CyD-1) to (CyD-10) stands for N. Especially preferably all symbols X stand for CR.


Particularly preferred groups CyD are therefore the groups of the following formulae (CyD-1a) to (CyD-10a),




embedded image


embedded image


where the symbols used have the meanings given above. If the group of the formula (3) is bonded to (CyD-1) to (CyD-10), two adjacent radicals R, together with the carbon atoms to which they are bonded, form a group of the formula (3) mentioned above or described in greater detail below.


Preferred groups amongst the groups (CyD-1) to (CyD-10) are the groups (CyD-1), (CyD-3), (CyD-4), (CyD-5) and (CyD-6), and particular preference is given to the groups (CyD-1a), (CyD-3a), (CyD-4a), (CyD-5a) and (CyD-6a).


The preferred groups CyC and CyD mentioned above can be combined with one another as desired. Preference is given to compounds in which CyC represents an aryl or heteroaryl group having 6 to 14 aromatic ring atoms and CyD represents a heteroaryl group having 5 to 13 aromatic ring atoms, each of which may be substituted by one or more radicals R. Particular preference is given to compounds in which CyC represents an aryl or heteroaryl group having 6 to 10 aromatic ring atoms and CyD represents a heteroaryl group having 5 to 10 aromatic ring atoms, each of which may be substituted by one or more radicals R. In particular, the following combinations of CyC and CyD are suitable in the ligand L:














No.
CyC
CyD

















1
CyC-1
CyD-1


2
CyC-1
CyD-2


3
CyC-1
CyD-3


4
CyC-1
CyD-4


5
CyC-1
CyD-5


6
CyC-1
CyD-6


7
CyC-1
CyD-7


8
CyC-1
CyD-8


9
CyC-1
CyD-9


10
CyC-1
CyD-10


11
CyC-2
CyD-1


12
CyC-2
CyD-2


13
CyC-2
CyD-3


14
CyC-2
CyD-4


15
CyC-2
CyD-5


16
CyC-2
CyD-6


17
CyC-2
CyD-7


18
CyC-2
CyD-8


19
CyC-2
CyD-9


20
CyC-2
CyD-10


21
CyC-3
CyD-1


22
CyC-3
CyD-2


23
CyC-3
CyD-3


24
CyC-3
CyD-4


25
CyC-3
CyD-5


26
CyC-3
CyD-6


27
CyC-3
CyD-7


28
CyC-3
CyD-8


29
CyC-3
CyD-9


30
CyC-3
CyD-10


31
CyC-4
CyD-1


32
CyC-4
CyD-2


33
CyC-4
CyD-3


34
CyC-4
CyD-4


35
CyC-4
CyD-5


36
CyC-4
CyD-6


37
CyC-4
CyD-7


38
CyC-4
CyD-8


39
CyC-4
CyD-9


40
CyC-4
CyD-10


41
CyC-5
CyD-1


42
CyC-5
CyD-2


43
CyC-5
CyD-3


44
CyC-5
CyD-4


45
CyC-5
CyD-5


46
CyC-5
CyD-6


47
CyC-5
CyD-7


48
CyC-5
CyD-8


49
CyC-5
CyD-9


50
CyC-5
CyD-10


51
CyC-6
CyD-1


52
CyC-6
CyD-2


53
CyC-6
CyD-3


54
CyC-6
CyD-4


55
CyC-6
CyD-5


56
CyC-6
CyD-6


57
CyC-6
CyD-7


58
CyC-6
CyD-8


59
CyC-6
CyD-9


60
CyC-6
CyD-10


61
CyC-7
CyD-1


62
CyC-7
CyD-2


63
CyC-7
CyD-3


64
CyC-7
CyD-4


65
CyC-7
CyD-5


66
CyC-7
CyD-6


67
CyC-7
CyD-7


68
CyC-7
CyD-8


69
CyC-7
CyD-9


70
CyC-7
CyD-10


71
CyC-8
CyD-1


72
CyC-8
CyD-2


73
CyC-8
CyD-3


74
CyC-8
CyD-4


75
CyC-8
CyD-5


76
CyC-8
CyD-6


77
CyC-8
CyD-7


78
CyC-8
CyD-8


79
CyC-8
CyD-9


80
CyC-8
CyD-10


81
CyC-9
CyD-1


82
CyC-9
CyD-2


83
CyC-9
CyD-3


84
CyC-9
CyD-4


85
CyC-9
CyD-5


86
CyC-9
CyD-6


87
CyC-9
CyD-7


88
CyC-9
CyD-8


89
CyC-9
CyD-9


90
CyC-9
CyD-10


91
CyC-10
CyD-1


92
CyC-10
CyD-2


93
CyC-10
CyD-3


94
CyC-10
CyD-4


95
CyC-10
CyD-5


96
CyC-10
CyD-6


97
CyC-10
CyD-7


98
CyC-10
CyD-8


99
CyC-10
CyD-9


100
CyC-10
CyD-10


101
CyC-11
CyD-1


102
CyC-11
CyD-2


103
CyC-11
CyD-3


104
CyC-11
CyD-4


105
CyC-11
CyD-5


106
CyC-11
CyD-6


107
CyC-11
CyD-7


108
CyC-11
CyD-8


109
CyC-11
CyD-9


110
CyC-11
CyD-10


111
CyC-12
CyD-1


112
CyC-12
CyD-2


113
CyC-12
CyD-3


114
CyC-12
CyD-4


115
CyC-12
CyD-5


116
CyC-12
CyD-6


117
CyC-12
CyD-7


118
CyC-12
CyD-8


119
CyC-12
CyD-9


120
CyC-12
CyD-10


121
CyC-13
CyD-1


122
CyC-13
CyD-2


123
CyC-13
CyD-3


124
CyC-13
CyD-4


125
CyC-13
CyD-5


126
CyC-13
CyD-6


127
CyC-13
CyD-7


128
CyC-13
CyD-8


129
CyC-13
CyD-9


130
CyC-13
CyD-10


131
CyC-14
CyD-1


132
CyC-14
CyD-2


133
CyC-14
CyD-3


134
CyC-14
CyD-4


135
CyC-14
CyD-5


136
CyC-14
CyD-6


137
CyC-14
CyD-7


138
CyC-14
CyD-8


139
CyC-14
CyD-9


140
CyC-14
CyD-10


141
CyC-15
CyD-1


142
CyC-15
CyD-2


143
CyC-15
CyD-3


144
CyC-15
CyD-4


145
CyC-15
CyD-5


146
CyC-15
CyD-6


147
CyC-15
CyD-7


148
CyC-15
CyD-8


149
CyC-15
CyD-9


150
CyC-15
CyD-10


151
CyC-16
CyD-1


152
CyC-16
CyD-2


153
CyC-16
CyD-3


154
CyC-16
CyD-4


155
CyC-16
CyD-5


156
CyC-16
CyD-6


157
CyC-16
CyD-7


158
CyC-16
CyD-8


159
CyC-16
CyD-9


160
CyC-16
CyD-10


161
CyC-17
CyD-1


162
CyC-17
CyD-2


163
CyC-17
CyD-3


164
CyC-17
CyD-4


165
CyC-17
CyD-5


166
CyC-17
CyD-6


167
CyC-17
CyD-7


168
CyC-17
CyD-8


169
CyC-17
CyD-9


170
CyC-17
CyD-10


171
CyC-18
CyD-1


172
CyC-18
CyD-2


173
CyC-18
CyD-3


174
CyC-18
CyD-4


175
CyC-18
CyD-5


176
CyC-18
CyD-6


177
CyC-18
CyD-7


178
CyC-18
CyD-8


179
CyC-18
CyD-9


180
CyC-18
CyD-10


181
CyC-19
CyD-1


182
CyC-19
CyD-2


183
CyC-19
CyD-3


184
CyC-19
CyD-4


185
CyC-19
CyD-5


186
CyC-19
CyD-6


187
CyC-19
CyD-7


188
CyC-19
CyD-8


189
CyC-19
CyD-9


190
CyC-19
CyD-10









The groups CyC and CyD mentioned above as particularly preferred are particularly preferably combined with one another. Particular preference is thus given to the following combinations of CyC and CyD in the ligand L:














No.
CyC
CyD

















1
CyC-1a
CyD-1a


2
CyC-1a
CyD-2a


3
CyC-1a
CyD-3a


4
CyC-1a
CyD-4a


5
CyC-1a
CyD-5a


6
CyC-1a
CyD-6a


7
CyC-1a
CyD-7a


8
CyC-1a
CyD-8a


9
CyC-1a
CyD-9a


10
CyC-1a
CyD-10a


11
CyC-2a
CyD-1a


12
CyC-2a
CyD-2a


13
CyC-2a
CyD-3a


14
CyC-2a
CyD-4a


15
CyC-2a
CyD-5a


16
CyC-2a
CyD-6a


17
CyC-2a
CyD-7a


18
CyC-2a
CyD-8a


19
CyC-2a
CyD-9a


20
CyC-2a
CyD-10a


21
CyC-3a
CyD-1a


22
CyC-3a
CyD-2a


23
CyC-3a
CyD-3a


24
CyC-3a
CyD-4a


25
CyC-3a
CyD-5a


26
CyC-3a
CyD-6a


27
CyC-3a
CyD-7a


28
CyC-3a
CyD-8a


29
CyC-3a
CyD-9a


30
CyC-3a
CyD-10a


31
CyC-4a
CyD-1a


32
CyC-4a
CyD-2a


33
CyC-4a
CyD-3a


34
CyC-4a
CyD-4a


35
CyC-4a
CyD-5a


36
CyC-4a
CyD-6a


37
CyC-4a
CyD-7a


38
CyC-4a
CyD-8a


39
CyC-4a
CyD-9a


40
CyC-4a
CyD-10a


41
CyC-5a
CyD-1a


42
CyC-5a
CyD-2a


43
CyC-5a
CyD-3a


44
CyC-5a
CyD-4a


45
CyC-5a
CyD-5a


46
CyC-5a
CyD-6a


47
CyC-5a
CyD-7a


48
CyC-5a
CyD-8a


49
CyC-5a
CyD-9a


50
CyC-5a
CyD-10a


51
CyC-6a
CyD-1a


52
CyC-6a
CyD-2a


53
CyC-6a
CyD-3a


54
CyC-6a
CyD-4a


55
CyC-6a
CyD-5a


56
CyC-6a
CyD-6a


57
CyC-6a
CyD-7a


58
CyC-6a
CyD-8a


59
CyC-6a
CyD-9a


60
CyC-6a
CyD-10a


61
CyC-7a
CyD-1a


62
CyC-7a
CyD-2a


63
CyC-7a
CyD-3a


64
CyC-7a
CyD-4a


65
CyC-7a
CyD-5a


66
CyC-7a
CyD-6a


67
CyC-7a
CyD-7a


68
CyC-7a
CyD-8a


69
CyC-7a
CyD-9a


70
CyC-7a
CyD-10a


71
CyC-8a
CyD-1a


72
CyC-8a
CyD-2a


73
CyC-8a
CyD-3a


74
CyC-8a
CyD-4a


75
CyC-8a
CyD-5a


76
CyC-8a
CyD-6a


77
CyC-8a
CyD-7a


78
CyC-8a
CyD-8a


79
CyC-8a
CyD-9a


80
CyC-8a
CyD-10a


81
CyC-9a
CyD-1a


82
CyC-9a
CyD-2a


83
CyC-9a
CyD-3a


84
CyC-9a
CyD-4a


85
CyC-9a
CyD-5a


86
CyC-9a
CyD-6a


87
CyC-9a
CyD-7a


88
CyC-9a
CyD-8a


89
CyC-9a
CyD-9a


90
CyC-9a
CyD-10a


91
CyC-10a
CyD-1a


92
CyC-10a
CyD-2a


93
CyC-10a
CyD-3a


94
CyC-10a
CyD-4a


95
CyC-10a
CyD-5a


96
CyC-10a
CyD-6a


97
CyC-10a
CyD-7a


98
CyC-10a
CyD-8a


99
CyC-10a
CyD-9a


100
CyC-10a
CyD-10a


101
CyC-11a
CyD-1a


102
CyC-11a
CyD-2a


103
CyC-11a
CyD-3a


104
CyC-11a
CyD-4a


105
CyC-11a
CyD-5a


106
CyC-11a
CyD-6a


107
CyC-11a
CyD-7a


108
CyC-11a
CyD-8a


109
CyC-11a
CyD-9a


110
CyC-11a
CyD-10a


111
CyC-12a
CyD-1a


112
CyC-12a
CyD-2a


113
CyC-12a
CyD-3a


114
CyC-12a
CyD-4a


115
CyC-12a
CyD-5a


116
CyC-12a
CyD-6a


117
CyC-12a
CyD-7a


118
CyC-12a
CyD-8a


119
CyC-12a
CyD-9a


120
CyC-12a
CyD-10a


121
CyC-13a
CyD-1a


122
CyC-13a
CyD-2a


123
CyC-13a
CyD-3a


124
CyC-13a
CyD-4a


125
CyC-13a
CyD-5a


126
CyC-13a
CyD-6a


127
CyC-13a
CyD-7a


128
CyC-13a
CyD-8a


129
CyC-13a
CyD-9a


130
CyC-13a
CyD-10a


131
CyC-14a
CyD-1a


132
CyC-14a
CyD-2a


133
CyC-14a
CyD-3a


134
CyC-14a
CyD-4a


135
CyC-14a
CyD-5a


136
CyC-14a
CyD-6a


137
CyC-14a
CyD-7a


138
CyC-14a
CyD-8a


139
CyC-14a
CyD-9a


140
CyC-14a
CyD-10a


141
CyC-15a
CyD-1a


142
CyC-15a
CyD-2a


143
CyC-15a
CyD-3a


144
CyC-15a
CyD-4a


145
CyC-15a
CyD-5a


146
CyC-15a
CyD-6a


147
CyC-15a
CyD-7a


148
CyC-15a
CyD-8a


149
CyC-15a
CyD-9a


150
CyC-15a
CyD-10a


151
CyC-16a
CyD-1a


152
CyC-16a
CyD-2a


153
CyC-16a
CyD-3a


154
CyC-16a
CyD-4a


155
CyC-16a
CyD-5a


156
CyC-16a
CyD-6a


157
CyC-16a
CyD-7a


158
CyC-16a
CyD-8a


159
CyC-16a
CyD-9a


160
CyC-16a
CyD-10a


161
CyC-17a
CyD-1a


162
CyC-17a
CyD-2a


163
CyC-17a
CyD-3a


164
CyC-17a
CyD-4a


165
CyC-17a
CyD-5a


166
CyC-17a
CyD-6a


167
CyC-17a
CyD-7a


168
CyC-17a
CyD-8a


169
CyC-17a
CyD-9a


170
CyC-17a
CyD-10a


171
CyC-18a
CyD-1a


172
CyC-18a
CyD-2a


173
CyC-18a
CyD-3a


174
CyC-18a
CyD-4a


175
CyC-18a
CyD-5a


176
CyC-18a
CyD-6a


177
CyC-18a
CyD-7a


178
CyC-18a
CyD-8a


179
CyC-18a
CyD-9a


180
CyC-18a
CyD-10a


181
CyC-19a
CyD-1a


182
CyC-19a
CyD-2a


183
CyC-19a
CyD-3a


184
CyC-19a
CyD-4a


185
CyC-19a
CyD-5a


186
CyC-19a
CyD-6a


187
CyC-19a
CyD-7a


188
CyC-19a
CyD-8a


189
CyC-19a
CyD-9a


190
CyC-19a
CyD-10a









If the radicals R on CyC and CyD together form a ring, the following ligand structures (L1) to (L6) then preferably arise:




embedded image


where X has the meanings given above and * indicates the position of the coordination to M.


As described above, it is essential to the invention that CyD and/or CyC or the preferred embodiments described above have two adjacent carbon atoms, each of which are substituted by radicals R, where the respective radicals R, together with the C atoms, form a bi or polycyclic structure of the formula (3) mentioned above.


In a preferred embodiment of the invention, the ligand L contains precisely one group of the formula (3). Either CyC or CyD here can have this structure. In general, the group of the formula (3) can be bonded to CyC or CyD in any possible position.


The preferred positions for adjacent groups X which stand for CR, where the respective radicals R, together with the C atoms to which they are bonded, form a ring of the above-mentioned formula (3), are in each case depicted in the following groups (CyC-1-1) to (CyC-19-1) and (CyD-1-1) to (CyD-10-1),




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


where the symbols and indices used have the meanings given above and o in each case denotes the positions which stand for CR, where the respective radicals R, together with the C atoms to which they are bonded, form a ring of the above-mentioned formula (3).


For the combinations of CyC and CyD, the groups (CyC-1-1) to (CyC-19-1) and (CyD-1-1) to (CyD-10-4) respectively in the two tables shown above are likewise preferred instead of the groups (CyC-1) to (CyC-19) and (CyD-1) to (CyD-19) shown in the tables.


Preferred positions for the bonding of the group of the formula (3) in the ligands (L1) to (L6) are depicted in the following structures (L1-1) to (L6-6):




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


where the symbols used have the meanings given above.


Preferred embodiments of the group of the formula (3) are shown below.


The group of the formula (3) is a bicyclic structure. It is essential that it contains no acidic benzylic protons. Benzylic protons are taken to mean protons which are bonded to a carbon atom which is bonded directly to the aromatic or heteroaromatic ligand. The absence of acidic benzylic protons is achieved in the structure of the formula (3) through it being a bicyclic structure whose bridgehead is bonded directly to the aromatic group of CyC or CyD. Owing to the rigid spatial arrangement, the substituent R2 which is bonded to the bridgehead if A1 or A2 stands for CR2 and R2 stands for H is significantly less acidic than benzylic protons in a non-bicyclic structure, since the corresponding anion of the bicyclic structure is not mesomerism-stabilised. Such a proton is thus a non-acidic proton in the sense of the present application.


In a preferred embodiment of the invention, A1 and A2 both stand, identically or differently, for CR2, or A1 and A2 both stand for N. A1 and A2 particularly preferably stand, identically or differently, for CR2. The bridgehead atoms are thus particularly preferably carbon.


In a preferred embodiment of the invention, the radical R2 which is bonded to the bridgehead atom is selected, identically or differently on each occurrence, from the group consisting of H, D, F, a straight-chain alkyl group having 1 to 10 C atoms, which may be substituted by one or more radicals R1, but is preferably unsubstituted, a branched or cyclic alkyl group having 3 to 10 C atoms, which may be substituted by one or more radicals R4, but is preferably unsubstituted, or an aromatic or heteroaromatic ring system having 5 to 12 aromatic ring atoms, which may in each case be substituted by one or more radicals R4. The radical R2 which is bonded to the bridgehead atom is particularly preferably selected, identically or differently on each occurrence, from the group consisting of H, F, a straight-chain alkyl group having 1 to 4 C atoms, a branched alkyl group having 3 or 4 C atoms or a phenyl group, which may be substituted by an alkyl group having 1 to 4 C atoms, but is preferably unsubstituted. The radical R2 is very particularly preferably selected on each occurrence, identically or differently, from the group consisting of H, methyl and tert-butyl.


In a further preferred embodiment, both groups A1 and A2 in formula (3) stand for CR2 and the two radicals R2 are selected identically.


In a further preferred embodiment of the invention, A3 and A4 stand, identically or differently on each occurrence, for an alkylene group having 2 or 3 carbon atoms, which may be substituted by one or more radicals R3. A3 and A4 thus preferably contain no oxygen atoms in the alkylene group.


In a preferred embodiment of the invention, the radical R3 which is bonded to A3 or A4 is selected, identically or differently on each occurrence, from the group consisting of H, D, F, a straight-chain alkyl group having 1 to 10 C atoms, which may be substituted by one or more radicals R4, but is preferably unsubstituted, a branched or cyclic alkyl group having 3 to 10 C atoms, which may be substituted by one or more radicals R4, but is preferably unsubstituted, or an aromatic or heteroaromatic ring system having 5 to 12 aromatic ring atoms, which may in each case be substituted by one or more radicals R4; two radicals R3 here may form a ring with one another and thus form a polycyclic, aliphatic ring system. Ring formation is also possible and preferred between a radical R3 which is bonded to A3 and a radical R3 which is bonded to A4. Ring formation between a radical R3 which is bonded to A3 and a radical R3 which is bonded to A4 preferably takes place by means of a single bond, oxygen, a methylene group, which may be substituted by one or two groups R4, but is preferably unsubstituted, or an ethylene group, which may be substituted by one or more groups R4, but is preferably unsubstituted. The radical R3 is particularly preferably selected, identically or differently on each occurrence, from the group consisting of H, F, a straight-chain alkyl group having 1 to 4 C atoms or a branched alkyl group having 3 or 4 C atoms; two radicals R3 here may form a ring with one another and thus form a polycyclic, aliphatic ring system.


Particularly preferably, A1 and A2 stand, identically or differently, for CR2, and A3 and A4 stand, identically or differently on each occurrence, for an alkylene group having 2 or 3 carbon atoms, which may be substituted by one or more radicals R3, where the preferred definitions given above preferably apply to R2 and R3.


In a preferred embodiment of the invention, A3 and A4 each stand for an ethylene group, which may be substituted by one or more radicals R3. In a further preferred embodiment of the invention, A3 stands for an ethylene group and A4 for a propylene group, each of which may be substituted by one or more radicals R3. In still a further embodiment of the invention, A3 and A4 each stand for a propylene group, which may be substituted by one or more radicals R3. It is thus preferably a group of the following formula (4), (5) or (6):




embedded image


where A1 and A2 have the meanings given above, and the ethylene groups or propylene groups, which are shown unsubstituted for clarity, may be substituted by one or more radicals R3, where R3 has the meanings given above. In particular, two radicals R3 which are bonded to the two different ethylene or propylene groups may also be linked to one another to form a ring system.


Preferred structures of the formulae (4), (5) and (6) are the structures of the following formulae (4a), (5a) and (6a):




embedded image


where the ethylene groups or propylene groups may be substituted by one or more radicals R3, where R3 has the meanings given above. In particular, two radicals R3 which are bonded to the two different ethylene or propylene groups may also be linked to one another to form a ring system.


Preferred structures of the formulae (4) and (6) in which two radicals R3 are linked to one another to form a ring system are the structures of the following formulae (4b) and (6b):




embedded image


where A1 and A2 have the meanings given above, the ethylene and propylene groups may be substituted by one or more radicals R3, and G1 stands for an ethylene group, which may be substituted by one or more groups R4, but is preferably unsubstituted, and G2 stands for a single bond, a methylene group or an ethylene group, each of which may be substituted by one or more groups R4, but is preferably unsubstituted, or for an oxygen atom. A1 and A2 in the formulae (4b) and (6b) preferably stand, identically or differently, for CR2.


Examples of suitable structures of the formula (4) are the following structures:




embedded image


The following two structures are particularly preferred here:




embedded image


Examples of suitable structures of the formula (5) are the following structure,




embedded image


Examples of suitable structures of the formula (6) are the following structures:




embedded image


Examples of suitable structures of the formulae (4b) and (6b) are the following structures:




embedded image


The three following structures are particularly preferred here:




embedded image


If radicals R which do not stand for a group of the formula (3) are bonded in the moiety of the formula (2), these radicals R are preferably selected on each occurrence, identically or differently, from the group consisting of H, D, F, Br, I, N(R1)2, CN, Si(R1)3, B(OR1)2, C(═O)R1, a straight-chain alkyl group having 1 to 10 C atoms or an alkenyl group having 2 to 10 C atoms or a branched or cyclic alkyl group having 3 to 10 C atoms, each of which may be substituted by one or more radicals R1, where one or more H atoms may be replaced by D or F, or an aromatic or heteroaromatic ring system having 5 to 30 aromatic ring atoms, which may in each case be substituted by one or more radicals R1; two adjacent radical R or R with R1 here may also form a mono- or polycyclic, aliphatic or aromatic ring system with one another. These radicals R are particularly preferably selected on each occurrence, identically or differently, from the group consisting of H, D, F, N(R1)2, a straight-chain alkyl group having 1 to 6 C atoms or a branched or cyclic alkyl group having 3 to 10 C atoms, where one or more H atoms may be replaced by D or F, or an aromatic or heteroaromatic ring system having 5 to 24 aromatic ring atoms, which may in each case be substituted by one or more radicals R1; two adjacent radicals R or R with R1 here may also form a mono- or polycyclic, aliphatic or aromatic ring system with one another. Furthermore, ring formation between CyC and CyD is also possible, as described above.


It is furthermore possible for the substituent R which is bonded in the ortho-position to the metal coordination to represent a coordinating group which is likewise coordinated or bonded to the metal M. Preferred coordinating groups R are aryl or heteroaryl groups, for example phenyl or pyridyl, aryl or alkyl cyanides, aryl or alkyl isocyanides, amines or amides, alcohols or alcoholates, thioalcohols or thioalcoholates, phosphines, phosphites, carbonyl functions, carboxylates, carbamides or aryl- or alkylacetylides. Examples of moieties ML of the formula (2) in which CyD stands for pyridine and CyC stands for benzene are the structures of the following formulae (7) to (18):




embedded image


embedded image


where the symbols and indices have the same meanings as described above, X1 stands, identically or differently on each occurrence, for C or N and W1 stands, identically or differently on each occurrence, for S, O or NR1.


Formulae (7) to (18) show, merely by way of example, how the substituent R can additionally coordinate to the metal. Other groups R which coordinate to the metal, for example also carbenes, are also accessible entirely analogously without further inventive step.


As described above, a bridging unit which links this ligand L to one or more further ligands L or L′ may also be present instead of one of the radicals R. In a preferred embodiment of the invention, a bridging unit is present instead of one of the radicals R, in particular instead of the radicals R which are in the ortho- or meta-position to the coordinating atom, so that the ligands have a tridentate or polydentate or polypodal character. It is also possible for two such bridging units to be present. This results in the formation of macrocyclic ligands or in the formation of cryptates.


Preferred structures containing polydentate ligands are the metal complexes of the following formulae (19) to (24),




embedded image


where the symbols and indices used have the above-mentioned meanings.


The ligands can likewise be bridged to one another via the cyclic group of the formula (3).


In the structures of the formulae (19) to (24), V preferably represents a single bond or a bridging unit containing 1 to 80 atoms from the third, fourth, fifth and/or sixth main group (IUPAC group 13, 14, 15 or 16) or a 3- to 6-membered homo- or heterocycle which covalently bonds the part-ligands L to one another or covalently bonds L to L′. The bridging unit V here may also have an asymmetrical structure, i.e. the linking of V to L and L′ need not be identical. The bridging unit V can be neutral, singly, doubly or triply negatively charged or singly, doubly or triply positively charged. V is preferably neutral or singly negatively charged or singly positively charged, particularly preferably neutral. The charge of V is preferably selected so that overall a neutral complex forms. The preferences mentioned above for the moiety MLn apply to the ligands, and n is preferably at least 2.


The precise structure and chemical composition of the group V does not have a significant effect on the electronic properties of the complex since the job of this group is essentially to increase the chemical and thermal stability of the complexes by bridging L to one another or to L′.


If V is a trivalent group, i.e. bridges three ligands L to one another or two ligands L to L′ or one ligand L to two ligands L′, V is preferably selected, identically or differently on each occurrence, from the group consisting of B, B(R1), B(C(R1)2)3, (R1)B(C(R1)2)3, B(O)3, (R1)B(O)3, B(C(R1)2C(R1)2)3, (R1)B(C(R1)2C(R1)2)3, B(C(R1)2O)3, (R1)B(C(R1)2O)3, B(OC(R1)2)3, (R1)B(OC(R1)2)3, C(R1), CO, CN(R1)2, (R1)C(C(R1)2)3, (R1)C(O)3, (R1)C(C(R1)2C(R1)2)3, (R1)C(C(R1)20)3, (R1)C(OC(R1)2)3, (R1)C(Si(R1)2)3, (R1)C(Si(R1)2C(R1)2)3, (R1)C(C(R1)2Si(R1)2)3, (R1)C(Si(R1)2Si(R1)2)3, Si(R1), (R1)Si(C(R1)2)3, (R1)Si(O)3, (R1)Si(C(R1)2C(R1)2)3, (R1)Si(OC(R1)2)3, (R1)Si(C(R1)2O)3, (R1)Si(Si(R1)2)3, (R1)Si(Si(R1)2C(R1)2)3, (R1)Si(C(R1)2Si(R1)2)3, (R1)Si(Si(R1)2Si(R1)2)3, N, NO, N(R1)+, N(C(R1)2)3, (R1)N(C(R1)2)3+, N(C═O)3, N(C(R1)2C(R1)2)3, (R1)N(C(R1)2C(R1)2)+, P, P(R1)+, PO, PS, P(O)3, PO(O)3, P(OC(R1)2)3, PO(OC(R1)2)3, P(C(R1)2)3, P(R1)(C(R1)2)3*, PO(C(R1)2)3, P(C(R1)2C(R1)2)3, P(R1) (C(R1)2C(R1)2)3+, PO(C(R1)2C(R1)2)3, S+, S(C(R1)2)3+, S(C(R1)2C(R1)2)3+,


or a unit of the formulae (25) to (29),




embedded image


where the dashed bonds in each case indicate the bond to the part-ligands L or L′, and Z is selected, identically or differently on each occurrence, from the group consisting of a single bond, O, S, S(═O), S(═O)2, NR1, PR1, P(═O)R1, C(R1)2, C(═O), C(═NR1), C(═C(R1)2), Si(R1)2 or BR1. The other symbols used have the meanings given above.


If V stands for a group CR2, the two radicals R may also be linked to one another, and consequently structures such as, for example, 9,9-fluorene, are also suitable groups V.


If V is a divalent group, i.e. bridges two ligands L to one another or one ligand L to L′, V is preferably selected, identically or differently on each occurrence, from the group consisting of aus BR1, B(R1)2, C(R1)2, C(═O), Si(R1)2, NR1, PR1, P(R1)2, P(═O)(R1), P(═S)(R1), O, S, Se, or a unit of the formulae (30) to (39),




embedded image


embedded image


where the dashed bonds in each case indicate the bond to the part-ligands L or L′, Y stands on each occurrence, identically or differently, for C(R1)2, N(R1), O or S, and the other symbols used each have the meanings indicated above.


Preferred ligands L′ as occur in formula (1) are described below. The ligand groups L′ can also be selected correspondingly if they are bonded to L via a bridging unit V, as indicated in formulae (19), (21) and (23).


The ligands L′ are preferably neutral, monoanionic, dianionic or trianionic ligands, particularly preferably neutral or monoanionic ligands. They can be monodentate, bidentate, tridentate or tetradentate and are preferably bidentate, i.e. preferably have two coordination sites. As described above, the ligands L′ can also be bonded to L via a bridging group V.


Preferred neutral, monodentate ligands L′ are selected from the group consisting of carbon monoxide, nitrogen monoxide, alkyl cyanides, such as, for example, acetonitrile, aryl cyanides, such as, for example, benzonitrile, alkyl isocyanides, such as, for example, methyl isonitrile, aryl isocyanides, such as, for example, benzoisonitrile, amines, such as, for example, tri-methylamine, triethylamine, morpholine, phosphines, in particular halo-phosphines, trialkylphosphines, triarylphosphines or alkylarylphosphines, such as, for example, trifluorophosphine, trimethylphosphine, tricyclohexylphosphine, tri-tert-butylphosphine, triphenylphosphine, tris(pentafluoro-phenyl)phosphine, dimethylphenylphosphine, methyldiphenylphosphine, bis(tert-butyl)phenylphosphine, phosphites, such as, for example, trimethyl phosphite, triethyl phosphite, arsines, such as, for example, trifluoroarsine, trimethylarsine, tricyclohexylarsine, tri-tert-butylarsine, triphenylarsine, tris(pentafluorophenyl)arsine, stibines, such as, for example, trifluoro-stibine, trimethylstibine, tricyclohexylstibine, tri-tert-butylstibine, triphenyl-stibine, tris(pentafluorophenyl)stibine, nitrogen-containing heterocycles, such as, for example, pyridine, pyridazine, pyrazine, pyrimidine, triazine, and carbenes, in particular Arduengo carbenes.


Preferred monoanionic, monodentate ligands L′ are selected from hydride, deuteride, the halides F, Cl, Br and I, alkylacetylides, such as, for example, methyl-C≡C, tert-butyl-C≡C, arylacetylides, such as, for example, phenyl-C≡C, cyanide, cyanate, isocyanate, thiocyanate, isothiocyanate, aliphatic or aromatic alcoholates, such as, for example, methanolate, ethanolate, propanolate, isopropanolate, tert-butylate, phenolate, aliphatic or aromatic thioalcoholates, such as, for example, methanethiolate, ethane-thiolate, propanethiolate, isopropanethiolate, tert-thiobutylate, thiophenolate, amides, such as, for example, dimethylamide, diethylamide, diiso-propylamide, morpholide, carboxylates, such as, for example, acetate, trifluoroacetate, propionate, benzoate, aryl groups, such as, for example, phenyl, naphthyl, and anionic, nitrogen-containing heterocycles, such as pyrrolide, imidazolide, pyrazolide. The alkyl groups in these groups are preferably C1-C20-alkyl groups, particularly preferably C1-C10-alkyl groups, very particularly preferably C1-C4-alkyl groups. An aryl group is also taken to mean heteroaryl groups. These groups are as defined above.


Preferred di- or trianionic ligands are O2−, S2−, carbides, which result in coordination in the form R—C≡M, and nitrenes, which result in coordination in the form R—N=M, where R generally stands for a substituent, or N3−.


Preferred neutral or mono- or dianionic, bidentate or polydentate ligands L′ are selected from diamines, such as, for example, ethylenediamine, N,N,N′,N′-tetramethylethylenediamine, propylenediamine, N,N,N′,N′-tetra-methylpropylenediamine, cis- or trans-diaminocyclohexane, cis- or trans-N,N,N′,N′-tetramethyldiaminocyclohexane, imines, such as, for example, 2-[1-(phenylimino)ethyl]pyridine, 2-[1-(2-methylphenylimino)ethyl]pyridine, 2-[1-(2,6-diisopropylphenylimino)ethyl]pyridine, 2-[1-(methylimino)ethyl]-pyridine, 2-[1-(ethylimino)ethyl]pyridine, 2-[1-(isopropylimino)ethyl]pyridine, 2-[1-(tert-butylimino)ethyl]pyridine, diimines, such as, for example, 1,2-bis-(methylimino)ethane, 1,2-bis(ethylimino)ethane, 1,2-bis(isopropylimino)-ethane, 1,2-bis(tert-butylimino)ethane, 2,3-bis(methylimino)butane, 2,3-bis-(ethylimino)butane, 2,3-bis(isopropylimino)butane, 2,3-bis(tert-butylimino)-butane, 1,2-bis(phenylimino)ethane, 1,2-bis(2-methylphenylimino)ethane, 1,2-bis(2,6-diisopropylphenylimino)ethane, 1,2-bis(2,6-di-tert-butylphenyl-imino)ethane, 2,3-bis(phenylimino)butane, 2,3-bis(2-methylphenylimino)-butane, 2,3-bis(2,6-diisopropylphenylimino)butane, 2,3-bis(2,6-di-tert-butyl-phenylimino)butane, heterocycles containing two nitrogen atoms, such as, for example, 2,2′-bipyridine, o-phenanthroline, diphosphines, such as, for example, bis(diphenylphosphino)methane, bis(diphenylphosphino)ethane, bis(diphenylphosphino)propane, bis(diphenylphosphino)butane, bis-(dimethylphosphino)methane, bis(dimethylphosphino)ethane, bis(dimethyl-phosphino)propane, bis(diethylphosphino)methane, bis(diethylphosphino)-ethane, bis(diethylphosphino)propane, bis(di-tert-butylphosphino)methane, bis(di-tert-butylphosphino)ethane, bis(tert-butylphosphino)propane, 1,3-diketonates derived from 1,3-diketones, such as, for example, acetyl-acetone, benzoylacetone, 1,5-diphenylacetylacetone, dibenzoylmethane, bis(1,1,1-trifluoroacetyl)methane, 3-ketonates derived from 3-ketoesters, such as, for example, ethyl acetoacetate, carboxylates derived from aminocarboxylic acids, such as, for example, pyridine-2-carboxylic acid, quinoline-2-carboxylic acid, glycine, N,N-dimethylglycine, alanine, N,N-dimethylaminoalanine, salicyliminates derived from salicylimines, such as, for example, methylsalicylimine, ethylsalicylimine, phenylsalicylimine, dialcoholates derived from dialcohols, such as, for example, ethylene glycol, 1,3-propylene glycol, and dithiolates derived from dithiols, such as, for example, 1,2-ethylenedithiol, 1,3-propylenedithiol, bis(pyrazolyl) borates, bis(imidazolyl) borates, 3-(2-pyridyl)diazoles or 3-(2-pyridyl)triazoles.


Preferred tridentate ligands are borates of nitrogen-containing heterocycles, such as, for example, tetrakis(1-imidazolyl) borate and tetrakis-(1-pyrazolyl) borate.


Preference is furthermore given to bidentate monoanionic, neutral or dianionic ligands L′, in particular monoanionic ligands, which, with the metal, form a cyclometallated five- or six-membered ring with at least one metal-carbon bond, in particular a cyclometallated five-membered ring. These are, in particular, ligands as are generally used in the area of phosphorescent metal complexes for organic electroluminescent devices, i.e. ligands of the type phenylpyridine, naphthylpyridine, phenylquinoline, phenylisoquinoline, etc., each of which may be substituted by one or more radicals R. A multiplicity of ligands of this type is known to the person skilled in the art in the area of phosphorescent electroluminescent devices, and he will be able, without inventive step, to select further ligands of this type as ligand L′ for compounds of the formula (1). The combination of two groups as depicted by the following formulae (40) to (64) is generally particularly suitable for this purpose, where one group is preferably bonded via a neutral nitrogen atom or a carbene carbon atom and the other group is preferably bonded via a negatively charged carbon atom or a negatively charged nitrogen atom. The ligand L′ can then be formed from the groups of the formulae (40) to (64) through these groups bonding to one another in each case at the position denoted by #. The position at which the groups coordinate to the metal is denoted by *. These groups may also be bonded to the ligand L via one or two bridging units V.




embedded image


embedded image


embedded image


W here has the meaning given above and X stands on each occurrence, identically or differently, for CR or N, where the above-mentioned limitation, that at least two adjacent groups X stand for CR and the radicals R form a ring of the formula (3), does not apply here; and R has the same meaning as described above. Preferably, a maximum of three symbols X in each group stand for N, particularly preferably a maximum of two symbols X in each group stand for N, very particularly preferably a maximum of one symbol X in each group stands for N. Especially preferably, all symbols X stand for CR.


Likewise preferred ligands L are η5-cyclopentadienyl, η5-pentamethyl-cyclopentadienyl, η6-benzene or η7-cycloheptatrienyl, each of which may be substituted by one or more radicals R.


Likewise preferred ligands L′ are 1,3,5-cis,cis-cyclohexane derivatives, in particular of the formula (65), 1,1,1-tri(methylene)methane derivatives, in particular of the formula (66), and 1,1,1-trisubstituted methanes, in particular of the formula (67) and (68),




embedded image


where the coordination to the metal M is shown in each of the formulae, R has the meaning given above, and A stands, identically or differently on each occurrence, for O, S, COO, PR2 or NR2.


Preferred radicals R in the structures shown above are selected on each occurrence, identically or differently, from the group consisting of H, D, F, Br, N(R1)2, CN, B(OR1)2, C(═O)R1, P(═O)(R1)2, a straight-chain alkyl group having 1 to 10 C atoms or a straight-chain alkenyl or alkynyl group having 2 to 10 C atoms or a branched or cyclic alkyl group having 3 to 10 C atoms, each of which may be substituted by one or more radicals R1, where one or more H atoms may be replaced by D or F, or an aromatic or heteroaromatic ring system having 5 to 14 aromatic ring atoms, which may in each case be substituted by one or more radicals R1; two or more adjacent radicals R here may also form a mono- or polycyclic, aliphatic, aromatic and/or benzo-fused ring system with one another. Particularly preferred radicals R are selected on each occurrence, identically or differently, from the group consisting of H, D, F, Br, CN, B(OR1)2, a straight-chain alkyl group having 1 to 5 C atoms, in particular methyl, or a branched or cyclic alkyl group having 3 to 5 C atoms, in particular isopropyl or tert-butyl, where one or more H atoms may be replaced by D or F, or an aromatic or heteroaromatic ring system having 5 to 12 aromatic ring atoms, which may in each case be substituted by one or more radicals R1; two or more radicals R here may also form a mono- or polycyclic, aliphatic, aromatic and/or benzo-fused ring system with one another.


In a preferred embodiment of the invention, L′ is coordinated to M via one or more aromatic or heteroaromatic groups, but is not coordinated via non-aromatic and non-heteroaromatic groups.


The complexes according to the invention can be facial or pseudofacial or they can be meridional or pseudomeridional.


The ligands L may also be chiral, depending on the structure. This is the case, for example, if the groups A3 and A4 in the structure of the formula (3) are different or if they contain substituents, for example alkyl, alkoxy, dialkylamino or aralkyl groups, which have one or more stereocentres. Since the basic structure of the complex may also be a chiral structure, the formation of diastereomers and a number of enantiomer pairs is possible. The complexes according to the invention then encompass both the mixtures of the various diastereomers or the corresponding racemates and also the individual isolated diastereomers or enantiomers.


The compounds can also be employed as chiral, enantiomerically pure complexes, which are able to emit circular-polarised light. This may have advantages, since it makes the polarisation filter on the device superfluous. In addition, complexes of this type are also suitable for use in safety labels, since, besides the emission, they also have the polarisation of the light as readily legible feature.


The preferred embodiments indicated above can be combined with one another as desired. In a particularly preferred embodiment of the invention, the preferred embodiments indicated above apply simultaneously.


The metal complexes according to the invention can in principle be prepared by various processes. However, the processes described below have proven particularly suitable.


The present invention therefore furthermore relates to a process for the preparation of the metal complex compounds of the formula (1) by reaction of the corresponding free ligands L and optionally L′ with metal alkoxides of the formula (69), with metal ketoketonates of the formula (70), with metal halides of the formula (71) or with dimeric metal complexes of the formula (72) or with metal complexes of the formula (73),




embedded image


where the symbols M, m, n and R have the meanings indicated above, Hal=F, Cl, Br or I, L″ stands for an alcohol, in particular for an alcohol having 1 to 4 C atoms, or a nitrile, in particular acetonitrile or benzonitrile, and (anion) stands for a non-coordinating anion, such as, for example, triflate


It is likewise possible to use metal compounds, in particular iridium compounds, which carry both alkoxide and/or halide and/or hydroxyl radicals as well as ketoketonate radicals. These compounds may also be charged. Corresponding iridium compounds which are particularly suitable as starting materials are disclosed in WO 2004/085449. [IrCl2(acac)2], for exam-pie Na[IrCl2(acac)2], are particularly suitable. Metal complexes with acetyl-acetonate derivatives as ligand, for example Ir(acac)3 or tris(2,2,6,6-tetra-methylheptane-3,5-dionato)iridium, and IrCl3.xH2O, where x usually stands for a number between 2 and 4.


Suitable platinum starting materials are, for example, PtCl2, K2[PtCl4], PtCl2(DMSO)2, Pt(Me)2(DMSO)2 or PtCl2(benzonitrile)2.


The synthesis of the complexes is preferably carried out as described in WO 2002/060910, WO 2004/085449 and WO 2007/065523. Heteroleptic complexes can also be synthesised, for example, in accordance with WO 2005/042548. The synthesis here can also be activated, for example, thermally, photochemically and/or by microwave radiation. In order to activate the reaction, it is furthermore also possible to add a Lewis acid, for example a silver salt or AlCl3.


The reactions can be carried out without addition of solvents or melting aids in a melt of the corresponding ligands to be o-metallated. If necessary, solvents or melting aids can be added. Suitable solvents are protic or aprotic solvents, such as aliphatic and/or aromatic alcohols (methanol, ethanol, isopropanol, t-butanol, etc.), oligo- and polyalcohols (ethylene glycol, 1,2-propanediol, glycerol, etc.), alcohol ethers (ethoxyethanol, diethylene glycol, triethylene glycol, polyethylene glycol, etc.), ethers (di- and triethylene glycol dimethyl ether, diphenyl ether, etc.), aromatic, heteroaromatic and/or aliphatic hydrocarbons (toluene, xylene, mesitylene, chlorobenzene, pyridine, lutidine, quinoline, isoquinoline, tridecane, hexa-decane, etc.), amides (DMF, DMAC, etc.), lactams (NMP), sulfoxides (DMSO) or sulfones (dimethyl sulfone, sulfolane, etc.). Suitable melting aids are compounds which are in solid form at room temperature, but melt on warming of the reaction mixture and dissolve the reactants, so that a homogeneous melt forms. Particularly suitable are biphenyl, m-terphenyl, triphenylene, 1,2-, 1,3-, 1,4-bisphenoxybenzene, triphenylphosphine oxide, 18-crown-6, phenol, 1-naphthol, hydroquinone, etc.


These processes, optionally followed by purification, such as, for example, recrystallisation or sublimation, enable the compounds of the formula (1) according to the invention to be obtained in high purity, preferably greater than 99% (determined by means of 1H-NMR and/or HPLC).


The compounds according to the invention can also be rendered soluble by suitable substitution, for example by relatively long alkyl groups (about 4 to 20 C atoms), in particular branched alkyl groups, or optionally substituted aryl groups, for example, xylyl, mesityl or branched terphenyl or quaterphenyl groups. Compounds of this type are then soluble in common organic solvents, such as, for example, toluene or xylene, at room temperature in sufficient concentration to be able to process the complexes from solution. These soluble compounds are particularly suitable for processing from solution, for example by printing processes.


The compounds according to the invention can also be mixed with a polymer. It is likewise possible to incorporate these compounds covalently into a polymer. This is possible, in particular, with compounds which are substituted by reactive leaving groups, such as bromine, iodine, chlorine, boronic acid or boronic acid ester, or by reactive, polymerisable groups, such as olefins or oxetanes. These can be used as monomers for the production of corresponding oligomers, dendrimers or polymers. The oligomerisation or polymerisation here preferably takes place via the halogen functionality or the boronic acid functionality or via the polymerisable group. It is furthermore possible to crosslink the polymers via groups of this type. The compounds and polymers according to the invention can be employed as crosslinked or uncrosslinked layer.


The invention therefore furthermore relates to oligomers, polymers or dendrimers containing one or more of the above-mentioned compounds according to the invention, where one or more bonds are present from the compound according to the invention to the polymer, oligomer or dendrimer. Depending on the linking of the compound according to the invention, this therefore forms a side chain of the oligomer or polymer or is linked in the main chain. The polymers, oligomers or dendrimers may be conjugated, partially conjugated or non-conjugated. The oligomers or polymers may be linear, branched or dendritic. The same preferences as described above apply to the recurring units of the compounds according to the invention in oligomers, dendrimers and polymers.


For the preparation of the oligomers or polymers, the monomers according to the invention are homopolymerised or copolymerised with further monomers. Preference is given to copolymers, where the units of the formula (1) or the preferred embodiments described above are present in amounts of 0.01 to 99.9 mol %, preferably 5 to 90 mol %, particularly preferably 20 to 80 mol %. Suitable and preferred comonomers which form the polymer backbone are selected from fluorenes (for example in accordance with EP 842208 or WO 2000/022026), spirobifluorenes (for example in accordance with EP 707020, EP 894107 or WO 2006/061181), paraphenylenes (for example in accordance with WO 92/18552), carbazoles (for example in accordance with WO 2004/070772 or WO 2004/113468), thiophenes (for example in accordance with EP 1028136), dihydrophenanthrenes (for example in accordance with WO 2005/014689), cis- and trans-indeno-fluorenes (for example in accordance with WO 2004/041901 or WO 2004/113412), ketones (for example in accordance with WO 2005/040302), phenanthrenes (for example in accordance with WO 2005/104264 or WO 2007/017066) or also a plurality of these units. The polymers, oligomers and dendrimers may also contain further units, for example hole-transport units, in particular those based on triarylamines, and/or electron-transport units.


The present invention again furthermore relates to a formulation comprising a compound according to the invention or an oligomer, polymer or dendrimer according to the invention and at least one further compound. The further compound can be, for example, a solvent. However, the further compound can also be a further organic or inorganic compound which is likewise employed in the electronic device, for example a matrix material. This further compound may also be polymeric.


Formulations of the compounds according to the invention are necessary for processing of the compounds according to the invention from the liquid phase, for example by spin coating or by printing processes. These formulations can be, for example, solutions, dispersions or emulsions. It may be preferred to use mixtures of two or more solvents for this purpose. Suitable and preferred solvents are, for example, toluene, anisole, o-, m- or p-xylene, methyl benzoate, mesitylene, tetralin, veratrol, THF, methyl-THF, THP, chlorobenzene, dioxane, phenoxytoluene, in particular 3-phenoxytoluene, (−)-fenchone, 1,2,3,5-tetramethylbenzene, 1,2,4,5-tetramethylbenzene, 1-methylnaphthalene, 2-methylbenzothiazole, 2-phenoxyethanol, 2-pyrrolidinone, 3-methylanisole, 4-methylanisole, 3,4-dimethylanisole, 3,5-dimethylanisole, acetophenone, α-terpineol, benzothiazole, butyl benzoate, cumene, cyclohexanol, cyclohexanone, cyclohexylbenzene, decalin, dodecylbenzene, ethyl benzoate, indane, methyl benzoate, NMP, p-cymene, phenetole, 1,4-diisopropylbenzene, dibenzyl ether, diethylene glycol butyl methyl ether, triethylene glycol butyl methyl ether, diethylene glycol dibutyl ether, triethylene glycol dimethyl ether, diethylene glycol monobutyl ether, tripropylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, 2-isopropylnaphthalene, pentylbenzene, hexylbenzene, heptylbenzene, octylbenzene, 1,1-bis(3,4-dimethylphenyl)ethane or mixtures of these solvents.


The complexes of the formula (1) described above or the preferred embodiments indicated above can be used as active component in the electronic device. An electronic device is taken to mean a device which comprises an anode, a cathode and at least one layer, where this layer comprises at least one organic or organometallic compound. The electronic device according to the invention thus comprises an anode, a cathode and at least one layer which comprises at least one compound of the formula (1) given above. Preferred electronic devices here are selected from the group consisting of organic electroluminescent devices (OLEDs, PLEDs), organic integrated circuits (O-ICs), organic field-effect transistors (O-FETs), organic thin-film transistors (O-TFTs), organic light-emitting transistors (O-LETs), organic solar cells (O-SCs), organic optical detectors, organic photoreceptors, organic field-quench devices (O-FQDs), light-emitting electrochemical cells (LECs) or organic laser diodes (O-lasers), comprising at least one compound of the formula (1) given above in at least one layer. Particular preference is given to organic electroluminescent devices. Active components are generally the organic or inorganic materials which have been introduced between the anode and cathode, for example charge-injection, charge-transport or charge-blocking materials, but in particular emission materials and matrix materials. The compounds according to the invention exhibit particularly good properties as emission material in organic electroluminescent devices. Organic electroluminescent devices are therefore a preferred embodiment of the invention. Furthermore, the compounds according to the invention can be employed for the generation of singlet oxygen or in photocatalysis.


The organic electroluminescent device comprises a cathode, an anode and at least one emitting layer. Apart from these layers, it may also comprise further layers, for example in each case one or more hole-injection layers, hole-transport layers, hole-blocking layers, electron-transport layers, electron-injection layers, exciton-blocking layers, electron-blocking layers, charge-generation layers and/or organic or inorganic p/n junctions. It is possible here for one or more hole-transport layers to be p-doped, for example with metal oxides, such as MoO3 or WO3, or with (per)fluorinated electron-deficient aromatic compounds, and/or for one or more electron-transport layers to be n-doped. Interlayers which have, for example, an exciton-blocking function and/or control the charge balance in the electroluminescent device may likewise be introduced between two emitting layers. However, it should be pointed out that each of these layers does not necessarily have to be present.


The organic electroluminescent device here may comprise one emitting layer or a plurality of emitting layers. If a plurality of emission layers are present, these preferably have in total a plurality of emission maxima between 380 nm and 750 nm, resulting overall in white emission, i.e. various emitting compounds which are able to fluoresce or phosphoresce are used in the emitting layers. Particular preference is given to three-layer systems, where the three layers exhibit blue, green and orange or red emission (for the basic structure see, for example, WO 2005/011013), or systems which have more than three emitting layers. It may also be a hybrid system, where one or more layers fluoresce and one or more other layers phosphoresce.


In a preferred embodiment of the invention, the organic electroluminescent device comprises the compound of the formula (1) or the preferred embodiments indicated above as emitting compound in one or more emitting layers.


If the compound of the formula (1) is employed as emitting compound in an emitting layer, it is preferably employed in combination with one or more matrix materials. The mixture comprising the compound of the formula (1) and the matrix material comprises between 1 and 99% by vol., preferably between 2 and 90% by vol., particularly preferably between 3 and 40% by vol., especially between 5 and 15% by vol., of the compound of the formula (1), based on the mixture as a whole comprising emitter and matrix material. Correspondingly, the mixture comprises between 99.9 and 1% by vol., preferably between 99 and 10% by vol., particularly preferably between 97 and 60% by vol., in particular between 95 and 85% by vol., of the matrix material, based on the mixture as a whole comprising emitter and matrix material.


The matrix material employed can in general be all materials which are known for this purpose in accordance with the prior art. The triplet level of the matrix material is preferably higher than the triplet level of the emitter.


Suitable matrix materials for the compounds according to the invention are ketones, phosphine oxides, sulfoxides and sulfones, for example in accordance with WO 2004/013080, WO 2004/093207, WO 2006/005627 or WO 2010/006680, triarylamines, carbazole derivatives, for example CBP (N,N-biscarbazolylbiphenyl), m-CBP or the carbazole derivatives disclosed in WO 2005/039246, US 2005/0069729, JP 2004/288381, EP 1205527, WO 2008/086851 or US 2009/0134784, indolocarbazole derivatives, for example in accordance with WO 2007/063754 or WO 2008/056746, indenocarbazole derivatives, for example in accordance with WO 2010/136109 or WO 2011/000455, azacarbazoles, for example in accordance with EP 1617710, EP 1617711, EP 1731584, JP 2005/347160, bipolar matrix materials, for example in accordance with WO 2007/137725, silanes, for example in accordance with WO 2005/111172, azaboroles or boronic esters, for example in accordance with WO 2006/117052, diazasilole derivatives, for example in accordance with WO 2010/054729, diazaphosphole derivatives, for example in accordance with WO 2010/054730, triazine derivatives, for example in accordance with WO 2010/015306, WO 2007/063754 or WO 2008/056746, zinc complexes, for example in accordance with EP 652273 or WO 2009/062578, dibenzofuran derivatives, for example in accordance with WO 2009/148015, or bridged carbazole derivatives, for example in accordance with US 2009/0136779, WO 2010/050778, WO 2011/042107 or WO 2011/088877.


It may also be preferred to employ a plurality of different matrix materials as a mixture, in particular at least one electron-conducting matrix material and at least one hole-conducting matrix material. A preferred combination is, for example, the use of an aromatic ketone, a triazine derivative or a phosphine oxide derivative with a triarylamine derivative or a carbazole derivative as mixed matrix for the metal complex according to the invention. Preference is likewise given to the use of a mixture of a charge-transporting matrix material and an electrically inert matrix material which is not involved or not essentially involved in charge transport, as described, for example, in WO 2010/108579.


It is furthermore preferred to employ a mixture of two or more triplet emitters together with a matrix. The triplet emitter having the shorter-wave emission spectrum serves as co-matrix for the triplet-emitter having the longer-wave emission spectrum. Thus, for example, the complexes of the formula (1) according to the invention can be employed as co-matrix for triplet emitters emitting at longer wavelength, for example for green- or red-emitting triplet emitters.


The compounds according to the invention can also be employed in other functions in the electronic device, for example as hole-transport material in a hole-injection or -transport layer, as charge-generation material or as electron-blocking material. The complexes according to the invention can likewise be employed as matrix material for other phosphorescent metal complexes in an emitting layer.


The cathode preferably comprises metals having a low work function, metal alloys or multilayered structures comprising various metals, such as, for example, alkaline-earth metals, alkali metals, main-group metals or lanthanoids (for example Ca, Ba, Mg, Al, In, Mg, Yb, Sm, etc.). Also suitable are alloys comprising an alkali metal or alkaline-earth metal and silver, for example an alloy comprising magnesium and silver. In the case of multilayered structures, further metals which have a relatively high work function, such as, for example, Ag, may also be used in addition to the said metals, in which case combinations of the metals, such as, for example, Mg/Ag, Ca/Ag or Ba/Ag, are generally used. It may also be preferred to introduce a thin interlayer of a material having a high dielectric constant between a metallic cathode and the organic semiconductor. Suitable for this purpose are, for example, alkali metal or alkaline-earth metal fluorides, but also the corresponding oxides or carbonates (for example LiF, Li2O, BaF2, MgO, NaF, CsF, Cs2CO3, etc.). Organic alkali-metal complexes, for example Liq (lithium quinolinate), are likewise suitable for this purpose. The layer thickness of this layer is preferably between 0.5 and 5 nm.


The anode preferably comprises materials having a high work function. The anode preferably has a work function of greater than 4.5 eV vs. vacuum. Suitable for this purpose are on the one hand metals having a high redox potential, such as, for example, Ag, Pt or Au. On the other hand, metal/metal oxide electrodes (for example Al/Ni/NiOx, Al/PtOx) may also be preferred. For some applications, at least one of the electrodes must be transparent or partially transparent in order either to facilitate irradiation of the organic material (O-SCs) or the coupling-out of light (OLEDs/PLEDs, O-LASERs). Preferred anode materials here are conductive mixed metal oxides. Particular preference is given to indium tin oxide (ITO) or indium zinc oxide (IZO). Preference is furthermore given to conductive, doped organic materials, in particular conductive doped polymers, for example PEDOT, PANI or derivatives of these polymers. It is furthermore preferred for a p-doped hole-transport material to be applied to the anode as hole-injection layer, where suitable p-dopants are metal oxides, for example MoO3 or WO3, or (per)fluorinated electron-deficient aromatic compounds. Further suitable p-dopants are HAT-CN (hexacyanohexaazatriphenylene) or the compound NPD9 from Novaled. A layer of this type simplifies hole injection in materials having a low HOMO, i.e. a large value of the HOMO.


All materials as are used in accordance with the prior art for the layers can generally be used in the further layers, and the person skilled in the art will be able to combine each of these materials with the materials according to the invention in an electronic device without inventive step.


The device is correspondingly structured (depending on the application), provided with contacts and finally hermetically sealed, since the lifetime of such devices is drastically shortened in the presence of water and/or air.


Preference is furthermore given to an organic electroluminescent device, characterised in that one or more layers are applied by means of a sublimation process, in which the materials are vapour-deposited in vacuum sublimation units at an initial pressure of usually less than 10−5 mbar, preferably less than 100 mbar. It is also possible for the initial pressure to be even lower or even higher, for example less than 10−7 mbar.


Preference is likewise given to an organic electroluminescent device, characterised in that one or more layers are applied by means of the OVPD (organic vapour phase deposition) process or with the aid of carrier-gas sublimation, in which the materials are applied at a pressure of between 105 mbar and 1 bar. A special case of this process is the OVJP (organic vapour jet printing) process, in which the materials are applied directly through a nozzle and thus structured (for example M. S. Arnold et al., Appl. Phys. Lett. 2008, 92, 053301).


Preference is furthermore given to an organic electroluminescent device, characterised in that one or more layers are produced from solution, such as, for example, by spin coating, or by means of any desired printing process, such as, for example, screen printing, flexographic printing, offset printing or nozzle printing, but particularly preferably LITI (light induced thermal imaging, thermal transfer printing) or ink-jet printing. Soluble compounds are necessary for this purpose, which are obtained, for example, through suitable substitution.


The organic electroluminescent device may also be produced as a hybrid system by applying one or more layers from solution and applying one or more other layers by vapour deposition. Thus, for example, it is possible to apply an emitting layer comprising a compound of the formula (1) and a matrix material from solution and to apply a hole-blocking layer and/or an electron-transport layer on top by vacuum vapour deposition.


These processes are generally known to the person skilled in the art and can be applied by him without problems to organic electroluminescent devices comprising compounds of the formula (1) or the preferred embodiments indicated above.


The electronic devices according to the invention, in particular organic electroluminescent devices, are distinguished over the prior art by one or more of the following surprising advantages:

  • 1. Organic electroluminescent devices comprising compounds according to the invention as emitting materials have a very long lifetime.
  • 2. Organic electroluminescent devices comprising compounds according to the invention as emitting materials have excellent efficiency. In particular, the efficiency is significantly higher compared with analogous compounds which do not contain a structural unit of the formula (3).
  • 3. The metal complexes according to the invention have excellent solubility in a multiplicity of organic solvents, in particular in organic hydrocarbons. The solubility here is significantly improved compared with analogous compounds which do not contain a structural unit of the formula (3). This results in simplified purification during the synthesis of the complexes and in excellent suitability thereof for the production of OLEDs in solution-processed processes, for example printing processes.
  • 4. The metal complexes according to the invention have very high oxidation stability in air and light, enabling them to be processed from solution, for example by printing processes, even in air.
  • 5. Some of the metal complexes according to the invention have a very narrow emission spectrum, which results in high colour purity of the emission, as desired, in particular, for display applications.
  • 6. The metal complexes according to the invention have reduced aggregation compared with analogous compounds which do not contain a structural unit of the formula (3). This is evident from a lower sublimation temperature compared with analogous complexes which do not contain a structural unit of the formula (3).


These advantages mentioned above are not accompanied by an impairment of the other electronic properties.


The invention is explained in greater detail by the following examples, without wishing to restrict it thereby. The person skilled in the art will be able to produce further electronic devices on the basis of the descriptions without inventive step and will thus be able to carry out the invention throughout the range claimed.





DESCRIPTION OF THE FIGURES


FIG. 1 shows the photoluminescence spectrum of a tris(benzo[h]quinoline)iridium complex which contains a group of the formula (3), compared with the spectrum of the corresponding complex without the group of the formula (3). The spectra were measured in an approx. 10−5 molar solution in degassed toluene at room temperature. The narrower emission band having a full width at half maximum (FWHM) value of 68 nm compared with 81 nm in the case of the compound without a group of the formula (3) is clearly evident.





EXAMPLES

The following syntheses are carried out, unless indicated otherwise, in dried solvents under a protective-gas atmosphere. The metal complexes are additionally handled with exclusion of light or under yellow light. The solvents and reagents can be purchased, for example, from Sigma-ALDRICH or ABCR. The respective numbers in square brackets or the numbers indicated for individual compounds relate to the CAS numbers of the compounds known from the literature.


A: Synthesis of the Synthones S and SB
Example S1
1,1,2,2,3,3-Hexamethylindane-d18, S1



embedded image


Preparation analogous to J. Baran, et al., J. Org. Chem. 1988, 53, 19, 4626.


18.7 ml (170 mmol) of titanium tetrachloride are added dropwise with vigorous stirring to a mixture, cooled to −78° C., of 160.7 g (1 mol) of 2-chloro-2-phenylpropane-d6 [53102-26-4], 230.8 g (2.4 mol) of 2,3-dimethylbut-2-ene-d12 [69165-86-2] and 2500 ml of anhydrous dichloromethane, and the mixture is stirred for a further 2 h. The cold reaction mixture is poured into 1500 ml of 3 N hydrochloric acid with vigorous stirring, stirred for a further 20 min., the organic phase is separated off, washed twice with 1000 ml of water each time, once with 500 ml of saturated sodium carbonate solution, once with 500 ml of saturated sodium chloride solution, dried over magnesium sulfate, the desiccant is filtered off, the filtrate is freed from dichloromethane in vacuo, and the residue is subjected to fractional distillation (core fraction 60-65° C., about 0.5 mbar). Yield: 163.1 g (740 mmol), 74%; purity: about 95% according to NMR.


The following compounds can be prepared analogously:















Ex.
Starting materials
Product
Yield







S2


embedded image




embedded image


68%






1716-38-7/563-79-1
S2






S3


embedded image




embedded image


49%






934-53-2/563-79-1
S3




Use of 4.4 mol





of 2,3-dimethylbut-2-ene









Example S4
Pinacolyl 1,1,3,3-tetramethylindane-5-boronate, S4
Variant 1



embedded image


A) 5-Bromo-1,1,3,3-tetramethylindane [169695-24-3], S4-Br



embedded image


0.6 g of anhydrous iron(III) chloride and then, dropwise with exclusion of light, a mixture of 25.6 ml (500 mol) of bromine and 300 ml of dichloromethane are added to a solution, cooled to 0° C., of 87.2 g (500 mmol) of 1,1,3,3-tetramethylindane [4834-33-7] in 1000 ml of dichloromethane at such a rate that the temperature does not exceed +5° C. The reaction mixture is stirred at room temperature for a further 16 h, 300 ml of saturated sodium sulfite solution are then slowly added, the aqueous phase is separated off, the organic phase is washed three times with 1000 ml of water each time, dried over sodium sulfate, filtered through a short silica-gel column, and the solvent is then stripped off. Finally, the solid is recrystallised once from a little (about 100-150 ml) ethanol. Yield: 121.5 g (480 mmol), 96%; purity: about 95% according to 1H-NMR.


B) Pinacolyl 1,1,3,3-tetramethylindane-5-boronate, S4

A mixture of 25.3 g (100 mmol) of S4-Br, 25.4 g (120 mmol) of bis(pinacolato)diborane [73183-34-3], 29.5 g (300 mmol) of potassium acetate, anhydrous, 561 mg (2 mmol) of tricyclohexylphosphine and 249 mg (1 mmol) of palladium(II) acetate and 400 ml of dioxane is stirred at 80° C. for 16 h. After removal of the solvent in vacuo, the residue is taken up in 500 ml of dichloromethane, filtered through a Celite bed, the filtrate is evaporated in vacuo until crystallisation commences, and finally about 100 ml of methanol are also added dropwise in order to complete the crystallisation. Yield: 27.9 g (93 mmol), 93%; purity: about 95% according to 1H-NMR. Boronic acid esters formed as oil can also be reacted further without purification.


Variant 2



embedded image


3.3 g (5 mmol) of bis[(1,2,5,6-t)-1,5-cyclooctadiene]di-μ-methoxydiiridium-(I) [12148-71-9], then 2.7 g (10 mmol) of 4,4′-di-tert-butyl-[2,2′]bipyridinyl [72914-19-3] and then 5.1 g (10 mmol) of bis(pinacolato)diborane are added to 800 ml of n-heptane, and the mixture is stirred at room temperature for 15 min. 127.0 g (500 mmol) of bis(pinacolato)diborane and then 87.2 g (500 mmol) of 1,1,3,3-tetramethylindane [4834-33-7] are subsequently added, and the mixture is warmed at 80° C. for 12 h (TLC check, heptane:ethyl acetate 5:1). After cooling of the reaction mixture, 300 ml of ethyl acetate are added, the mixture is filtered through a silica-gel bed, and the filtrate is evaporated to dryness in vacuo. The crude product is recrystallised twice from acetone (about 800 ml). Yield: 136.6 g (455 mmol), 91%; purity: about 99% according to 1H-NMR.


The following compounds can be prepared analogously:



















Product






Boronic acid






ester



Ex.
Starting material
Bromide
Variant
Yield







S5


embedded image

  91324-94-6



embedded image

  S5-Br



embedded image


80%








S51






S5


embedded image

  91324-94-6




embedded image


95%








S51






S6


embedded image

  S1



embedded image

  S6-Br



embedded image


78%








S61






S7


embedded image

  479070-73-0



embedded image

  S7-Br Separation of regioisomers by distillation



embedded image


60%








S71






S8


embedded image

  142076-41-3



embedded image

  S8-Br



embedded image


81%








S81






S9


embedded image

  S2



embedded image

  S9-Br Separation of regioisomers by distillation



embedded image


43%








S91






S10


embedded image

  59508-28-0



embedded image

  S10-Br



embedded image


78%








S101






S11


embedded image

  4486-29-7



embedded image

  16499-72-2 S11-Br



embedded image


80%








S111






S12


embedded image

  215725-16-9



embedded image

  S12-Br Separation of regioisomers by distillation



embedded image


68%








S121






S13


embedded image

  66684-45-5



embedded image

  S13-Br



embedded image


77%








S131






S13


embedded image

  66684-45-5




embedded image


93%








S132






S14


embedded image

  113710-83-1



embedded image

  S14-Br



embedded image


79%








S141






S14


embedded image

  113710-83-1




embedded image


89%








S-142






S15


embedded image

  65089-09-0



embedded image

  S15-Br



embedded image


70%








S151






S16


embedded image

  1020726-74-2



embedded image

  S16-Br Separation of regioisomers by distillation



embedded image


54%








S161






S17


embedded image

  651-39-8



embedded image

  S17-Br



embedded image


81%








S171






S18


embedded image

  124797-68-8



embedded image

  S18-Br Separation of regioisomers by distillation



embedded image


56%








S181






S19



embedded image

  73790-19-9 S19-Br



embedded image


94% 1 Step








S191






S20


embedded image

  35185-96-7



embedded image

  S20-Br



embedded image


82%








S201






S21


embedded image

  61200-08-6



embedded image

  S21-Br



embedded image


79%








S211






S22


embedded image

  3723-85-1



embedded image

  S22-Br



embedded image


23%








S221






S23


embedded image

  S3



embedded image

  S22-Br



embedded image


77%








S231






SB1


embedded image

  4175-52-4



embedded image

  SB1-Br



embedded image


80%








SB11






SB1


embedded image

  4175-52-4




embedded image


93%








SB12






SB2


embedded image

  2716-23-6



embedded image




embedded image


81%







SB2-Br
SB21






SB2


embedded image

  2716-23-6




embedded image


90%








SB22






SB3


embedded image

  35349-64-5




embedded image


89%








SB32






SB4


embedded image

  60749-53-3



embedded image

  SB4-Br



embedded image


74%








SB41






SB4


embedded image

  60749-53-3




embedded image


94%








SB42









Example S24
5,5,7,7-Tetramethyl-6,7-dihydro-5H-[2]pyridine, S24



embedded image


Procedure analogous to D. L. Boger et al., J. Org. Chem., 1981, 46, 10, 2180. A mixture of 14.0 g (100 mmol) of 2,2,4,4-tetramethylcyclopenta-none [4694-11-5], 9.0 ml (110 mmol) of pyrrolidine [123-75-1], 951 mg (5 mmol) of p-toluenesulfonic acid monohydrate [6192-52-5] and 500 ml of toluene is heated on a water separator until the separation of water is complete (typically about 16 h). The toluene is then removed in vacuo, and the oily residue is subjected to a bulb-tube distillation. The 17.4 g (90 mmol) of 1-(3,3,5,5-tetramethylcyclopent-1-enyl)pyrrolidine obtained as amber-coloured oil are taken up in 50 ml of chloroform and slowly added dropwise at room temperature to a solution of 10.5 g (130 mmol) of 1,2,4-triazine in 50 ml of chloroform. When the addition is complete, the orange solution is stirred at room temperature for a further 2 h, the temperature is then raised to 50° C., and the mixture is stirred for a further 45 h. After removal of the chloroform in vacuo, the residue is chromatographed on silica gel with diethyl ether:n-heptane (1:1, vv). Yield: 8.9 g (51 mmol), 51%; purity: about 97% according to 1H-NMR.


The following compounds are prepared analogously:

















Ex.
Starting materials
Product
Yield








S25


embedded image




embedded image


42%






S26


embedded image




embedded image


37%









Example 27
5,6-Dibromo-1,1,2,2,3,3-hexamethylindane, S27



embedded image


1.3 g of anhydrous iron(III) chloride and then, dropwise with exclusion of light, a mixture of 64.0 ml (1.25 mol) of bromine and 300 ml of dichloromethane are added to a solution of 101.2 g (500 mmol) of 1,1,2,2,3,3-hexamethylindane [91324-94-6] in 2000 ml of dichloromethane at such a rate that the temperature does not exceed 25° C. If necessary, the mixture is counter-cooled using a cold-water bath. The reaction mixture is stirred at room temperature for a further 16 h, 500 ml of saturated sodium sulfite solution are then slowly added, the aqueous phase is separated off, the organic phase is washed three times with 1000 ml of water each time, dried over sodium sulfate, filtered through a short silica-gel column, and the solvent is then stripped off. Finally, the solid is recrystallised once from a little (about 100 ml) ethanol. Yield: 135.8 g (377 mmol), 75%; purity: about 95% according to 1H-NMR.


The following compounds are prepared analogously:















Ex.
Starting materials
Product
Yield







S28


embedded image




embedded image


78%





S29


embedded image




embedded image


73%





S30


embedded image




embedded image


76%





S31


embedded image




embedded image


80%





S32


embedded image




embedded image


77%





S33


embedded image




embedded image


19%





S34


embedded image




embedded image


23%





SB5


embedded image




embedded image


69%





SB6


embedded image




embedded image


72%





SB7


embedded image




embedded image


74%





SB8


embedded image




embedded image


78%









Example S35
5,6-Diamino-1,1,2,2,3,3-hexamethylindane, S35



embedded image


A: 5,6-Dinitro-1,1,2,2,3,3-tetramethylindane, S35a



embedded image


350 ml of 100% by weight nitric acid are slowly added dropwise to a vigorously stirred mixture, cooled to 0° C., of 101.2 g (500 mmol) of 1,1,2,2,3,3-hexamethylindane [91324-94-6] and 350 ml of 95% by weight sulfuric acid at such a rate that the temperature does not exceed +5° C. The reaction mixture is subsequently allowed to warm slowly to room temperature over 2-3 h and is then poured into a vigorously stirred mixture of 6 kg of ice and 2 kg of water. The pH is adjusted to 8-9 by addition of 40% by weight NaOH, the mixture is extracted three times with 1000 ml of ethyl acetate each time, the combined organic phases are washed twice with 1000 ml of water each time, dried over magnesium sulfate, the ethyl acetate is then removed virtually completely in vacuo until crystallisation commences, and the crystallisation is completed by addition of 500 ml of heptane. The beige crystals obtained in this way are filtered off with suction and dried in vacuo. Yield: 136.2 g (466 mmol), 93%; purity: about 94% according to 1H-NMR, remainder about 4% of 4,6-dinitro-1,1,3,3-tetramethylindane. About 3% of 4,5-dinitro-1,1,3,3-tetramethylindane, S35b, can be isolated from the mother liquor.


B: 5,6-Diamino-1,1,2,2,3,3-hexamethylindane, S35

136.2 g (466 mmol) of 5,6-dinitro-1,1,2,2,3,3-hexamethylindane, S35a, are hydrogenated at room temperature in 1200 ml of ethanol on 10 g of palladium/carbon at a hydrogen pressure of 3 bar for 24 h. The reaction mixture is filtered twice through a Celite bed, the brown solid obtained after removal of the ethanol is subjected to a bulb-tube distillation (T about 160° C., p about 10−4 mbar). Yield: 98.5 g (424 mmol), 91%; purity: about 95% according to 1H-NMR.


The following compounds are prepared analogously:















Ex.
Starting materials
Product
Yield







S35b


embedded image




embedded image


 2%





S36


embedded image




embedded image


80%





S37


embedded image




embedded image


84%





S38


embedded image




embedded image


76%





S39


embedded image




embedded image


68%





S40


embedded image




embedded image


63%





S41


embedded image




embedded image


77%





S42


embedded image




embedded image


16%





SB9


embedded image




embedded image


72%





SB10


embedded image




embedded image


70%





SB11


embedded image




embedded image


65%





SB12


embedded image




embedded image


74%









Example S43
N-[2-(1,1,2,2,3,3-Hexamethylindan-5-yl)ethyl]benzamide, S43



embedded image


A: 1,1,2,2,3,3-Hexamethylindane-5-carboxaldehyde, S43a



embedded image


200 ml (500 mmol) of n-BuLi, 2.5 M in n-hexane, are added dropwise to a vigorously stirred solution, cooled to −78° C., of 140.6 g (500 mmol) of 5-bromo-1,1,2,2,3,3-hexamethylindane, S5-Br, in 1000 ml of THF at such a rate that the temperature does not exceed −55° C. When the addition is complete, the mixture is stirred for a further 30 min., and a mixture of 42.3 ml (550 mmol) of DMF and 50 ml of THF is then allowed to run in with vigorous stirring. The mixture is stirred at −78° C. for a further 1 h, then allowed to warm to room temperature and quenched by addition of 300 ml of saturated ammonium chloride solution. The organic phase is separated off, the THF is removed in vacuo, the residue is taken up in 500 ml of ethyl acetate, washed once with 300 ml of 5% hydrochloric acid, twice with 300 ml of water each time, once with 300 ml of saturated sodium chloride solution, the organic phase is dried over magnesium sulfate, and the solvent is then removed in vacuo. The residue is employed in step B without further purification. Yield: 107.1 g (465 mmol), 93%; purity: about 95% according to 1H-NMR.


The following compounds can be prepared analogously:
















Starting




Ex.
material
Product
Yield







S44a


embedded image




embedded image


91%





S45a


embedded image




embedded image


89%





S46a


embedded image




embedded image


95%





S47a


embedded image




embedded image


90%





SB13a


embedded image




embedded image


88%









B: 2-(1,1,2,2,3,3-Hexamethyl-5-indanyl)ethylamine, S43b



embedded image


A mixture of 80.6 g (350 mmol) of 1,1,2,2,3,3-Hexamethylindane-5-carboxaldehyde, S43a, 400 ml of nitromethane and 4.6 g (70 mmol) of ammonium acetate, anhydrous, is heated under reflux for 2 h until the starting material has been consumed (TLC check). After cooling, the reaction mixture is poured into 1000 ml of water, extracted three times with 300 ml of dichloromethane each time, the combined organic phases are washed three times with saturated sodium hydrogencarbonate solution, three times with 300 ml of water each time and once with 300 ml of saturated sodium chloride solution, dried over magnesium sulfate, and the solvent is removed in vacuo. The dark oily residue is dissolved in 100 ml of THF and slowly added dropwise with ice-cooling to a solution of 38.0 g (1.0 mol) of lithium aluminium hydride in 1000 ml of THF (care: exothermic reaction!). When the addition is complete, the reaction mixture is allowed to warm to room temperature and is stirred at room temperature for a further 20 h. The reaction mixture is hydrolysed with ice-cooling by slow addition of 500 ml of saturated sodium sulfate solution. The salts are filtered off with suction, rinsed with 500 ml of THF, the THF is removed in vacuo, the residue is taken up in 1000 ml of dichloromethane, the solution is washed three times with 300 ml of water each time, once with 300 ml of saturated sodium chloride solution, dried over magnesium sulfate, and the solvent is then removed in vacuo. The purification is carried out by bulb-tube distillation (p about 10−4 mbar, T=200° C.). Yield: 67.0 g (273 mmol), 78%; purity: about 95% according to 1H-NMR.


The following compounds can be prepared analogously:
















Starting




Ex.
material
Product
Yield







S44b


embedded image




embedded image


74%





S45b


embedded image




embedded image


77%





S46b


embedded image




embedded image


75%





S47b


embedded image




embedded image


71%





SB13b


embedded image




embedded image


72%









C: N-[2-(1,1,2,2,3,3-Hexamethylindan-5-yl)ethyl]benzamide, S43

A solution of 14.1 ml (100 mmol) of benzoyl chloride [98-88-4] in 100 ml of dichloromethane is added dropwise with vigorous stirring at 0*C to a mixture of 24.5 g (100 mmol) of 2-(1,1,2,2,3,3-hexamethyl-5-indanyl)ethylamine, S43b, 14.1 ml (100 mmol) of triethylamine and 150 ml of dichloromethane at such a rate that the temperature does not exceed 30° C. The mixture is subsequently stirred at room temperature for a further 1 h. The dichloromethane is removed in vacuo, 100 ml of methanol are added to the colourless solid, which is filtered off with suction, washed three times with 50 ml of methanol and dried in vacuo. Yield: 31.1 g (89 mmol), 89%; purity: about 98% according to 1H-NMR.


The following compounds can be prepared analogously:

















Starting
Carboxylic




Ex.
material
acid chloride
Product
Yield







S44


embedded image




embedded image




embedded image


74%





S45


embedded image




embedded image




embedded image


77%





S46


embedded image




embedded image




embedded image


75%





S47


embedded image




embedded image




embedded image


71%





S48


embedded image




embedded image




embedded image


86%





S49


embedded image




embedded image




embedded image


88%





SB13


embedded image




embedded image




embedded image


82%









Example S50
2,7-Di-tort-butyl-9,9′-(6-bromopyridin-2-yl)xanthene, S50



embedded image


120 ml (300 mmol) of n-BuLi, 2.5 M in n-hexane, are added at room temperature to a solution of 84.7 g (300 mmol) of di(4-tert-butylphenyl) ether [24085-65-2] in 1500 ml of diethyl ether, and the mixture is then stirred under reflux for 60 h. After the reaction mixture has been cooled to −10° C., 82.1 g (240 mmol) of bis(6-bromopyridin-2-yl)methanone are added in portions, and the mixture is then stirred at −10° C. for a further 1.5 h. The reaction mixture is quenched by addition of 30 ml of ethanol, the solvent is removed completely in vacuo in a rotary evaporator, the residue is taken up in 1000 ml of glacial acetic acid, 150 ml of acetic anhydride and then, dropwise, 30 ml of conc. sulfuric acid are added with stirring, and the mixture is stirred at 60° C. for a further 3 h. The solvent is then removed in vacuo, the residue is taken up in 1000 ml of dichloromethane, and the mixture is rendered alkaline by addition of 10% by weight aqueous NaOH with ice-cooling. The organic phase is separated off, washed three times with 500 ml of water each time, dried over magnesium sulfate, the organic phase is evaporated to dryness, and the residue is taken up in 500 ml of methanol, homogenised at elevated temperature and then stirred for a further 12 h, during which the product crystallises. The solid obtained after filtration with suction is dissolved in 1000 ml of dichloromethane, the solution is filtered through a Celite bed, the filtrate is evaporated to dryness, the residue is recrystallised twice from toluene: methanol (1:1) and then dried in vacuo. Yield: 56.3 g (87 mmol), 36%; purity: about 95% according to 1H-NMR.


The following compound can be prepared analogously:















Ex.
Starting material
Product
Yield







S51


embedded image




embedded image


28%









Example 852
Bis(1,1,2,2,3,3-hexamethylindan-5-yl) ether



embedded image


Procedure analogous to G. Chen et al., Tetrahedron Letters 2007, 48, 3, 47. A vigorously stirred mixture of 56.2 g (200 mmol) of 5-bromo-1,1,2,2,3,3-hexamethylindane, S5-Br, 212.2 g (800 mmol) of tripotassium phosphate trihydrate, 300 g of glass beads (diameter 3 mm), 449 mg (2 mmol) of palladium(II) acetate, 809 mg (4 mmol) of tri-tert-butylphosphine and 1000 ml of dioxane is heated under reflux for 20 h. After cooling, the salts are filtered off with suction, rinsed with 300 ml of dioxane, the filtrate is evaporated in vacuo, the residue is taken up in 500 ml of ethyl acetate, the solution is washed three times with 300 ml of water each time, once with 300 ml of saturated sodium chloride solution, dried over magnesium sulfate, and the ethyl acetate is then removed in vacuo. The residue is purified by bulb-tube distillation (p about 10−4 mbar, T about 180° C.). Yield: 32.6 g (78 mmol), 78%; purity: about 97% according to 1H-NMR.


Example 853
7-Bromo-1,2,3,4-tetrahydro-1,4-methanonaphthalene-6-carbaldehyde, S53



embedded image


Procedure analogous to L. S. Chen et al., J. Organomet. Chem. 1980, 193, 283-292.40 ml (100 mmol) of n-BuLi, 2.5 M in hexane, pre-cooled to −110° C., are added to a solution, cooled to −110° C., of 30.2 g (100 mmol) of 6,7-dibromo-1,2,3,4-tetrahydro-1,4-methanonaphthalene [42810-32-2] in a mixture of 1000 ml of THF and 1000 ml of diethyl ether at such a rate that the temperature does not exceed −105° C. The mixture is stirred for a further 30 min., a mixture, pre-cooled to −110° C., of 9.2 ml (120 mmol) of DMF and 100 ml of diethyl ether is then added dropwise, the mixture is then stirred for a further 2 h, allowed to warm to −10° C., 1000 ml of 2 N HCl are added, and the mixture is stirred at room temperature for a further 2 h. The organic phase is separated off, washed once with 500 ml of water, once with 500 ml of saturated sodium chloride solution, dried over magnesium sulfate, the solvent is removed in vacuo, and the residue is subjected to a bulb-tube distillation (T about 90° C., p about 10−4 mbar). Yield: 15.8 g (63 mmol), 63%; purity: about 95% according to 1H-NMR.


The following compounds can be prepared analogously:















Ex.
Starting materials
Product
Yield







S54


embedded image




embedded image


68%





S55


embedded image




embedded image


66%





S56


embedded image




embedded image


60%





S57


embedded image




embedded image


54%





SB14


embedded image




embedded image


55%





SB15


embedded image




embedded image


50%





SB16


embedded image




embedded image


47%





SB17


embedded image




embedded image


53%









Example S58
7-Phenylethynyl-1,2,3,4-tetrahydro-1,4-methanonaphthalene-6-carbaldehyde, S58



embedded image


1.6 g (6 mmol) of triphenylphosphine, 674 mg (3 mmol) of palladium(II) acetate, 571 mg (30 mmol) of copper(I) iodide and 15.3 g (150 mmol) of phenylacetylene [536-74-3] are added consecutively to a solution of 25.1 g (100 mmol) of 7-bromo-1,2,3,4-tetrahydro-1,4-methanonaphthalene-6-carbaldehyde, S53, in a mixture of 200 ml of DMF and 100 ml of triethylamine, and the mixture is stirred at 65° C. for 4 h. After cooling, the precipitated triethylammonium hydrochloride is filtered off with suction, rinsed with 30 ml of DMF. The filtrate is freed from the solvents in vacuo. The oily residue is taken up in 300 ml of ethyl acetate, the solution is washed five times with 100 ml of water each time and once with 100 ml of saturated sodium chloride solution, and the organic phase is dried over magnesium sulfate. After removal of the ethyl acetate in vacuo, the oily residue is chromatographed on silica gel (n-heptane:ethyl acetate 99:1). Yield: 19.6 g (72 mmol), 72%; purity: about 97% according to 1H-NMR.


The following derivatives can be prepared analogously:

















Bromo-





Ex.
arylaldehyde
Alkyne
Product
Yield







S59


embedded image




embedded image




embedded image


69%





S60


embedded image




embedded image




embedded image


69%





S61


embedded image




embedded image




embedded image


70%





S62


embedded image




embedded image




embedded image


66%





S63


embedded image




embedded image




embedded image


67%





S64


embedded image




embedded image




embedded image


70%





S65


embedded image




embedded image




embedded image


56%





SB18


embedded image




embedded image




embedded image


61%





SB19


embedded image




embedded image




embedded image


63%





SB20


embedded image




embedded image




embedded image


70%





SB21


embedded image




embedded image




embedded image


73%









Example SB22
5-[1-Hydroxymeth-(E)-ylidene]tricyclo-[4.3.1.1-3,8]-undecan-4-one, SB22



embedded image


A mixture of 16.4 g (100 mmol) of homoadamantanone [24669-56-5], 9.6 g (130 mmol) of ethyl formate [109-94-4] and 250 ml of methyl tert-butyl ether is added dropwise to a vigorously stirred suspension of 9.6 g (100 mmol) of sodium tert-butoxide in 300 ml of methyl tert-butyl ether (note: exothermic). When the addition is complete, the mixture is warmed at 60° C. for 16 h. After cooling, the beige-red solid which has precipitated out is filtered off with suction, washed once with a little methyl tert-butyl ether, resuspended in 300 ml of methyl tert-butyl ether and hydrolysed by addition of 200 ml of saturated ammonium chloride solution. The clear organic phase is separated off, washed three times with 100 ml of water each time, once with 100 ml of saturated sodium chloride solution, dried over magnesium sulfate, and the solvent is then removed in vacuo, leaving a yellow oil, which crystallises over time and can be employed in the next step without further purification. Yield: 15.6 g (81 mmol), 81%; purity: about 95% according to 1H NMR, where varying proportions of the (Z,E)-enol and aldehyde form are observed, depending on the compound, solvent, residual water content and pH, where the enol form usually strongly predominates.


The following compounds can be prepared analogously:















Ex.
Ketone
Product
Yield







SB23


embedded image




embedded image


80%





SB24


embedded image




embedded image


85%





SB25


embedded image




embedded image


88%





SB26


embedded image




embedded image


87%





SB27


embedded image




embedded image


83%





SB28


embedded image




embedded image


85%





SB29


embedded image




embedded image


83%





SB30


embedded image




embedded image


86%





SB31


embedded image




embedded image


88%









Example SB32



embedded image


Procedure analogous to G. Zhang et al., Ad. Synth. & Catal., 2011, 353(2+3), 291. A mixture of 28.4 g (100 mmol) of SB1, 9.4 g (105 mmol) of copper(I) cyanide, 41.5 g (300 mmol) of potassium carbonate, 100 g of glass beads (diameter 3 mm), 400 ml of DMF and 3.6 ml of water is stirred at 80° C. for 10 h. After cooling, the DMF is substantially removed in vacuo, the residue is diluted with 500 ml of dichloromethane, the salts are filtered off through a Celite bed, the filtrate is washed three times with 200 ml of water and once with 100 ml of saturated sodium chloride solution and then dried over magnesium sulfate. The oily residue which remains after removal of the dichloromethane is distilled in a bulb tube. Yield: 11.5 g (63 mmol), 63%; purity: about 97% according to 1H NMR.


The following compounds can be prepared analogously:















Ex.
Starting material
Product
Yield







S66


embedded image




embedded image


58%





S67


embedded image




embedded image


60%





S68


embedded image




embedded image


61%





SB33


embedded image




embedded image


65%





SB34


embedded image




embedded image


56%





SB35


embedded image




embedded image


66%









B: Synthesis of the Ligands L and LB
Example L1
2-(1,1,3,3-Tetramethylindan-6-yl)pyridine, L1



embedded image


821 mg (2 mmol) of S-Phos and then 249 mg (1 mmol) of palladium(II) acetate are added to a mixture of 30.0 g (100 mmol) of pinacolyl 1,1,3,3-tetramethylindane-5-boronate, S4-B, 17.4 g (110 mmol) of 2-bromo-pyridine [109-04-6], 46.1 g (200 mmol) of tripotassium phosphate monohydrate, 300 ml of dioxane and 100 ml of water, and the mixture is heated under reflux for 16 h. After cooling, the aqueous phase is separated off, the organic phase is evaporated to dryness, the residue is taken up in 500 ml of ethyl acetate, the organic phase is washed three times with 200 ml of water each time, once with 200 ml of saturated sodium chloride solution, dried over magnesium sulfate, the desiccant is filtered off via a Celite bed, and the filtrate is re-evaporated to dryness. The oil obtained in this way is freed from low-boiling components and non-volatile secondary components by fractional bulb-tube distillation twice. Yield: 15.3 g (61 mmol), 61%; purity: about 99.5% according to 1H-NMR.


The following compounds are prepared analogously. Solids are freed from low-boiling components and non-volatile secondary components by recrystallisation and fractional sublimation (p about 10−4-10−5 mbar, T about 160-240° C.). Oils are purified by chromatography, subjected to fractional bulb-tube distillation or dried in vacuo in order to remove low-boiling components.

















Product





Ex.
Boronic acid ester
Bromide
Ligand
Yield







L2


embedded image




embedded image




embedded image


66%





L3


embedded image




embedded image




embedded image


67%





L4


embedded image




embedded image




embedded image


64%





L5


embedded image




embedded image




embedded image


60%





L6


embedded image




embedded image




embedded image


61%





L7


embedded image




embedded image




embedded image


63%





L8


embedded image




embedded image




embedded image


63%





L9


embedded image




embedded image




embedded image


58%





L10


embedded image




embedded image




embedded image


60%





L11


embedded image




embedded image




embedded image


54%





L12


embedded image




embedded image




embedded image


59%





L13


embedded image




embedded image




embedded image


61%





L14


embedded image




embedded image




embedded image


48%





L15


embedded image




embedded image




embedded image


46%





L16


embedded image




embedded image




embedded image


66%





L17


embedded image




embedded image




embedded image


58%





L18


embedded image




embedded image




embedded image


59%





L19


embedded image




embedded image




embedded image


63%





L20


embedded image




embedded image




embedded image


65%





L21


embedded image




embedded image




embedded image


60%





L22


embedded image




embedded image




embedded image


64%





L23


embedded image




embedded image




embedded image


66%





L24


embedded image




embedded image




embedded image


68%





L25


embedded image




embedded image




embedded image


63%





L26


embedded image




embedded image




embedded image


45%





L27


embedded image




embedded image




embedded image


64%





L28


embedded image




embedded image




embedded image


65%





L29


embedded image




embedded image




embedded image


66%





L30


embedded image




embedded image




embedded image


67%





L31


embedded image




embedded image




embedded image


51%





L32


embedded image




embedded image




embedded image


64%





L33


embedded image




embedded image




embedded image


63%





L34


embedded image




embedded image




embedded image


61%





L35


embedded image




embedded image




embedded image


61%





L36


embedded image




embedded image




embedded image


62%





L37


embedded image




embedded image




embedded image


49%





L38


embedded image




embedded image




embedded image


57%





L39


embedded image




embedded image




embedded image


60%





L40


embedded image




embedded image




embedded image


59%





L41


embedded image




embedded image




embedded image


53%





LB1


embedded image




embedded image




embedded image


60%





LB2


embedded image




embedded image




embedded image


55%





LB3


embedded image




embedded image




embedded image


58%





LB4


embedded image




embedded image




embedded image


54%





LB5


embedded image




embedded image




embedded image


50%





LB6


embedded image




embedded image




embedded image


48%





LB7


embedded image




embedded image




embedded image


57%





LB8


embedded image




embedded image




embedded image


55%





LB9


embedded image




embedded image




embedded image


48%





LB10


embedded image




embedded image




embedded image


61%





LB11


embedded image




embedded image




embedded image


60%





LB12


embedded image




embedded image




embedded image


57%





LB13


embedded image




embedded image




embedded image


56%





LB14


embedded image




embedded image




embedded image


59%





LB15


embedded image




embedded image




embedded image


53%





LB16


embedded image




embedded image




embedded image


54%





LB17


embedded image




embedded image




embedded image


62%





LB18


embedded image




embedded image




embedded image


59%





LB19


embedded image




embedded image




embedded image


57%





LB20


embedded image




embedded image




embedded image


60%





LB21


embedded image




embedded image




embedded image


62%





LB22


embedded image




embedded image




embedded image


47%









Example 42
5,5,7,7-Tetramethyl-3-phenyl-6,7-dihydro-5H-[2]pyridine, L42



embedded image


Procedure analogous to A. Mazzanti et al., Eur. J. Org. Chem., 2011, 6725.


40 ml (100 mmol) of n-butyllithium, 2.5 M in n-hexane, are added dropwise to a mixture, cooled to −78° C., of 10.5 ml (100 mmol) of bromobenzene and 500 ml of diethyl ether, and the mixture is stirred for a further 30 min. 17.5 g (100 mmol) of 5,5,7,7-tetramethyl-6,7-dihydro-5H-[2]pyridine, S24, are then added dropwise, the mixture is allowed to warm to room temperature, stirred for a further 12 h, quenched by addition of 100 ml of water, the organic phase is separated off, dried over magnesium sulfate. After removal of the solvent, the oily residue is chromatographed on silica gel with diethyl ether:n-heptane (3:7, v:v) and subsequently subjected to fractional bulb-tube distillation twice. Yield: 12.1 g (48 mmol), 48%; purity: about 99.5% according to 1H-NMR.


The following compounds can be prepared analogously. Solids are freed from low-boiling components and non-volatile secondary components by recrystallisation and fractional sublimation (p about 10−4-10−5 mbar, T about 160-240° C.). Oils are purified by chromatography, subjected to fractional bulb-tube distillation or dried in vacuo in order to remove low-boiling components.
















Ex.
Pyridine
Bromide
Ligand
Yield







L43


embedded image

  S24



embedded image

  3972-64-3



embedded image


50%





L44


embedded image

  S24



embedded image

  2113-57-7



embedded image


48%





L45


embedded image

  S24



embedded image

  98905-03-4



embedded image


46%





L46


embedded image

  S24



embedded image

  580-13-2



embedded image


50%





L47


embedded image

  S24



embedded image

  86-76-0



embedded image


47%





L48


embedded image

  S24



embedded image

  S5-Br



embedded image


51%





L49


embedded image

  S24



embedded image

  S13-Br



embedded image


49%





L50


embedded image

  S24



embedded image

  16499-72-2 S11-Br



embedded image


45%





L51


embedded image

  S25



embedded image

  4165-57-5



embedded image


46%





L52


embedded image

  S26



embedded image

  S5-Br



embedded image


40%









Example 53
6,6,7,7,8,8-Hexamethyl-2-phenyl-7,8-dihydro-6H-cyclopenta[g]quinoxaline, L53



embedded image


Procedure analogous to S. V. More et al., Tetrahedron Lett. 2005, 46, 6345.


A mixture of 23.2 g (100 mmol) of 1,1,2,2,3,3-hexamethylindane-5,6-diamine, S35, 13.4 g (100 mmol) of oxophenylacetaldehyde [1074-12-0], 767 mg (3 mmol) of iodine and 75 ml of acetonitrile is stirred at room temperature for 16 h. The precipitated solid is filtered off with suction, washed once with 20 ml of acetonitrile, twice with 75 ml of n-heptane each time and then recrystallised twice from ethanol/ethyl acetate. Finally, the solid is freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−4-10−5 mbar, T about 220° C.). Yield: 22.1 g (67 mmol), 67%; purity: about 99.5% according to 1H-NMR.


The following compounds are prepared analogously. Solids are freed from low-boiling components and non-volatile secondary components by recrystallisation and fractional sublimation (p about 10−4-10−5 mbar, T about 160-240° C.). Oils are purified by chromatography, subjected to fractional bulb-tube distillation or dried in vacuo in order to remove low-boiling components.
















Ex.
Diamine
Diketone
Ligand
Yield







L54


embedded image

  S35



embedded image

  579-07-7



embedded image


58%





L55


embedded image

  S36



embedded image

  134-81-6



embedded image


69%





L56


embedded image

  S38



embedded image

  579-07-7



embedded image


60%





L57


embedded image

  S39



embedded image

  134-81-6



embedded image


70%





L58


embedded image

  S37



embedded image

  3457-48-5



embedded image


48%





L59


embedded image

  124639-03-8



embedded image

  579-07-7



embedded image


55%





L60


embedded image

  S40



embedded image

  134-81-6



embedded image


68%





L61


embedded image

  S41



embedded image

  134-81-6



embedded image


59%





L62


embedded image

  S35b



embedded image

  134-81-6



embedded image


62%





L63


embedded image

  S42



embedded image

  134-81-6



embedded image


51%





LB23


embedded image

  SB9



embedded image

  1074-12-0



embedded image


34%





LB24


embedded image

  SB9



embedded image

  579-07-7



embedded image


44%





LB25


embedded image

  SB9



embedded image

  134-81-6



embedded image


67%





LB26


embedded image

  SB10



embedded image

  1074-12-0



embedded image


38%





LB27


embedded image

  SB10



embedded image

  579-07-7



embedded image


50%





LB28


embedded image

  SB10



embedded image

  134-81-6



embedded image


71%





LB29


embedded image

  SB11



embedded image

  1074-12-0



embedded image


35%





LB30


embedded image

  SB12



embedded image

  1074-12-0



embedded image


38%





LB31


embedded image

  SB12



embedded image

  579-07-7



embedded image


43%





LB32


embedded image

  SB12



embedded image

  134-81-6



embedded image


59%









Example 64
5,5,6,6,7-Hexamethyl-1,2-diphenyl-1,5,6,7-tetrahydroindeno[5,6-d]imidazole, L64



embedded image


Procedure analogous to D. Zhao et al., Org. Lett., 2011, 13, 24, 6516. A mixture of 36.0 g (100 mmol) of 5,6-dibromo-1,1,2,2,3,3-hexamethylindane, 21.6 g (110 mmol) of N-phenylbenzamidine [1527-91-9], 97.8 g (300 mmol) of caesium carbonate, 100 g of molecular sieve 4 A, 1.2 g (2 mmol) of xantphos, 449 mg (2 mmol) of palladium(II) acetate and 600 ml of o-xylene is heated under reflux with vigorous stirring for 24 h. After cooling, the salts are filtered off with suction via a Celite bed, rinsed with 500 ml of o-xylene, the solvent is removed in vacuo, and the residue is recrystallised three times from cyclohexane/ethyl acetate. Finally, the solid is freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−4-10−5 mbar, T about 230° C.). Yield: 28.0 g (71 mmol), 71%; purity: about 99.5% according to 1H-NMR.


The following compounds are prepared analogously. Solids are freed from low-boiling components and non-volatile secondary components by recrystallisation and fractional sublimation (p about 10−4-10−5 mbar, T about 160-240° C.). Oils can be purified by chromatography, subjected to fractional bulb-tube distillation or dried in vacuo in order to remove low-boiling components.

















1,2-Dihalogen





Ex.
compound
Benzamidine
Ligand
Yield







L65


embedded image

  1311465-45-8



embedded image

  34028-17-6



embedded image


75%





L66


embedded image

  S28



embedded image

  57327-73-8



embedded image


77%





L67


embedded image

  S29



embedded image

  53510-31-9



embedded image


73%





L68


embedded image

  42810-32-2



embedded image

  72340-27-3



embedded image


68%





L69


embedded image

  S30



embedded image

  16239-27-3



embedded image


69%





L70


embedded image

  S31



embedded image

  856062-57-2



embedded image


71%





L71


embedded image

  S32



embedded image

  64499-61-2



embedded image


64%





L72


embedded image

  S33



embedded image

  787563-35-3



embedded image


36%





L73


embedded image

  S34



embedded image

  16239-27-3



embedded image


44%





L74


embedded image

  75267-72-0



embedded image

  16239-27-3



embedded image


43%





L75


embedded image

  75267-72-0



embedded image

  53510-31-9



embedded image


40%





L76


embedded image

  75267-72-0



embedded image

  787563-35-3



embedded image


38%





L77


embedded image

  301829-08-3



embedded image

  16239-27-3



embedded image


39%





LB33


embedded image

  SB5



embedded image

  16239-27-3



embedded image


44%





LB34


embedded image

  SB5



embedded image

  53510-31-9



embedded image


40%





LB35


embedded image

  SB5



embedded image

  787563-35-3



embedded image


45%





LB36


embedded image

  SB6



embedded image

  16239-27-3



embedded image


41%





LB37


embedded image

  SB6



embedded image

  53510-31-9



embedded image


37%





LB38


embedded image

  SB6



embedded image

  34028-17-6



embedded image


38%





LB39


embedded image

  SB7



embedded image

  16239-27-3



embedded image


34%





LB40


embedded image

  SB8



embedded image

  16239-27-3



embedded image


46%





LB41


embedded image

  SB8



embedded image

  53510-31-9



embedded image


43%





LB42


embedded image

  SB8



embedded image

  34028-17-6



embedded image


43%









Example 78
1,5,5,6,6,7,7-Heptamethyl-3-phenyl-1,5,6,7-tetrahydroindeno[5,6d]imidazolium iodide, L78



embedded image


A) 5,5,6,6,7,7-Hexamethyl-1,5,6,7-tatrahydroindeno[5,6-d]imidazole



embedded image


Procedure analogous to Z.-H. Zhang et al., J. Heterocycl. Chem. 2007, 44, 6, 1509. 1.3 g (5 mmol) of iodine are added to a vigorously stirred mixture of 116.2 g (500 mmol) of 1,1,2,2,3,3-hexamethylindane-5,6-diamine, S35, 90.9 ml (550 mmol) of triethoxymethane [122-51-0] and 400 ml of acetonitrile, and the mixture is stirred at room temperature for 5 h. The precipitated solid is filtered off with suction, washed once with a little acetonitrile, three times with 100 ml of n-heptane each time and dried in vacuo. Yield: 108.8 g (449 mmol), 90%; purity: about 97% according to 1H-NMR.


B) 5,5,6,6,7,7-Hexamethyl-1-phenyl-1,5,6,7-tetrahydroindeno[5,6-d]-imidazole



embedded image


Procedure analogous to S. Zhang et al., Chem. Commun. 2008, 46, 6170. A mixture of 24.2 g (100 mmol) of 5,5,6,6,7,7-hexamethyl-1,5,6,7-tetrahydroindeno[5,6-d]imidazole, A), 12.6 ml (120 mmol) of bromobenzene [108-86-1], 27.6 g (200 mmol) of potassium carbonate, 952 mg (5 mmol) of copper(I) iodide, 1.0 g (10 mmol) of N,N-dimethylglycine, 200 g of glass beads (diameter 3 mm) and 300 ml of DMSO is heated at 120° C. with vigorous stirring for 36 h. After cooling, the salts are filtered off with suction, rinsed with 1000 ml of ethyl acetate, the combined organic phases are washed five times with 500 ml of water each time, once with 500 ml of saturated sodium chloride solution, dried over magnesium sulfate, the solvent is removed in vacuo, and the residue is recrystallised twice from cyclohexane. Yield: 28.3 g (89 mmol), 89%; purity: about 97% according to 1H-NMR.


C) 1,5,5,6,6,7,7-Heptamethyl-3-phenyl-1,5,6,7-tetrahydroindeno-[5,6-d]imidazolium iodide, L78

12.6 ml (200 mmol) of methyl iodide [74-88-4] are added with stirring to a suspension of 28.3 g (89 mmol) of 5,5,6,6,7,7-hexamethyl-1-phenyl-1,5,6,7-tetrahydroindeno[5,6-d]imidazole, B), in 100 ml of THF, and the mixture is stirred at 45° C. for 24 h. After cooling, the precipitated solid is filtered off with suction, washed three times with 50 ml of ethanol each time and dried in vacuo. Yield: 23.5 g (51 mmol), 57%; purity: about 99% according to 1H-NMR.


The following compounds are prepared analogously:


















Brominated






aromatic






compound

Yield


Ex.
1,2-Diamine
Alkyl halide
Ligand
3 steps







L79


embedded image

  S37



embedded image

  623-00-7 MeI



embedded image


46%





L80


embedded image

  S38



embedded image

  86-76-0 MeI



embedded image


43%





L81


embedded image

  S39



embedded image

  26608-06-0 MeI



embedded image


34%





L82


embedded image

  124639-03-8



embedded image

  580-13-2 MeI



embedded image


41%





L83


embedded image

  S40



embedded image

  3972-65-4 MeI



embedded image

  Chromatographic separation of the regioisomers

19%





L84


embedded image

  S41



embedded image

  348-57-2 MeI



embedded image


37%





L85


embedded image

  S42



embedded image

  28320-31-2 MeI



embedded image


34%





L86


embedded image

  95-54-5 S35



embedded image

  S5-Br MeI



embedded image


43%





L87


embedded image

  95-54-5



embedded image

  S7-Br MeI



embedded image


45%





L88


embedded image

  95-54-5 S35



embedded image

  S12-Br MeI



embedded image


40%





LB43


embedded image

  SB9



embedded image

  623-00-7 MeI



embedded image


39%





LB44


embedded image

  SB9



embedded image

  S5-Br MeI



embedded image


37%





LB45


embedded image

  SB10



embedded image

  SB2-Br MeI



embedded image


40%





LB46


embedded image

  SB10



embedded image

  S5-Br MeI



embedded image


40%





LB47


embedded image

  SB11



embedded image

  3972-65-4 MeI



embedded image


33%





LB48


embedded image

  SB12



embedded image

  108-86-1 MeI



embedded image


42%





LB49


embedded image

  SB12



embedded image

  SB2-Br MeI



embedded image


38%





LB50


embedded image

  SB12



embedded image

  S5-Br MeI



embedded image


39%





LB51


embedded image

  SB12



embedded image

  SB4-Br



embedded image


36%









Example 89
1,4,4,6,6-Pentamethyl-3-phenyl-1,4,5,6-tetrahydrocyclo-pentaimidazolium iodide, L89



embedded image


A) 4,4,6,6-Tetramethyl-1,4,5,6-tetrahydrocyclopentaimidazole



embedded image


Preparation analogous to G. Bratulescu, Synthesis, 2009, 14, 2319. An intimate mixture of 1.54 g (10.0 mmol) of 3,3,5,5-tetramethylcyclopentane-1,2-dione [20633-06-1], 4.21 g (3.0 mmol) of urotropin, 7.7 g (10 mmol) of ammonium acetate and 0.3 ml of glacial acetic acid is heated in a temperature-controlled microwave until an internal temperature of about 120° C. has been reached, and is then held at this temperature for about 15 min. After cooling, the mass is added to 150 ml of water, the pH is adjusted to 8 using aqueous ammonia solution (10% by weight) with stirring, the precipitated solid is then filtered off with suction and washed with water. After drying, the product is recrystallised from ethanol/ethyl acetate. Yield: 1.17 g (7.1 mmol), 71%; purity: about 98% according to 1H-NMR.


B) 4,4,6,6-Tetramethyl-1-phenyl-1,4,5,6-tetrahydrocyclopentaimidazole



embedded image


Preparation analogous to Example 78, B). Use of 1.64 g (10.0 mmol) of 4,4,6,6-tetramethyl-1,4,5,6-tetrahydrocyclopentaimidazole, A), the remaining starting materials and solvents are correspondingly adapted stoichiometrically. Yield: 1.53 g (6.3 mmol), 63%; purity: about 98% according to 1H-NMR.


C) 1,4,4,6,6-Pentamethyl-3-phenyl-1,4,5,6-tetrahydrocyclopenta-imidazolium iodide, L89

Preparation analogous to Example 78, C). Use of 2.4 g (10.0 mmol) of 4,4,6,6-tetramethyl-1-phenyl-1,4,5,6-tetrahydrocyclopentaimidazole, B), the remaining starting materials and solvents are correspondingly adapted stoichiometrically. Yield: 2.26 g (5.9 mmol), 59%; purity: about 99% according to 1H-NMR.


The following compounds are prepared analogously:


















Brominated






aromatic






compound

Yield


Ex.
1,2-Dione
Alkyl halide
Ligand
3 steps







L90


embedded image

  16980-19-1



embedded image

  28320-31-2 MeI



embedded image


36%





L91


embedded image

  6236-71-1



embedded image

  S5-Br MeI



embedded image


40%





L92


embedded image

  62292-65-3



embedded image

  3972-65-4 MeI



embedded image


33%





LB52


embedded image

  4216-89-1



embedded image

  SB1-Br



embedded image


30%





LB53


embedded image

  26775-76-8



embedded image

  108-86-1 MeI



embedded image


31%





LB54


embedded image

  26775-76-8



embedded image

  S5-Br MeI



embedded image


34%









Example 93
Ligands of the benzo[4,5]imidazo[2,1-c]quinazoline type
General Ligand Synthesis
From 2-amidoarylaldehydes and 1,2-diaminobenzenes



embedded image


Step A:


A solution of 100 mmol of the 2-amidoarylaldehyde and 110 mmol of the 1,2-diaminobenzene in 70 ml of ethanol is placed in a 500 ml round-bottomed flask with water separator and stirred at 50° C. for 30 min. 70 ml of nitrobenzene are then added, and the temperature is increased step-wise to gentle reflux of the nitrobenzene, with the ethanol and water formed being distilled off during the heating. After 4 h under gentle reflux, the mixture is allowed to cool to 50° C., 40 ml of methanol are added, the mixture is then allowed to cool fully with stirring, stirred at room temperature for a further 2 h, the crystals of 2-(2-amidophenyl)benzimidazole formed are then filtered off with suction, washed twice with 20 ml of methanol each time and dried in vacuo. If the 2-(2-amidophenyl)benzimidazole does not crystallise out, the solvent is removed in vacuo, and the residue is employed in step B.


Step B:


Variant A:


350 mmol of the corresponding carbonyl chloride and 50 mmol of the corresponding carboxylic acid are added to a vigorously stirred mixture (precision glass stirrer) of 100 mmol of the 2-(2-amidophenyl)benzimidazole and 150 ml of dioxane or diethylene glycol dimethyl ether, and the mixture is heated under reflux (typically 4-48 h) until the 2-(2-amidophenyl)benzimidazole has reacted. Corresponding carbonyl chlorides and carboxylic acids are those which form the respective amide radical. After cooling, the reaction mixture is introduced with vigorous stirring into a mixture of 1000 g of ice and 300 ml of aqueous conc. ammonia. If the product is produced in the form of a solid, this is filtered off with suction, washed with water and sucked dry. If the product is produced in the form of an oil, this is extracted with three portions of 300 ml each of ethyl acetate or dichloromethane. The organic phase is separated off, washed with 500 ml of water and evaporated in vacuo. The crude product is taken up in ethyl acetate or dichloromethane, filtered through a short column of aluminium oxide, basic, activity grade 1, or silica gel in order to remove brown impurities. After recrystallisation (methanol, ethanol, acetone, dioxane, DMF, etc.) of the benzo[4,5]-imidazo[2,1-c]quinazoline obtained in this way, the latter is freed from low-boiling components and non-volatile secondary components by bulb-tube distillation or fractional sublimation (p about 10−4-10−5 mbar, T about 160-240° C.). Compounds containing aliphatic radicals having more than 6 C atoms, or those containing aralkyl groups having more than 9 C atoms, are typically purified by chromatography and then dried in vacuo in order to remove low-boiling components. Purity according to 1H-NMR typically >99.5%.


Variant B:


Analogous procedure to variant A, but 50 mmol of water are added instead of the carboxylic acid.


Variant C:


Analogous procedure to variant A, but no carboxylic acid is added.


Example L93



embedded image


Step A:


Use of 20.5 g (100 mmol) of S69 and 22.5 g (110 mmol) of S16.


The 2,2-dimethyl-N-[2-(5,5,7,7-tetramethyl-1,5,6,6-tetrahydroindeno[5,6-d]-imidazol-2-yl)phenyl]propionamide crystallises out, yield 31.6 g (81 mmol) 81%; purity: 97% according to 1H-NMR.


Step B, Variant A:


Use of 31.6 g (81 mmol) of 2,2-dimethyl-N-[2-(5,5,7,7-tetramethyl-1,5,6,6-tetrahydroindeno[5,6-d]imidazol-2-yl)phenyl]propionamide (step A), 120 ml of dioxane, 33.8 g (280 mmol) of pivaloyl chloride [3282-30-2] and 4.1 g (40 mmol) of pivalic acid [75-98-9], reaction time 16 h, the crude product is produced in the form of a solid on neutralisation, recrystallisation from DMF/ethanol, fractional sublimation of the product twice at T about 170° C., p about 10−4 mbar. Yield: 19.3 g (52 mmol), 64%; purity: about 99.5% according to 1H-NMR.


The following compounds are prepared analogously:

















2-Amidoaryl-
1,2-Diamino-

Yield


Ex.
aldehyde
benzene
Ligand
2 steps







L94


embedded image

  6141-21-5



embedded image

  S35



embedded image


55%





LB55


embedded image

  6141-21-5



embedded image

  SB9



embedded image


51%





LB56


embedded image

  6141-21-5



embedded image

  SB12



embedded image


50%









Example L95
1,1,2,2,3,3-Hexamethyl-5-phenyl-2,3-dihydro-1H-6-aza-cyclopenta[b]naphthalene, L95



embedded image


17.0 g (120 mmol) of phosphorus pentoxide are added in portions with vigorous stirring at 90° C. to a solution of 34.8 g (100 mmol) of N-[2-(1,1,2,2,3,3-hexamethylindan-5-yl)ethyl]benzamide, S43, in 150 ml of o-xylene. 28.0 ml (300 mmol) of phosphoryl chloride are added dropwise to this reaction mixture, which is then stirred under reflux for a further 4 h. The reaction mixture cooled to 80° C. is poured onto 1000 g of ice with vigorous stirring and then rendered alkaline (pH about 12) by addition of solid NaOH. The mixture is extracted three times with 300 ml of toluene each time, the organic phase is washed three times with water, dried over magnesium sulfate, and the solvent is removed in vacuo. The oily residue is dissolved in 200 ml of o-dichlorobenzene, 86.9 g (1 mol) of manganese dioxide are added to the solution, and the mixture is subsequently boiled under reflux on a water separator for 16 h. After cooling, the manganese dioxide is filtered off via a Celite bed, the solid is washed with 500 ml of a mixture of dichloromethane and ethanol (10:1), and the combined filtrates are freed from the solvents in vacuo. The residue is recrystallised from cyclohexane/ethyl acetate and finally freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−4-10−5 mbar, T about 230° C.). Yield: 20.1 g (61 mmol), 61%; purity: about 99.5% according to 1H-NMR.


The following compounds can be prepared analogously:















Ex.
Starting material
Product
Yield







L96


embedded image

  S44



embedded image


66%





L97


embedded image

  S45



embedded image


64%





L98


embedded image

  S46



embedded image


60%





L99


embedded image

  S47



embedded image


41%





L100


embedded image

  S48



embedded image


67%





L101


embedded image

  S49



embedded image


65%





LB57


embedded image

  SB13



embedded image


63%









Example L102
7,8,9,10-Tetrahydro-7,10-methano-6-phenylphen-anthridine, L102



embedded image


14.2 g (100 mmol) of boron trifluoride etherate are added dropwise to a vigorously stirred mixture of 46.6 g (500 mmol) of aniline, 58.4 g (550 mmol) of benzaldehyde, 94.2 g (1 mol) of norbornene and 1300 ml of dichloromethane, and the mixture is then heated under reflux for 40 h. After cooling, the reaction mixture is washed twice with 400 ml of water each time, the organic phase is dried over magnesium sulfate, and the dichloromethane is then removed in vacuo. The residue is taken up in 1000 ml of o-dichlorobenzene, 435 g (5 mol) of manganese dioxide are added, and the mixture is heated under reflux on a water separator for 16 h. After cooling, 1000 ml of ethyl acetate are added, the manganese dioxide is filtered off with suction via a Celite bed, the manganese dioxide is rinsed with 1000 ml of ethyl acetate, and the combined filtrates are freed from the solvents in vacuo. The residue is recrystallised twice from cyclohexane and finally freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−4-10−5 mbar, T about 230° C.). Yield: 76.0 g (280 mmol), 56%; purity: about 99.5% according to 1H-NMR.


The following compounds can be prepared analogously:















Ex.
Starting material
Product
Yield







L103


embedded image

  498-66-8   embedded image
  62-53-3



embedded image


66%








embedded image

  5779-95-3








L104


embedded image

embedded image
embedded image
  939-97-9



embedded image


64





L105


embedded image

embedded image
  106-49-0



embedded image


56%








embedded image









L106


embedded image

embedded image
embedded image
  100-52-7



embedded image


58%





L107


embedded image

embedded image
  769-92-6



embedded image


61%








embedded image









L108


embedded image

embedded image
  92-67-1



embedded image


63%








embedded image









L109


embedded image

embedded image
embedded image
  66-99-9



embedded image


58%





L110


embedded image

embedded image
embedded image
  848300-71-8



embedded image


55%





L111


embedded image

embedded image
embedded image
  51818-91-8



embedded image


60%





L112


embedded image

embedded image
embedded image
  1353684-87-3



embedded image


34%





L113


embedded image

embedded image
embedded image
  391900-69-9



embedded image


69%





L114


embedded image

embedded image
embedded image
104461-06-5



embedded image


67%





L115


embedded image

embedded image
  39919-70-5   embedded image



embedded image

  L115a

23%









embedded image

  L115b Chromatographic separation of the regioisomers

17%





L116


embedded image

embedded image
  59950-55-9   embedded image



embedded image


50%





L117


embedded image

  6541-60-2   embedded image



embedded image


48%








embedded image









L118


embedded image

  4453-90-1   embedded image



embedded image


68%








embedded image









L119


embedded image

  6705-50-6   embedded image



embedded image


45%








embedded image









L120


embedded image

  573-57-9   embedded image
  95-64-7



embedded image


65%








embedded image









L121


embedded image

embedded image
embedded image
  1204-60-0



embedded image


54%





L122


embedded image

embedded image
  139266-08-3



embedded image


38%








embedded image









L123


embedded image

embedded image
  4521-30-6



embedded image


34%








embedded image









L124


embedded image

embedded image
embedded image
  4265-16-1



embedded image


36%





L125


embedded image

embedded image
embedded image
  343238-30-2



embedded image


28%





L126


embedded image

embedded image
embedded image



embedded image


32%





L127


embedded image

  38667-10-6   embedded image



embedded image


25%








embedded image









LB58


embedded image

  931-64-6   embedded image



embedded image


27%








embedded image









LB59


embedded image

embedded image
  106-49-0



embedded image


27%








embedded image









LB60


embedded image

embedded image
embedded image
  100-52-7



embedded image


25%





LB61


embedded image

embedded image
  769-92-6



embedded image


29%








embedded image









LB62


embedded image

embedded image
embedded image
  1204-60-0



embedded image


30%





LB63


embedded image

embedded image
  139266-08-3



embedded image


24%








embedded image









LB64


embedded image

embedded image
embedded image
  4265-16-1



embedded image


26%





LB65


embedded image

  24669-57-6   embedded image



embedded image


32%








embedded image









LB66


embedded image

  931-64-6   embedded image
embedded image
  SB13a



embedded image


29%





LB67


embedded image

  24669-57-6   embedded image
embedded image
  SB13a



embedded image


31%









Example L128
5,8-Methano-5,6,7,8-tetrahydro-3-phenyl-2-azaanthra-cene, L128



embedded image


A mixture of 13.6 g (50 mmol) of 7-(3,3-dimethylbut-1-ynyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalene-6-carbaldehyde, S58, and 500 ml of methanolic ammonia solution (2 M) is stirred at 140° C. for 5 h in an autoclave. After cooling, the methanol is removed in vacuo, the oily residue is chromatographed on silica gel (n-heptane:ethyl acetate 95:5) and finally freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−4-10−5 mbar, T about 230° C.). Yield: 5.1 g (17 mmol), 34%; purity: about 99.5% according to 1H-NMR.


The following derivatives can be prepared analogously:















Ex.
Starting material
Product
Yield







L129


embedded image

  S59



embedded image

  L129

37%





L130


embedded image

  S60



embedded image

  L130

29%





L131


embedded image

  S61



embedded image

  L131

30%





L132


embedded image

  S62



embedded image

  L132

32%





L133


embedded image

  S63



embedded image

  L133

27%





L134


embedded image

  S64



embedded image

  L134

30%





L135


embedded image

  S65



embedded image

  L135

36%





LB68


embedded image

  SB18



embedded image


28%





LB69


embedded image

  SB19



embedded image


26%





LB70


embedded image

  SB20



embedded image


27%





LB71


embedded image

  SB21



embedded image


29%









Example L136
1R,4S-Methano-1,2,3,4-tetrahydro-9-phenyl-10-aza-phenanthrene, L136



embedded image


One drop of conc. sulfuric acid is added to a mixture of 26.1 g (100 mmol) of 2-bromophenylphenylmethanone [13047-06-8], 11.1 g (100 mmol) of (1R,2R,4S)-bicyclo[2.2.1]heptan-2-amine [7242-92-4] and 23.3 ml (105 mmol) of tetraethoxysilane [78-10-4], and the mixture is then heated at 160° C. in a water separator for 16 h, during which the ethanol distils off. After cooling, 500 ml of diethyl ether are added to the residue, the mixture is washed twice with 100 ml of saturated sodium hydrogencarbonate solution each time and twice with 300 ml of water each time and then dried over magnesium sulfate. After removal of the diethyl ether, 27.6 g (200 mmol) of potassium carbonate, 5 g of palladium/carbon (5% by weight), 2.6 g (10 mmol) of triphenylphosphine, 100 g of glass beads (diameter 3 mm) and 300 ml of mesitylene are added to the oily residue, and the mixture is again heated under reflux for 16 h. After cooling, the salts are filtered off with suction via a Celite bed, rinsed with 500 ml of toluene, and the combined filtrates are evaporated to dryness in vacuo. The residue is recrystallised three times from DMF/ethanol and finally freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−4-10−5 mbar, T about 230° C.). Yield: 14.9 g (55 mmol), 55%; purity: about 99.5% according to 1H-NMR.


The following derivatives can be prepared analogously:















Ex.
Starting material
Product
Yield







L137


embedded image

  80874-61-9



embedded image

  L137

47%





L138


embedded image

  951889-08-0



embedded image

  L138

45%














LB72


embedded image




embedded image

  20643-57-6 instead of 7242-92-4



embedded image


37%














80874-61-9
















LB73


embedded image




embedded image

  56419-24-0 instead of 7242-92-4



embedded image


40%














80874-61-9











Example LB74



embedded image


Preparation analogous to M. Ohashi et al., J. Am. Chem. Soc, 2011, 133, 18018.


A mixture of 13.4 g (100 mmol) of 2,3-dimethylenebicyclo[2.2.2]octane [36439-79-9], 5.2 g (50 mmol) of benzonitrile [100-47-0], 1.4 g (5 mmol) of biscyclooctadienenickel(0) [1295-35-8], 5.6 g (20 mmol) of tricyclohexylphosphine [2622-14-2] and 200 ml of o-xylene is heated under gentle reflux for 30 h while a gentle stream of argon is passed in. After cooling, the mixture is filtered through a Celite bed, and the solvent is removed in vacuo. The residue is distilled twice in a bulb tube. Yield: 6.4 g (27 mmol), 54%; purity: about 98% according to 1H NMR.


The following compounds can be prepared analogously:
















Ex.
Olefin
Nitrile
Product
Yield







LB75


embedded image

  36439-79-9



embedded image

  2102-15-0



embedded image


50%





LB76


embedded image

  36439-79-9



embedded image

  29021-90-7



embedded image


52%





LB77


embedded image

  36439-79-9



embedded image

  890134-27-7



embedded image


41%





LB78


embedded image

  36439-79-9



embedded image

  782504-06-7



embedded image


48%





LB79


embedded image

  36439-79-9



embedded image

  1264712-13-1



embedded image


18%





LB80


embedded image

  36439-79-9



embedded image

  2920-38-9



embedded image


54%





LB81


embedded image

  36439-79-9



embedded image

  20927-96-2



embedded image


53%





LB82


embedded image

  36439-79-9



embedded image

  540473-66-0



embedded image


45%





LB83


embedded image

  36439-79-9



embedded image

  1721-24-0



embedded image


49%





LB84


embedded image

  36439-79-9



embedded image

  S66



embedded image


47%





LB85


embedded image

  36439-79-9



embedded image

  S67



embedded image


46%





LB86


embedded image

  36439-79-9



embedded image

  S68



embedded image


51%





LB87


embedded image

  36439-79-9



embedded image

  SB32



embedded image


57%





LB88


embedded image

  38439-79-9



embedded image

  SB33



embedded image


52%





LB89


embedded image

  36439-79-9



embedded image

  SB34



embedded image


43%





LB90


embedded image

  95411-74-8



embedded image

  192699-47-1



embedded image


44%





LB91


embedded image

  95411-74-8



embedded image

  S66



embedded image


47%





LB92


embedded image

  95411-74-8



embedded image

  SB33



embedded image


48%





LB93


embedded image

  95411-74-8



embedded image

  SB35



embedded image


50%









Example LB94



embedded image


A mixture of 19.2 g (100 mmol) of 5-[1-hydroxymeth-[E]-ylidene-9-tricyclo-[4.3.1.1*3,8*]undecan-4-one, SB22, and 14.3 g (100 mmol) of 1-amino-naphthalene [134-32-7] is slowly heated to 160° C. on a water separator, during which the water formed during the reaction is slowly distilled off from the melt. After 10 h at 160° C., 100 ml of toluene are slowly added dropwise, and this is distilled off via the water separator in order to remove the residual water from the melt and the apparatus. About 300 g of poly-phosphoric acid are added to the deep-brown melt obtained in this way in a countercurrent of argon, and the mixture is stirred at 160° C. for a further 16 h. After cooling to 120° C., 400 ml of water are added dropwise to the black, viscous melt (note: exothermic!), and stirring is continued until the melt has completely homogenised, during which a brown solid precipitates out. The suspension is transferred into a beaker containing 2 l of water, the mixture is stirred for a further 1 h, and the solid is filtered off with suction and washed once with 300 ml of water. After sucking dry, the solid is re-suspended in 1 l of 15% by weight ammonia solution, and the mixture is stirred for a further 1 h, and the solid is again filtered off with suction, washed with water until neutral and then sucked dry. The solid is dissolved in 500 ml of dichloromethane, the solution is washed with saturated sodium chloride solution, and the organic phase is dried over magnesium sulfate. After removal of the drying agent, the solution is evaporated, and the glass-like residue is passed through a column with dichloromethane, once on aluminium oxide, basic, activity grade 1, and twice on silica gel. The solid obtained in this way is recrystallised three times from DMF/EtOH and then subjected to fractional sublimation twice (p about 10−5 mbar, T 290° C.). Yield: 15.0 g (50 mmol), 50%; purity: about 99.9% according to 1H NMR.


The following compounds can be prepared analogously:

















β-Hydroxy-





Ex.
methylene ketone
Amine
Product
Yield







LB95


embedded image

  SB23



embedded image

  78832-53-8



embedded image


47%





LB96


embedded image

  SB24



embedded image

  4523-45-9



embedded image


45%





LB97


embedded image

  SB25



embedded image

  87833-80-5



embedded image


41%





LB98


embedded image

  SB26



embedded image

  50358-40-2



embedded image


43%





LB99


embedded image

  SB27



embedded image

  64485-52-5



embedded image


45%





LB100


embedded image

  SB28



embedded image

  20335-61-9



embedded image


19%





LB101


embedded image

  SB29



embedded image

  134-32-7



embedded image


22%





LB102


embedded image

  SB30



embedded image

  134-32-7



embedded image


46%





LB103


embedded image

  SB31



embedded image

  23687-25-4



embedded image


14%





LB104


embedded image

  SB22



embedded image

  50358-40-2



embedded image


43%





LB105


embedded image

  SB22



embedded image

  161431-57-8



embedded image


28%





LB106


embedded image

  SB22



embedded image

  175229-87-5



embedded image


29%









Example LB107
Tetradentate Uganda



embedded image


A mixture of 47.8 g (100 mmol) of 9,9-bis(6-bromopyrid-2-yl)fluorene [1323362-54-4], 65.4 g (230 mmol) of SB1, 42.4 g (400 mmol) of sodium carbonate, 1.2 g (1 mmol) of tetrakistriphenylphosphinopalladium(0), 300 ml of toluene, 200 ml of dioxane and 300 ml of water is heated under reflux for 30 h. After cooling, the organic phase is separated off, filtered through a Celite bed, with the Celite being rinsed with 300 ml of toluene, the combined filtrates are washed three times with 300 ml of water each time, dried over magnesium sulfate and then freed from toluene in vacuo. The residue is recrystallised three times from ethanol with addition of a little ethyl acetate and finally freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−5 mbar, T about 300° C.). Yield: 32.3 g (51 mmol), 51%; purity: about 99.5% according to 1H-NMR.


The following compounds can be prepared analogously:

















Starting
Starting




Ex.
material
material
Product
Yield







LB108


embedded image

  1421759-18-3



embedded image

  SB1



embedded image


50%





LB109


embedded image

  S50



embedded image

  SB4



embedded image


55%





LB110


embedded image

  S51



embedded image

  SB4



embedded image


53%









Example LB111
Tetradentate Ligands



embedded image


Procedure analogous to C. Cao et al., Synth. Commun. 2012, 42, 380.


A mixture of 15.0 g (50 mmol) of LB43 B), and 4.7 g (25 mmol) of 1,2-dibromoethane [106-93-4] is heated at 120° C. for 6 h in an autoclave. After cooling, the solid mass is taken up in 100 ml of tert-butyl methyl ether, homogenised with stirring, the white solid is filtered off, washed twice with 50 ml of tert-butyl methyl ether each time and dried in vacuo. Yield: 15.8 g (20 mmol), 80%; purity: about 98.0% according to 1H-NMR.


The following compounds can be prepared analogously:















Ex.
Imidazole
Ligand
Yield







LB112


embedded image

  LB43 B)



embedded image


81%





LB113


embedded image

  LB48 B)



embedded image


80%





LB114


embedded image

  LB53 B)



embedded image


83%









Example LB115
Hexadentate Ligands



embedded image


A mixture of 51.4 g (100 mmol) of tris(6-bromopyridin-2-yl)methoxy-methane [336158-91-9], 93.8 g (330 mmol) of SB1, 42.4 g (400 mmol) of sodium carbonate, 1.2 g (1 mmol) of tetrakistriphenylphosphinopalladium(0), 500 ml of toluene, 300 ml of dioxane and 500 ml of water is heated under reflux for 36 h. After cooling, the organic phase is separated off, filtered through a Celite bed, with the Celite being rinsed with 400 ml of toluene, the combined filtrates are washed three times with 300 ml of water each time, dried over magnesium sulfate and then freed from toluene in vacuo. The residue is recrystallised three times from isopropanol with addition of a little ethyl acetate and finally freed from low-boiling components and non-volatile secondary components by fractional sublimation (p about 10−5 mbar, T about 310° C.). Yield: 36.6 g (47 mmol), 47%; purity: about 99.5% according to 1H-NMR.


The following compounds can be prepared analogously:

















Starting
Starting




Ex.
material
material
Product
Yield







LB116


embedded image

  760177-68-2



embedded image

  SB4



embedded image


50%





LB117


embedded image

  197776-47-9



embedded image

  SB2



embedded image


45%









Example LB118
Hexadentate Ligands



embedded image


Procedure analogous to LB111, where the 1,2-dibromoethane is replaced by 5.2 g (16.7 mmol) of 1,1,1-tris(bromomethyl)ethane [60111-68-4]. Yield: 14.5 g (12 mmol), 72%; purity: about 99.0% according to 1H-NMR.


Compound LB119 can be prepared analogously:




embedded image


1,1,1-Tris(bromomethyl)ethane is replaced by 6.1 g (16.7 mmol) of cis,cis-1,2,3-cydopropanetrimethanol trimethanesulfonate [945230-85-3]. Yield: 16.5 g (13 mmol), 78%; purity: about 99.0% according to 1H-NMR.


C: Synthesis of the Metal Complexes
1) Homoleptic Tris-Facial Iridium Complexes of the Phenylpyridine, Phenylimidazole or Phenylbenzimidazole Type
Variant A: Trisacetylacetonatoiridium(III) as Iridium Starting Material

A mixture of 10 mmol of trisacetylacetonatoiridium(III) [15635-87-7] and 40-60 mmol (preferably 40 mmol) of the ligand L, optionally 1-10 g—typically in of an inert high-boiling additive as melting aid or solvent, e.g. hexa-decane, m-terphenyl, triphenylene, diphenyl ether, 3-phenoxytoluene, 1,2-, 1,3-, 1,4-bisphenoxybenzene, triphenylphosphine oxide, sulfolane, 18-crown-6, triethylene glycol, glycerol, polyethylene glycols, phenol, 1-naphthol, etc., and a glass-clad magnetic stirrer bar are melted into a thick-walled 50 ml glass ampoule in vacuo (10−5 mbar). The ampoule is heated at the temperature indicated for the time indicated, during which the molten mixture is stirred with the aid of a magnetic stirrer. In order to prevent sublimation of the ligands onto relatively cold parts of the ampoule, the entire ampoule must have the temperature indicated. Alternatively, the synthesis can be carried out in a stirred autoclave with glass insert. After cooling (NOTE: the ampoules are usually under pressure!), the ampoule is opened, the sinter cake is stirred for 3 h with 100 g of glass beads (diameter 3 mm) in 100 ml of a suspension medium (the suspension medium is selected so that the ligand is readily soluble, but the metal complex has low solubility therein, typical suspension media are methanol, ethanol, dichloromethane, acetone, THF, ethyl acetate, toluene, etc.) and mechanically digested in the process. The fine suspension is decanted off from the glass beads, the solid is filtered off with suction, rinsed with 50 ml of the suspension medium and dried in vacuo. The dry solid is placed on a 3-5 cm deep aluminium oxide bed (aluminium oxide, basic, activity grade 1) in a continuous hot extractor and then extracted with an extractant (initially introduced amount about 500 ml, the extractant is selected so that the complex is readily soluble therein at elevated temperature and has low solubility therein when cold, particularly suitable extractants are hydrocarbons, such as toluene, xylenes, mesitylene, naphthalene, o-dichlorobenzene, halogenated aliphatic hydrocarbons are generally unsuitable since they may halogenate or decompose the complexes). When the extraction is complete, the extractant is evaporated to about 100 ml in vacuo. Metal complexes which have excessively good solubility in the extractant are brought to crystallisation by dropwise addition of 200 ml of methanol. The solid of the suspensions obtained in this way is filtered off with suction, washed once with about 50 ml of methanol and dried. After drying, the purity of the metal complex is determined by means of NMR and/or HPLC. If the purity is below 99.5%, the hot extraction step is repeated, omitting the aluminium oxide bed from the 2nd extraction. When a purity of 99.5-99.9% has been reached, the metal complex is heated or sublimed. The heating is carried out in a high vacuum (p about 10−5 mbar) in the temperature range from about 200-300° C., preferably for complexes having molecular weights greater than about 1300 g/mol. The sublimation is carried out in a high vacuum (p about 10−6 mbar) in the temperature range from about 230-400° C., with the sublimation preferably being carried out in the form of a fractional sublimation. Complexes which are readily soluble in organic solvents may alternatively also be chromatographed on silica gel.


Ifchiral ligands are employed, the derived fac-metal complexes are produced in the form of a diastereomer mixture. The enantiomers Λ,Δ in point group C3 generally have significantly lower solubility in the extractant than the enantiomers in point group C1, which are consequently enriched in the mother liquor. Separation of the C3 diastereomers from the C1 diastereomers is frequently possible by this method. In addition, the diastereomers can also be separated by chromatography. If ligands in point group C1 are employed in enantiomerically pure form, a diastereomer pair Λ,Δ in point group C3 is formed. The diastereomers can be separated by crystallisation or chromatography and thus obtained as enantiomerically pure compounds.


Variant B: Tris-(2,2,6,6-tatramethyl-3,5-heptanedionato)iridium(III) as iridium starting material

Procedure analogous to variant A, using 10 mmol of tris(2,2,6,6-tetramethyl-3,5-heptanedionato)iridium [99581-86-9] instead of 10 mmol of tris-acetylacetonatoiridium(III) [15635-87-7]. The use of this starting material is advantageous since the purity of the crude products obtained is frequently better than in the case of variant A. In addition, the build-up of pressure in the ampoule is frequently not so pronounced.


Variant C: Sodium [cis,trans-dichloro(bisacetylacetonato)]iridate(III) as iridium starting material

A mixture of 10 mmol of sodium [cis,trans-dichloro(bisacetylacetonato)]-iridate(III) [876296-21-8] and 60 mmol of the ligand in 50 ml of ethylene glycol, propylene glycol or diethylene glycol is heated under gentle reflux under a gentle stream of argon for the time indicated. After cooling to 60° C., the reaction mixture is diluted with a mixture of 50 ml of ethanol and 50 ml of 2 N hydrochloric acid with stirring and stirred for a further 1 h, the precipitated solid is filtered off with suction, washed three times with 30 ml of ethanol each time and then dried in vacuo. Purification by hot extraction or chromatography and fractional sublimation, as described under A.



















Variant






Reaction medium






Melting aid






Reaction temp.






Reaction time




Ligand
Ir complex
Suspension medium



Ex.
L
Diastereomer
Extractant
Yield







Ir(LB1)3
LB1


embedded image


A — — 270° C. 24 h EtOH Ethyl acetate
48%





Ir(LB1)3
LB1


embedded image


C Propylene glycol — RF 100 h — o-Xylene
40%





Ir(LB2)3
LB2


embedded image


A — — 270° C. 24 h EtOH Ethyl acetate
50%





Ir(LB3)3
LB3


embedded image


as for Ir(LB2)3
52%





Ir(LB4)3
LB4


embedded image


as for Ir(LB2)3
47%





Ir(LB5)3
LB5


embedded image


as for Ir(LB2)3
38%





Ir(LB6)3
LB6


embedded image


A — Hydroquinone 280° C. 40 h EtOH Ethyl acetate
13%





Ir(LB7)3
LB7


embedded image


A — — 280° C. 30 h EtOH Ethyl acetate/ cyclohexane 1:1
33%





Ir(LB8)3
LB8


embedded image

  Λ,Δ-C3

as for Ir(LB2)3
24%





Ir(LB9)3
LB9


embedded image


A — — 270° C. 24 h — — Chromatography silica gel/toluene
38%





Ir(LB10)3
LB10


embedded image


as for Ir(LB2)3
43%





Ir(LB11)3
LB11


embedded image


as for Ir(LB2)3
41%





Ir(LB12)3
LB12


embedded image


as for Ir(LB2)3
33%





Ir(LB13)3
LB13


embedded image


as for Ir(LB2)3
40%





Ir(LB14)3
LB14


embedded image


B — Hydroquinone 280° C. 40 h EtOH Ethyl acetate
10%





Ir(LB15)3
LB15


embedded image

  Λ,Δ-C3

as for Ir(LB2)3
20%





Ir(LB16)3
LB16


embedded image

  Λ,Δ-C3

as for Ir(LB2)3
16%





Ir(LB17)3
LB17


embedded image


as for Ir(LB2)3
36%





Ir(LB18)3
LB18


embedded image

  Λ,Δ-C3

B — — 280° C. 24 h — — Chromatography silica gel n-heptane:DCM 8:1
34%





Ir(LB19)3
LB19


embedded image


as for Ir(LB2)3
46%





Ir(LB20)3
LB20


embedded image


as for Ir(LB2)3
39%





Ir(LB21)3
LB21


embedded image


as for Ir(LB14)3
9%





Ir(LB22)3
LB22


embedded image


B — — 275° C. 20 h — — Chromatography silica gel cyclohexane
30%





Ir(LB33)3
LB33


embedded image


A — — 280° C. 24 h EtOH Ethyl acetate
45%





Ir(LB34)3
LB34


embedded image


as for Ir(LB33)3
40%





Ir(LB35)3
LB35


embedded image


A — — 280° C. 45 h EtOH Toluene
36%





Ir(LB36)3
LB36


embedded image


as for Ir(LB33)3
37%





Ir(LB37)3
LB37


embedded image


as for Ir(LB33)3
27%





Ir(LB38)3
LB38


embedded image


as for Ir(LB33)3
35%





Ir(LB39)3
LB39


embedded image

  Λ,Δ-C3

as for Ir(LB33)3
17%





Ir(LB40)3
LB40


embedded image


as for Ir(LB33)3
39%





Ir(LB41)3
LB41


embedded image


as for Ir(LB33)3
32%





Ir(LB42)3
LB42


embedded image


as for Ir(LB33)3
35%





Ir(LB55)3
LB55


embedded image


A — — 290° C. 120 h Acetone Toluene
40%





Ir(LB56)3
LB56


embedded image


A — — 290° C. 120 h Acetone Toluene
38%





Ir(LB57)3
LB57


embedded image


as for Ir(LB2)3
44%





Ir(LB59)3
LB59


embedded image


as for Ir(LB14)3
7%





Ir(LB68)3
LB68


embedded image


as for Ir(LB2)3
42%





Ir(LB69)3
LB69


embedded image


as for Ir(LB2)3
40%





Ir(LB70)3
LB70


embedded image

  Diastereomer mixture

as for Ir(LB2)3
29%





Ir(LB71)3
LB71


embedded image


A — — 270° C. 20 h — — Chromatography silica gel cyclohexane
42%





Ir(LB74)3
LB74


embedded image


as for Ir(LB2)3
50%





Ir(LB75)3
LB75


embedded image


as for Ir(LB2)3
40%





Ir(LB76)3
LB76


embedded image


as for Ir(LB2)3
40%





Ir(LB77)3
LB77


embedded image


as for Ir(LB2)3
43%





Ir(LB78)3
LB78


embedded image


as for Ir(LB2)3
42%





Ir(LB79)3
LB79


embedded image


as for Ir(LB2)3
34%





Ir(LB80)3
LB80


embedded image


as for Ir(LB2)3
47%





Ir(LB81)3
LB81


embedded image


as for Ir(LB2)3
45%





Ir(LB83)3
LB83


embedded image


A — — 285° C. 30 h EtOH o-Xylene
31%





Ir(LB84)3
LB84


embedded image


A — — 275° C. 22 h EtOH Cyclohexane
50%





Ir(LB85)3
LB85


embedded image


as for Ir(LB84)3
47%





Ir(LB86)3
LB86


embedded image


as for Ir(LB84)3
52%





Ir(LB87)3
LB87


embedded image


as for Ir(LB84)3
46%





Ir(LB88)3
LB88


embedded image


as for Ir(LB84)3
47%





Ir(LB89)3
LB89


embedded image

  Diastereomer mixture

as for Ir(LB84)3
32%





Ir(LB90)3
LB90


embedded image


as for Ir(LB2)3
47%





Ir(LB91)3
LB91


embedded image


as for Ir(LB84)3
43%





Ir(LB92)3
LB92


embedded image


as for Ir(LB84)3
45%





Ir(LB93)3
LB93


embedded image


as for Ir(LB84)3
40%





Ir(LB94)3
LB94


embedded image


A — Hydroquinone 270° C. 20 h MeOH Chromatography silica gel dichloromethane
47%





Ir(LB95)3
LB95


embedded image


A — Hydroquinone 280° C. 28 h MeOH Chromatography silica gel dichloromethane
31%





Ir(LB96)3
LB96


embedded image


as for Ir(LB94)3
45%





Ir(LB97)3
LB97


embedded image

  Diastereomer mixture

as for Ir(LB94)3
41%





Ir(LB98)3
LB98


embedded image


A — Hydroquinone 290° C. 25 h MeOH Chromatography silica gel dichloromethane
18%





Ir(LB99)3
LB99


embedded image


as for Ir(LB98)3
25%





Ir(LB100)3
LB100


embedded image

  Diastereomer mixture

A — Hydroquinone 260° C. 25 h MeOH Chromatography silica gel dichloromethane
13%





Ir(LB101)3
LB101


embedded image


A — Hydroquinone 260° C. 25 h MeOH Chromatography silica gel dichloromethane
18%





Ir(LB102)3
LB102


embedded image


as for Ir(LB94)3
45%





Ir(LB103)3
LB103


embedded image


as for Ir(LB94)3
48%





Ir(LB104)3
LB104


embedded image


as for Ir(LB98)3
26%





Ir(LB105)3
LB105


embedded image


as for Ir(LB98)3
18%





Ir(LB106)3
LB106


embedded image


as for Ir(LB98)3
23%









2) Homoleptic Iridium Complexes of the Arduengo Carbene Type

Preparation analogous to K. Tsuchiya, et al., Eur. J. Inorg. Chem., 2010, 926.


A mixture of 10 mmol of the ligand, 3 mmol of iridium(III) chloride hydrate, 10 mmol of silver carbonate, 10 mmol of sodium carbonate in 75 ml of 2-ethoxyethanol is warmed under reflux for 24 h. After cooling, 300 ml of water are added, the precipitated solid is filtered off with suction, washed once with 30 ml of water and three times with 15 ml of ethanol each time and dried in vacuo. The fac/mer isomer mixture obtained in this way is chromatographed on silica gel. The isomers are subsequently subjected to fractional sublimation or freed from the solvent in a high vacuum (fac-Ir(LB49)3, fac-Ir(LB50)3, fac-Ir(LB51)3).
















Ligand
Ir complex



Ex.
L
Diastereomer
Yield







fac-Ir(LB43)3 mer-Ir(LB43)3
LB43


embedded image


39% 11%





fac-Ir(LB44)3 mer-Ir(LB44)3
LB44


embedded image


36% 10%





fac-Ir(LB45)3 mer-Ir(LB45)3
LB45


embedded image


44% 11%





fac-Ir(LB46)3 mer-Ir(LB46)3
LB46


embedded image


41%  5%





fac-Ir(LB47)3
LB47


embedded image

  fac-Λ,Δ-C3

33%





fac-Ir(LB48)3
LB48


embedded image


36%





fac-Ir(LB49)3
LB49


embedded image


42%





fac-Ir(LB50)3
LB50


embedded image


39%





fac-Ir(LB51)3
LB51


embedded image


38%





fac-Ir(LB52)3
LB52


embedded image


30%





fac-Ir(LB53)3
LB53


embedded image


28%





fac-Ir(LB54)3
LB54


embedded image


33%









3) Iridium complexes of the [Ir(L)2C]2 type
Variant A

A mixture of 22 mmol of the ligand, 10 mmol of iridium(III) chloride hydrate, 75 ml of 2-ethoxyethanol and 25 ml of water is heated under reflux for 16-24 h with vigorous stirring. If the ligand does not dissolve or does not dissolve completely in the solvent mixture under reflux, 1,4-dioxane is added until a solution has formed. After cooling, the precipitated solid is filtered off with suction, washed twice with ethanol/water (1:1, w) and then dried in vacuo. The chloro dimer of the formula [Ir(L)2Cl]2 obtained in this way is reacted further without purification.


Variant B

A mixture of 10 mmol of sodium bisacetylacetonatodichloroiridate(III) [770720-50-8], 24 mmol of ligand L and a glass-clad magnetic stirrer bar are melted into a thick-walled 50 ml glass ampoule in vacuo (10−5 mbar). The ampoule is heated at the temperature indicated for the time indicated, during which the molten mixture is stirred with the aid of a magnetic stirrer. After cooling—NOTE: the ampoules are usually under pressure!—the ampoule is opened, the sinter cake is stirred for 3 h with 100 g of glass beads (diameter 3 mm) in 100 ml of the suspension medium indicated (the suspension medium is selected so that the ligand is readily soluble, but the chloro dimer of the formula [Ir(L)2Cl]2 has low solubility therein, typical suspension media are dichloromethane, acetone, ethyl acetate, toluene, etc.) and mechanically digested at the same time. The fine suspension is decanted off from the glass beads, the solid [Ir(L)2Cl]2 which still contains about 2 eq. of NaCl, referred to below as the crude chloro dimer) is filtered off with suction and dried in vacuo. The crude chloro dimer of the formula [Ir(L)2Cl]2 obtained in this way is reacted further without purification.
















Ligand
Ir complex Variant



Ex.
L
Temp./time Diastereomer
Yield







[Ir(L1)2Cl]2
L1 


embedded image


76%







A






[Ir(L2)2Cl]2
L2 
Ir[(L2)Cl]2
81%




A






[Ir(L5)2Cl]2
L5 


embedded image


61%







A






[Ir(L6)2Cl]2
L6 
Ir[(L6)Cl]2
74%




A






[Ir(L10)2Cl]2
L10 


embedded image


63%







A





Diastereomer mixture






[Ir(L11)2Cl]2
L11 


embedded image


69%







A





Diastereomer mixture






[Ir(L12)2Cl]2
L12 
Ir[(L12)Cl]2
75%




B






[Ir(L14)2Cl]2
L14 


embedded image








[Ir(L21)2Cl]2
L21 
Ir[(L21)Cl]2
53%




A





Diastereomer mixture






[Ir(L25)2Cl]2
L25 


embedded image


73%







A





Diastereomer mixture






[Ir(L42)2Cl]2
L42 


embedded image


84%







A






[Ir(L47)2Cl]2
L47 


embedded image


80%







A






[Ir(L48)2Cl]2
L48 


embedded image


78%







B





200° C./80 h






[Ir(L53)2Cl]2
L53 


embedded image


46%







A






[Ir(L55)2Cl]2
L55 
Ir[(L55)Cl]2
44%




A



[Ir(L59)2Cl]2
L59 
[Ir(L59)2Cl]2
57%




A





Diastereomer mixture



[Ir(L60)2Cl]2
L60 
[Ir(L60)2Cl]2
63%




A



[Ir(L62)2Cl]2
L62 
[Ir(L62)2Cl]2
65%




B





240° C./48 h






[Ir(L64)2Cl]2
L64 


embedded image


88%







B





250° C./80 h






[Ir(L72)2Cl]2
L72 


embedded image


78%







B





270° C./80 h






[Ir(L74)2Cl]2
L74 


embedded image


66%







B





250° C./80 h






[Ir(L95)2Cl]2
L95 


embedded image


88%







B





240° C./60 h






[Ir(L96)2Cl]2
L96 
[Ir(L96)2Cl]2
86%




as for [Ir(L95)2Cl]2



[Ir(L100)2Cl]2
L100
[Ir(L100)2Cl]2
87%




as for [Ir(L95)2Cl]2






[Ir(L102)2Cl]2
L102


embedded image


92%







B





250° C./60 h





Diastereomer mixture






[Ir(L103)2Cl]2
L103
[Ir(L103)2Cl]2
90%




as for [Ir(L102)2Cl]2



[Ir(L104)2Cl]2
L104
[Ir(L104)2Cl]2
90%




as for [Ir(L102)2Cl]2



[Ir(L105)2Cl]2
L105
[Ir(L105)2Cl]2
83%




as for [Ir(L102)2Cl]2



[Ir(L106)2Cl]2
L106
[Ir(L106)2Cl]2
91%




as for [Ir(L102)2Cl]2



[Ir(L107)2Cl]2
L107
[Ir(L107)2Cl]2
90%




as for [Ir(L102)2Cl]2



[Ir(L108)2Cl]2
L108
[Ir(L108)2Cl]2
87%




as for [Ir(L102)2Cl]2



[Ir(L109)2Cl]2
L109
[Ir(L109)2Cl]2
90%




as for [Ir(L102)2Cl]2



[Ir(L110)2Cl]2
L110
[Ir(L110)2Cl]2
92%




as for [Ir(L102)2Cl]2



[Ir(L111)2Cl]2
L111
[Ir(L111)2Cl]2
89%




as for [Ir(L102)2Cl]2



[Ir(L112)2Cl]2
L112
[Ir(L112)2Cl]2
84%




as for [Ir(L102)2Cl]2



[Ir(L113)2Cl]2
L113
[Ir(L113)2Cl]2
78%




B





250° C. /60 h





Diastereomer mixture



[Ir(L114)2Cl]2
L114
[Ir(L114)2Cl]2
64%




B





280° C. /60 h





Diastereomer mixture



[Ir(L115a)2Cl]2
 L115a
[Ir(L115a)2Cl]2
89%




as for [Ir(L102)2Cl]2



[Ir(L115b)2Cl]2
 L115b
[Ir(L115b)2Cl]2
91%




as for [Ir(L102)2Cl]2



[Ir(L116)2Cl]2
L116
[Ir(L116)2Cl]2
87%




as for [Ir(L114)2Cl]2



[Ir(L117)2Cl]2
L117
[Ir(L117)2Cl]2
88%




as for [Ir(L102)2Cl]2



[Ir(L118)2Cl]2
L118
[Ir(L118)2Cl]2
88%




as for [Ir(L102)2Cl]2



[Ir(L119)2Cl]2
L119
[Ir(L119)2Cl]2
90%




as for [Ir(L102)2Cl]2



[Ir(L120)2Cl]2
L120
[Ir(L120)2Cl]2
89%




as for [Ir(L102)2Cl]2



[Ir(L121)2Cl]2
L121
[Ir(L121)2Cl]2
89%




as for [Ir(L102)2Cl]2



[Ir(L122)2Cl]2
L122
[Ir(L122)2Cl]2
87%




as for [Ir(L102)2Cl]2



[Ir(L123)2Cl]2
L123
[Ir(L123)2Cl]2
93%




as for [Ir(L102)2Cl]2



[Ir(L124)2Cl]2
L124
[Ir(L124)2Cl]2
78%




B





250° C. /30 h





Diastereomer mixture



[Ir(L125)2Cl]2
L125
[Ir(L125)2Cl]2
80%




as for [Ir(L124)2Cl]2



[Ir(L126)2Cl]2
L126
[Ir(L126)2Cl]2
67%




as for [Ir(L124)2Cl]2



[Ir(L127)2Cl]2
L127
[Ir(L127)2Cl]2
69%




B





260° C./28 h






[Ir(L129)2Cl]2
L129


embedded image


91%







B





260° C./30 h






[Ir(L136)2Cl]2
L136


embedded image


85%







B





280° C./40 h





Diastereomer mixture
85%





[Ir(L137)2Cl]2
L137
[Ir(L137)2Cl]2
86%




as for [Ir(L136)2Cl]2



[Ir(L138)2Cl]2
L138
[Ir(L138)2Cl]2
84%




as for [Ir(L136)2Cl]2






[Ir(LB1)2Cl]2
LB1 


embedded image


76%







A






[Ir(LB2)2Cl]2
LB2 


embedded image


76%







B





240° C./20 h






[Ir(LB3)2Cl]2
LB3 
[Ir(LB3)2Cl]2
75%




as for [Ir(LB1)2Cl]2



[Ir(LB4)2Cl]2
LB4 
[Ir(LB4)2Cl]2
80%




as for [Ir(LB1)2Cl]2



[Ir(LB5)2Cl]2
LB5 
[Ir(LB5)2Cl]2
79%




as for [Ir(LB1)2Cl]2



[Ir(LB6)2Cl]2
LB6 
[Ir(LB6)2Cl]2
73%




as for [Ir(LB2)2Cl]2



[Ir(LB7)2Cl]2
LB7 
[Ir(LB7)2Cl]2
74%




as for [Ir(LB2)2Cl]2



[Ir(LB8)2Cl]2
LB8 
[Ir(LB8)2Cl]2
77%




as for [Ir(LB2)2Cl]2



[Ir(LB9)2Cl]2
LB9 
[Ir(LB9)2Cl]2
81%




as for [Ir(LB2)2Cl]2



[Ir(LB10)2Cl]2
LB10
[Ir(LB10)2Cl]2
76%




as for [Ir(LB1)2Cl]2



[Ir(LB11)2Cl]2
LB11
[Ir(LB11)2Cl]2
84%




as for [Ir(LB2)2Cl]2



[Ir(LB12)2Cl]2
LB12
[Ir(LB12)2Cl]2
84%




as for [Ir(LB2)2Cl]2



[Ir(LB13)2Cl]2
LB13
[Ir(LB13)2Cl]2
80%




as for [Ir(LB2)2Cl]2



[Ir(LB14)2Cl]2
LB14
[Ir(LB14)2Cl]2
79%




as for [Ir(LB2)2Cl]2



[Ir(LB15)2Cl]2
LB15
[Ir(LB15)2Cl]2
83%




as for [Ir(LB2)2Cl]2



[Ir(LB16)2Cl]2
LB16
[Ir(LB16)2Cl]2
82%




as for [Ir(LB2)2Cl]2



[Ir(LB17)2Cl]2
LB17
[Ir(LB17)2Cl]2
80%




as for [Ir(LB2)2Cl]2



[Ir(LB18)2Cl]2
LB18
[Ir(LB18)2Cl]2
86%




as for [Ir(LB2)2Cl]2



[Ir(LB19)2Cl]2
LB19
[Ir(LB19)2Cl]2
80%




as for [Ir(LB2)2Cl]2



[Ir(LB20)2Cl]2
LB20
[Ir(LB20)2Cl]2
81%




as for [Ir(LB2)2Cl]2



[Ir(LB21)2Cl]2
LB21
[Ir(LB21)2Cl]2
73%




as for [Ir(LB2)2Cl]2






[Ir(LB22)2Cl]2
LB22


embedded image


86%







as for [Ir(LB2)2Cl]2






[Ir(LB23)2Cl]2
LB23


embedded image


53%







A






[Ir(LB24)2Cl]2
LB24


embedded image


60%







B





250° C./20 h






[Ir(LB25)2Cl]2
LB25
[Ir(LB25)2Cl]2
60%




as for [Ir(LB24)2Cl]2



[Ir(LB26)2Cl]2
LB26
[Ir(LB26)2Cl]2
52%




as for [Ir(LB24)2Cl]2



[Ir(LB27)2Cl]2
LB27
[Ir(LB27)2Cl]2
64%




as for [Ir(LB24)2Cl]2



[Ir(LB28)2Cl]2
LB28
[Ir(LB28)2Cl]2
67%




as for [Ir(LB24)2Cl]2



[Ir(LB29)2Cl]2
LB29
[Ir(LB29)2Cl]2
53%




as for [Ir(LB23)2Cl]2



[Ir(LB30)2Cl]2
LB30
[Ir(LB30)2Cl]2
52%




as for [Ir(LB24)2Cl]2



[Ir(LB31)2Cl]2
LB31
[Ir(LB31)2Cl]2
59%




as for [Ir(LB24)2Cl]2



[Ir(LB32)2Cl]2
LB32
[Ir(LB32)2Cl]2
66%




as for [Ir(LB24)2Cl]2






[Ir(LB33)2Cl]2
LB33


embedded image


75%







B





270° C./60 h






[Ir(LB34)2Cl]2
LB34
[Ir(LB34)2Cl]2
57%




as for [Ir(LB33)2Cl]2



[Ir(LB35)2Cl]2
LB35
[Ir(LB35)2Cl]2
48%




B





285° C./80 h



[Ir(LB36)2Cl]2
LB36
[Ir(LB36)2Cl]2
77%




as for [Ir(LB33)2Cl]2



[Ir(LB37)2Cl]2
LB37
[Ir(LB37)2Cl]2
60%




as for [Ir(LB33)2Cl]2



[Ir(LB38)2Cl]2
LB38
[Ir(LB38)2Cl]2
64%




as for [Ir(LB33)2Cl]2



[Ir(LB39)2Cl]2
LB39
[Ir(LB39)2Cl]2
78%




as for [Ir(LB33)2Cl]2



[Ir(LB40)2Cl]2
LB40
[Ir(LB40)2Cl]2
76%




as for [Ir(LB33)2Cl]2



[Ir(LB41)2Cl]2
LB41
[Ir(LB41)2Cl]2
51%




as for [Ir(LB33)2Cl]2



[Ir(LB42)2Cl]2
LB42
[Ir(LB42)2Cl]2
65%




as for [Ir(LB33)2Cl]2






[Ir(LB58)2Cl]2
LB58


embedded image


81%







B





250° C./50 h






[Ir(LB59)2Cl]2
LB59
[Ir(LB59)2Cl]2
92%




as for [Ir(LB58)2Cl]2



[Ir(LB60)2Cl]2
LB60
[Ir(LB60)2Cl]2
90%




as for [Ir(LB58)2Cl]2



[Ir(LB61)2Cl]2
LB61
[Ir(LB61)2Cl]2
89%




as for [Ir(LB58)2Cl]2



[Ir(LB62)2Cl]2
LB62
[Ir(LB62)2Cl]2
89%




as for [Ir(LB58)2Cl]2



[Ir(LB63)2Cl]2
LB63
[Ir(LB63)2Cl]2
82%




as for [Ir(LB58)2Cl]2



[Ir(LB64)2Cl]2
LB64
[Ir(LB64)2Cl]2
67%




as for [Ir(LB58)2Cl]2



[Ir(LB65)2Cl]2
LB65
[Ir(LB65)2Cl]2
88%




as for [Ir(LB58)2Cl]2



[Ir(LB66)2Cl]2
LB66
[Ir(LB66)2Cl]2
90%




as for [Ir(LB58)2Cl]2



[Ir(LB67)2Cl]2
LB67
[Ir(LB67)2Cl]2
91%




as for [Ir(LB58)2Cl]2






[Ir(LB68)2Cl]2
LB68


embedded image


88%







B





260° C./30 h






[Ir(LB69)2Cl]2
LB69
[Ir(LB69)2Cl]2
85%




as for [Ir(LB69)2Cl]2



[Ir(LB70)2Cl]2
LB70
[Ir(LB70)2Cl]2
67%




as for [Ir(LB69)2Cl]2



[Ir(LB71)2Cl]2
LB71
[Ir(LB71)2Cl]2
87%




as for [Ir(LB69)2Cl]2






[Ir(LB72)2Cl]2
LB72


embedded image


56%







B





280° C./40 h






[Ir(LB73)2Cl]2
LB73
[Ir(LB73)2Cl]2
59%




as for [Ir(LB72)2Cl]2






[Ir(LB74)2Cl]2
LB74


embedded image


86%







A






[Ir(LB75)2Cl]2
LB75
[Ir(LB75)2Cl]2
90%




B





260° C./25 h



[Ir(LB76)2Cl]2
LB76
[Ir(LB76)2Cl]2
89%




as for [Ir(LB75)2Cl]2



[Ir(LB77)2Cl]2
LB77
[Ir(LB77)2Cl]2
90%




as for [Ir(LB75)2Cl]2



[Ir(LB78)2Cl]2
LB78
[Ir(LB78)2Cl]2
83%




as for [Ir(LB75)2Cl]2



[Ir(LB79)2Cl]2
LB79
[Ir(LB79)2Cl]2
87%




as for [Ir(LB75)2Cl]2



[Ir(LB80)2Cl]2
LB80
[Ir(LB80)2Cl]2
86%




as for [Ir(LB75)2Cl]2



[Ir(LB81)2Cl]2
LB81
[Ir(LB81)2Cl]2
90%




as for [Ir(LB75)2Cl]2



[Ir(LB82)2Cl]2
LB82
[Ir(LB82)2Cl]2
61%




as for [Ir(LB75)2Cl]2



[Ir(LB83)2Cl]2
LB83
[Ir(LB83)2Cl]2
86%




as for [Ir(LB75)2Cl]2



[Ir(LB84)2Cl]2
LB84
[Ir(LB84)2Cl]2
85%




as for [Ir(LB75)2Cl]2



[Ir(LB85)2Cl]2
LB85
[Ir(LB85)2Cl]2
88%




as for [Ir(LB75)2Cl]2



[Ir(LB86)2Cl]2
LB86
[Ir(LB86)2Cl]2
86%




as for [Ir(LB75)2Cl]2



[Ir(LB87)2Cl]2
LB87
[Ir(LB87)2Cl]2
91%




as for [Ir(LB75)2Cl]2



[Ir(LB88)2Cl]2
LB88
[Ir(LB88)2Cl]2
90%




as for [Ir(LB75)2Cl]2



[Ir(LB90)2Cl]2
LB90
[Ir(LB90)2Cl]2
90%




as for [Ir(LB75)2Cl]2



[Ir(LB91)2Cl]2
LB91
[Ir(LB91)2Cl]2
85%




as for [Ir(LB75)2Cl]2



[Ir(LB92)2Cl]2
LB92
[Ir(LB92)2Cl]2
83%




as for [Ir(LB75)2Cl]2



[Ir(LB93)2Cl]2
LB93
[Ir(LB93)2Cl]2
86%




as for [Ir(LB75)2Cl]2






[Ir(LB94)2Cl]2
LB94


embedded image


66%







B





280° C./25 h






[Ir(LB95)2Cl]2
LB95
[Ir(LB95)2Cl]2
36%


[Ir(LB102)2Cl]2
LB96
[Ir(LB102)2Cl]2
70%


[Ir(LB103)2Cl]2
 LB103
[Ir(LB103)2Cl]2
68%


[Ir(LB104)2Cl]2
 LB104
[Ir(LB104)2Cl]2
30%









4) Iridium complexes of the [Ir(L)2(HOMe)2]OTf type

5 ml of methanol and then 10 mmol of silver(I) trifluoromethanesulfonate [2923-28-6] are added to a suspension of 5 mmol of the chloro dimer [Ir(L)2Cl]2 in 150 ml of dichloromethane, and the mixture is stirred at room temperature for 18 h. The precipitated silver(1) chloride is filtered off with suction via a Celite bed, the filtrate is evaporated to dryness, the yellow residue is taken up in 30 ml of toluene or cyclohexane, the solid is filtered off, washed with n-heptane and dried in vacuo. The product of the formula [Ir(L)2(HOMe)2]OTf obtained in this way is reacted further without purification.















Ex.
[Ir(L)2Cl]2
[Ir(L)2(HOMe)2]OTf
Yield







[Ir(L1)2(HOMe)2]OTf
Ir[(L1)Cl]2


embedded image


81%





[Ir(L2)2(HOMe)2]OTf
[Ir(L2)2Cl]2
[Ir(L2)2(HOMe)2]OTf
79%


[Ir(L5)2(HOMe)2]OTf
[Ir(L5)2Cl]2
[Ir(L5)2(HOMe)2]OTf
77%


[Ir(L6)2(HOMe)2]OTf
[Ir(L6)2Cl]2
[Ir(L6)2(HOMe)2]OTf
77%


[Ir(L10)2(HOMe)2]OTf
[Ir(L10)2Cl]2
[Ir(L10)2(HOMe)2]OTf
80%


[Ir(L11)2(HOMe)2]OTf
[Ir(L11)2Cl]2
[Ir(L11)2(HOMe)2]OTf
76%


[Ir(L12)2(HOMe)2]OTf
[Ir(L12)2Cl]2
[Ir(L12)2(HOMe)2]OTf
64%


[Ir(L14)2(HOMe)2]OTf
[Ir(L14)2Cl]2
[Ir(L14)2(HOMe)2]OTf
82%


[Ir(L21)2(HOMe)2]OTf
[Ir(L21)2Cl]2
[Ir(L21)2(HOMe)2]OTf
79%


[Ir(L25)2(HOMe)2]OTf
[Ir(L25)2Cl]2
[Ir(L25)2(HOMe)2]OTf
80%


[Ir(L42)2(HOMe)2]OTf
[Ir(L42)2Cl]2
[Ir(L42)2(HOMe)2]OTf
75%


[Ir(L47)2(HOMe)2]OTf
[Ir(L47)2Cl]2
[Ir(L47)2(HOMe)2]OTf
86%


[Ir(L48)2(HOMe)2]OTf
[Ir(L48)2Cl]2
[Ir(L48)2(HOMe)2]OTf
78%


[Ir(L53)2(HOMe)2]OTf
[Ir(L53)2Cl]2
[Ir(L53)2(HOMe)2]OTf
81%


[Ir(L55)2(HOMe)2]OTf
[Ir(L55)2Cl]2
[Ir(L55)2(HOMe)2]OTf
82%


[Ir(L59)2(HOMe)2]OTf
[Ir(L59)2Cl]2
[Ir(L59)2(HOMe)2]OTf
80%


[Ir(L60)2(HOMe)2]OTf
[Ir(L60)2Cl]2
[Ir(L60)2(HOMe)2]OTf
78%


[Ir(L62)2(HOMe)2]OTf
[Ir(L62)2Cl]2
[Ir(L62)2(HOMe)2]OTf
77%


[Ir(L64)2(HOMe)2]OTf
[Ir(L64)2Cl]2
[Ir(L64)2(HOMe)2]OTf
76%


[Ir(L72)2(HOMe)2]OTf
[Ir(L72)2Cl]2
[Ir(L72)2(HOMe)2]OTf
79%


[Ir(L74)2(HOMe)2]OTf
[Ir(L74)2Cl]2
[Ir(L74)2(HOMe)2]OTf
83%


[Ir(L95)2(HOMe)2]OTf
[Ir(L95)2Cl]2
[Ir(L95)2(HOMe)2]OTf
83%


[Ir(L96)2(HOMe)2]OTf
[Ir(L96)2Cl]2
[Ir(L96)2(HOMe)2]OTf
77%


[Ir(L100)2(HOMe)2]OTf
[Ir(L100)2Cl]2
[Ir(L100)2(HOMe)2]OTf
74%


[Ir(L102)2(HOMe)2]OTf
[Ir(L102)2Cl]2
[Ir(L102)2(HOMe)2]OTf
76%


[Ir(L129)2(HOMe)2]OTf
[Ir(L129)2Cl]2
[Ir(L129)2(HOMe)2]OTf
86%





[Ir(LB1)2(HOMe)2]OTf
Ir[(LB1)Cl]2


embedded image


82%





[Ir(LB2)2(HOMe)2]OTf
Ir[(LB2)2Cl]2
[Ir(LB2)2(HOMe)2]OTf



[Ir(LB3)2(HOMe)2]OTf
Ir[(LB3)2Cl]2
[Ir(LB3)2(HOMe)2]OTf
74%


[Ir(LB4)2(HOMe)2]OTf
Ir[(LB4)2Cl]2
[Ir(LB4)2(HOMe)2]OTf
82%


[Ir(LB5)2(HOMe)2]OTf
Ir[(LB5)2Cl]2
[Ir(LB5)2(HOMe)2]OTf
78%


[Ir(LB6)2(HOMe)2]OTf
Ir[(LB6)2Cl]2
[Ir(LB6)2(HOMe)2]OTf
77%


[Ir(LB8)2(HOMe)2]OTf
Ir[(LB8)2Cl]2
[Ir(LB8)2(HOMe)2]OTf
82%


[Ir(LB9)2(HOMe)2]OTf
Ir[(LB9)2Cl]2
[Ir(LB9)2(HOMe)2]OTf
79%


[Ir(LB11)2(HOMe)2]OTf
Ir[(LB11)2Cl]2
[Ir(LB11)2(HOMe)2]OTf
77%


[Ir(LB14)2(HOMe)2]OTf
Ir[(LB14)2Cl]2
[Ir(LB14)2(HOMe)2]OTf
74%


[Ir(LB17)2(HOMe)2]OTf
Ir[(LB17)2Cl]2
[Ir(LB17)2(HOMe)2]OTf
78%


[Ir(LB21)2(HOMe)2]OTf
Ir[(LB21)2Cl]2
[Ir(LB21)2(HOMe)2]OTf
79%


[Ir(LB22)2(HOMe)2]OTf
Ir[(LB222)Cl]2
[Ir(LB22)2(HOMe)2]OTf
76%


[Ir(LB33)2(HOMe)2]OTf
Ir[(LB33)2Cl]2
[Ir(LB33)2(HOMe)2]OTf
78%


[Ir(LB42)2(HOMe)2]OTf
Ir[(LB42)2Cl]2
[Ir(LB42)2(HOMe)2]OTf
75%


[Ir(LB57)2(HOMe)2]OTf
Ir[(LB57)2Cl]2
[Ir(LB57)2(HOMe)2]OTf
82%


[Ir(LB58)2(HOMe)2]OTf
Ir[(LB58)2Cl]2
[Ir(LB58)2(HOMe)2]OTf
82%


[Ir(LB60)2(HOMe)2]OTf
Ir[(LB60)2Cl]2
[Ir(LB60)2(HOMe)2]OTf
75%


[Ir(LB67)2(HOMe)2]OTf
Ir[(LB67)2Cl]2
[Ir(LB67)2(HOMe)2]OTf
78%


[Ir(LB68)2(HOMe)2]OTf
Ir[(LB68)2Cl]2
[Ir(LB68)2(HOMe)2]OTf
76%


[Ir(LB74)2(HOMe)2]OTf
Ir[(LB74)2Cl]2
[Ir(LB74)2(HOMe)2]OTf
77%


[Ir(LB76)2(HOMe)2]OTf
Ir[(LB76)2Cl]2
[Ir(LB76)2(HOMe)2]OTf
79%


[Ir(LB81)2(HOMe)2]OTf
Ir[(LB81)2Cl]2
[Ir(LB81)2(HOMe)2]OTf
81%


[Ir(LB85)2(HOMe)2]OTf
Ir[(LB85)2Cl]2
[Ir(LB85)2(HOMe)2]OTf
79%


[Ir(LB91)2(HOMe)2]OTf
Ir[(LB91)2Cl]2
[Ir(LB91)2(HOMe)2]OTf
78%


[Ir(LB93)2(HOMe)2]OTf
Ir[(LB93)2Cl]2
[Ir(LB93)2(HOMe)2]OTf
81%


[Ir(LB94)2(HOMe)2]OTf
Ir[(LB94)2Cl]2
[Ir(LB94)2(HOMe)2]OTf
74%









5) Heteroleptic tris-facial Iridium complexes of the phenylpyridine, phenylimidazole or phenylbenzimidazole type

A mixture of 10 mmol of the ligand L, 10 mmol of bis(methanol)bis[2-(2-pyridinyl-κN)phenyl-κC]iridium(III) trifluoromethanesulfonate [1215692-14-0] or bis(methanol)bis[2-(6-methyl-2-pyridinyl-κN)phenyl-κC]iridium(III) trifluoromethanesulfonate [1215692-29-7] or iridium complexes of the [Ir(L)2(HOMe)2]OTf type according to the invention, 11 mmol of 2,6-dimethylpyridine and 150 ml of ethanol is heated under reflux for 40 h. After cooling, the precipitated solid is filtered off with suction, washed three times with 30 ml of ethanol each time and dried in vacuo. The crude product obtained in this way is chromatographed on silica gel (solvent or mixtures thereof, for example DCM, THF, toluene, n-heptane, cyclohexane) and subjected to fractional sublimation as described under 1) variant A.
















[Ir(L)2(HOMe)2]OTf





Ligand
Ir complex



Ex.
L
Diastereomer
Yield







Ir500
1215692-14-0 LB1 


embedded image


41%





Ir501
1215692-14-0 LB2 


embedded image


46%





Ir502
1215692-14-0 LB3 


embedded image


45%





Ir503
1215692-29-7 LB6 


embedded image


24%





Ir504
1215692-14-0 LB9 


embedded image


44%





Ir505
1215692-14-0 LB17


embedded image


51%





Ir506
1215692-14-0 LB22


embedded image


54%





Ir507
1215692-14-0 L23 


embedded image


28%





IR508
1215692-14-0 LB40


embedded image


46%





Ir509
1215692-14-0 LB57


embedded image


40%





Ir510
1215692-14-0 LB60


embedded image


28%





Ir511
1215692-29-7 LB71


embedded image


47%





Ir512
1215692-29-7 LB74


embedded image


49%





Ir513
1215692-14-0 LB77


embedded image


47%





Ir514
1215692-14-0 LB78


embedded image


50%





Ir515
1215692-14-0 LB85


embedded image


44%





Ir516
1215692-14-0 LB87


embedded image


46%





Ir517
1215692-14-0 LB96


embedded image


21%





Ir518
[Ir(LB1)2(HOMe)2]OTf 1008-89-56


embedded image


40%





Ir519
[Ir(LB2)2(HOMe)2]OTf 1008-89-56


embedded image


41%





Ir520
[Ir(LB3)2(HOMe)2]OTf 1008-89-56


embedded image


42%





Ir521
[Ir(LB6)2(HOMe)2]OTf 1008-89-56


embedded image


20%





Ir522
[Ir(LB9)2(HOMe)2]OTf 1008-89-56


embedded image


43%





Ir523
[Ir(LB11)2(HOMe)2]OTf 1008-89-56


embedded image


46%





Ir524
[Ir(LB33)2(HOMe)2]OTf 1008-89-56


embedded image


33%





Ir525
[Ir(LB67)2(HOMe)2]OTf 1008-89-56


embedded image


21%





Ir526
[Ir(LB81)2(HOMe)2]OTf 1008-89-56


embedded image


52%





Ir527
[Ir(L1)2HOMe)]2]OTf LB3 


embedded image


44%





Ir528
[Ir(L2)2HOMe)]2]OTf LB10


embedded image


45%





Ir529
[Ir(L12)2HOMe)]2]OTf LB36


embedded image


31%





Ir530
[Ir(L1)2HOMe)]2]OTf LB87


embedded image


48%





Ir531
[Ir(L2)2HOMe)]2]OTf LB79


embedded image


45%





Ir532
[Ir(LB1)2(HOMe)2]OTf LB17


embedded image


49%





Ir533
[Ir(LB1)2(HOMe)2]OTf LB74


embedded image


53%





Ir534
[Ir(LB1)2(HOMe)2]OTf LB93


embedded image


46%





Ir535
[Ir(LB33)2(HOMe)2]OTf LB35


embedded image


19%









6) Heteroleptic Tris-Facial Iridium Complexes Containing Ligands of the Arduengo Carbene Type

Preparation analogous to A. G. Tennyson et al., Inorg. Chem., 2009, 48, 6924.


A mixture of 22 mmol of the ligand, 10 mmol of iridium chloro dimer [Ir(L)2Cl]2, 10 mmol of silver(I) oxide and 300 ml of 1,2-dichloroethane is stirred at 90° C. for 30 h. After cooling, the precipitated solid is filtered off with suction via a Celite bed, washed once with 30 ml of 1,2-dichloroethane, and the filtrate is evaporated to dryness in vacuo. The crude product obtained in this way is chromatographed on silica gel (solvent or mixtures thereof, for example dichloromethane, THF, toluene, n-heptane, cyclohexane) and subjected to fractional sublimation as described under 1) variant A.
















[Ir(L)2Cl]2
Ir complex



Ex.
Ligand L
Diastereomer
Yield







Ir536
[Ir(PPy)2Cl]2 603109-48-48 LB43


embedded image


50%





Ir537
[Ir(L64)2Cl]2 LB45


embedded image


42%









7) Iridium Complexes of the Ir(L)2L′ Type Containing Non-o-Metallated Ligands L′

A mixture of 25 mmol of the ligand L′, 10 mmol of iridium chloro dimer [Ir(L)2Cl]2, 30 mmol of sodium hydrogencarbonate, 100 ml of 2-ethoxyethanol and 30 ml of water is stirred at 90° C. for 16 h. After cooling, the precipitated solid is filtered off with suction, washed three times with 30 ml of ethanol each time and dried in vacuo. The crude product obtained in this way is chromatographed on silica gel (solvent or mixtures thereof, for example dichloromethane, THF, toluene, n-heptane, cyclohexane) or recrystallised, and subjected to fractional sublimation as described under 1) variant A.
















[Ir(L)2Cl]2
Ir complex



Ex.
Ligand L′
Diastereomer
Yield







Ir538
[Ir(LB1)2Cl]2 123-54-6


embedded image


76%





Ir539
[Ir(LB22)2Cl]2 123-54-6


embedded image


72%





Ir540
[Ir(LB23)2Cl]2 123-54-6


embedded image


48%





Ir541
[Ir(LB58)2Cl]2 123-54-6


embedded image


40%





Ir542
[Ir(LB59)2Cl]2
Ir542
38%



123-54-6
as for [Ir(LB58)2Cl]2



Ir543
[Ir(LB60)2Cl]2
Ir543
33%



123-54-6
as for [Ir(LB58)2Cl]2



Ir544
[Ir(LB61)2Cl]2
Ir544
35%



123-54-6
as for [Ir(LB58)2Cl]2



Ir545
[Ir(LB62)2Cl]2
Ir545
31%



123-54-6
as for [Ir(LB58)2Cl]2



Ir546
[Ir(LB63)2Cl]2
Ir546
33%



123-54-6
as for [Ir(LB58)2Cl]2



Ir547
[Ir(LB64)2Cl]2
Ir547
30%



123-54-6
as for [Ir(LB58)2Cl]2



Ir548
[Ir(LB65)2Cl]2
Ir548
36%



123-54-6
as for [Ir(LB58)2Cl]2



Ir549
[Ir(LB66)2Cl]2
Ir549
35%



123-54-6
as for [Ir(LB58)2Cl]2



Ir550
[Ir(LB67)2Cl]2
Ir550
35%



123-54-6
as for [Ir(LB58)2Cl]2






Ir551
[Ir(LB68)2Cl]2 123-54-6


embedded image


70%





Ir552
[Ir(LB72)2Cl]2 1118-71-4


embedded image


28%





Ir553
[Ir(LB94)2Cl]2 1118-71-4


embedded image


55%









8) Platinum Complexes of the PtLL′ Type Containing Non-o-Metallated Ligands L′

Preparation analogous to J. Brooks et al., Inorg. Chem. 2002, 41, 3055. A mixture of 20 mmol of the ligand L, 10 mmol of K2PtCl4, 75 ml of 2-ethoxyethanol and 25 ml of water is heated under reflux for 16 h. After cooling and addition of 100 ml of water, the precipitated solid is filtered off with suction, washed once with 30 ml of water and dried in vacuo. The platinum chloro dimer of the formula [PtLCl]2 obtained in this way is suspended in 100 ml of 2-ethoxyethanol, 30 mmol of the ligands L′ and 50 mmol of sodium carbonate are added, the reaction mixture is stirred at 100° C. for 16 h and then evaporated to dryness in vacuo. The crude product obtained in this way is chromatographed on silica gel (solvent or mixtures thereof, for example dichloromethane, THF, toluene, n-heptane, cyclohexane) or recrystallised, and subjected to fractional sublimation as described under 1) variant A.
















Ligand L




Ex.
Ligand L′
Pt complex
Yield







Pt001
LB1 123-54-6


embedded image


31%





Pt002
LB5 1118-71-4


embedded image


34%





Pt003
LB93 123-54-6


embedded image


43%





Pt004
LB41 1118-71-4


embedded image


40%









9) Platinum Complexes of Tetradentate Ligands

A mixture of 10 mmol of the ligand L, 10 mmol of K2PtCl4, 400 mmol of lithium acetate, anhydrous, and 200 ml of glacial acetic acid is heated under reflux for 60 h. After cooling and addition of 200 ml of water, the mixture is extracted twice with 250 ml of toluene each time, dried over magnesium sulfate, filtered through a Celite bed, the Celite is rinsed with 200 ml of toluene, and the toluene is then removed in vacuo. The solid obtained in this way is purified as described under 1) variant A by hot extraction and then subjected to fractional sublimation.

















Ligand

Extrac-



Ex.
L
Pt complex
tant
Yield







Pt(LB107)
LB107


embedded image


Toluene
41%


Pt(LB108)
LB108
Pt(LB108)
Toluene
35%


Pt(LB109)
LB109
Pt(LB109)
Ethyl
37%





acetate






Cyclo-






hexane






2:8, vv



Pt(LB110)
LB110
Pt(LB110)
Cyclo-
38%





hexane









10) Platinum Complexes of Tetradentate Ligands of the Arduengo Carbene Type

A mixture of 10 mmol of the ligand, 10 mmol of silver(I) oxide and 200 ml of dioxane is stirred at room temperature for 16 h, 100 ml of butanone, 20 mmol of sodium carbonate and 10 mmol of cyclooctadienylplatinum dichloride are then added, and the mixture is heated under reflux for 16 h. After removal of the solvent, the solid is extracted by stirring with 500 ml of hot toluene, the suspension is filtered through a Celite bed, and the filtrate is evaporated to dryness. The solid obtained in this way is chromatographed on silica gel with DCM and then subjected to fractional sublimation as described under 1) variant A.















Ex.
Ligand
Pt complex
Yield







Pt(LB111)
LB111


embedded image


28%





Pt(LB112)
LB112
Pt(LB112)
25%


Pt(LB113)
LB113
Pt(LB113)
26%


Pt(LB114)
LB114
Pt(LB114)
30%









11) Iridium Complexes of Hexadentate Ligands

A mixture of 10 mmol of the ligand L, 10 mmol of sodium bisacetylacetonatodichloroiridate(II) [770720-50-8] and 200 ml of triethylene glycol dimethyl ether is heated at 210° C. on a water separator for 48 h (the acetyl-acetone and thermal cleavage products of the solvent distil off). After cooling and addition of 200 ml of water, the precipitated solid is filtered off with suction and dried in vacuo. The solid is extracted by stirring with 500 ml of hot THF, the suspension is filtered through a Celite bed while still hot, the Celite is rinsed with 200 ml of THF, and the combined filtrates are evaporated to dryness. The solid obtained in this way is purified as described under 1) variant A by hot extraction with toluene and then subjected to fractional sublimation.


















Ex.
Ligand
Ir complex
Yield









Ir(LB115)
LB115


embedded image


23%







Ir(LB116)
LB116
Ir(LB116)
25%



Ir(LB117)
LB117
Ir(LB117)
30%










12) Iridium Complexes of Hexadentate Ligands of the Arduengo Carbene Type

Preparation analogous to K. Tsuchiya et al., Eur. J. Inorg. Chem. 2010, 926.


A mixture of 3 mmol of the ligand, 3 mmol of iridium(III) chloride hydrate, 10 mmol of silver carbonate and 10 mmol of sodium carbonate in 75 ml of 2-ethoxyethanol is warmed under reflux for 48 h. After cooling, 300 ml of water are added, the precipitated solid is filtered off with suction, washed once with 30 ml of water and three times with 15 ml of ethanol each time and dried in vacuo. The crude product obtained in this way is chromatographed on silica gel (DCM) and then subjected to fractional sublimation as described under 1) variant A.















Ex.
Ligand
Ir complex
Yield







Ir(LB118)
L118


embedded image


20%





Ir(LB119)
L119
L119
18%









Example
Comparison of the Photoluminescence Spectra


FIG. 1 shows the photoluminescence spectrum of the complex Ir(LB94)3, i.e. a tris(benzo[h]quinoline)iridium complex which contains a group of the formula (3), compared with the spectrum of the corresponding complex without the group of the formula (3). The spectra were measured in an approx. 10−5 molar solution in degassed toluene at room temperature. The narrower emission band with a full width at half maximum FWHM of 68 nm compared with 81 nm in the case of the compound without a group of the formula (3) is clearly evident. The complex according to the invention furthermore has higher photoluminescence quantum efficiency.


Example
Production of OLEDs
1) Vacuum-Processed Devices

OLEDs according to the invention and OLEDs in accordance with the prior art are produced by a general process in accordance with WO 2004/058911, which is adapted to the circumstances described here (layer-thickness variation, materials used).


The results for various OLEDs are presented in the following examples. Glass plates with structured ITO (50 nm, indium tin oxide) form the substrates to which the OLEDs are applied. The OLEDs have in principle the following layer structure: substrate 1 hole-transport layer 1 (HTL1) consisting of HTM doped with 3% of NDP-9 (commercially available from Novaled), 20 nm/hole-transport layer 2 (HTL2)/optional electron-blocking layer (EBL)/emission layer (EML)/optional hole-blocking layer (HBL)/electron-transport layer (ETL)/optional electron-injection layer (EIL) and finally a cathode. The cathode is formed by an aluminium layer with a thickness of 100 nm


Firstly, vacuum-processed OLEDs are described. For this purpose, all materials are applied by thermal vapour deposition in a vacuum chamber. The emission layer here always consists of at least one matrix material (host material) and an emitting dopant (emitter), which is admixed with the matrix material or matrix materials in a certain proportion by volume by co-evaporation. An expression such as M3:M2:Ir(L1)3 (55%:35%:10%) here means that material M3 is present in the layer in a proportion by volume of 55%, M2 is present in the layer in a proportion of 35% and Ir(L1)3 is present in the layer in a proportion of 10%. Analogously, the electron-transport layer may also consist of a mixture of two materials. The precise structure of the OLEDs is shown in Table 1. The materials used for the production of the OLEDs are shown in Table 3.


The OLEDs are characterised by standard methods. For this purpose, the electroluminescence spectra, the current efficiency (measured in cd/A) and the voltage (measured at 1000 cd/m2 in V) are determined from current/voltage/luminance characteristic lines (IUL characteristic lines). For selected experiments, the lifetime is determined. The lifetime is defined as the time after which the luminous density has dropped to a certain proportion from a certain initial luminous density. The expression LT50 means that the lifetime given is the time at which the luminous density has dropped to 50% of the initial luminous density, i.e. from, for example, 1000 cd/m2 to 500 cd/m2. Depending on the emission colour, different initial luminances were selected. The values for the lifetime can be converted to a figure for other initial luminous densities with the aid of conversion formulae known to the person skilled in the art. The lifetime for an initial luminous density of 1000 cd/m2 is a usual figure here.


Use of Compounds According to the Invention as Emitter Materials in Phosphorescent OLEDs


The compounds according to the invention can be employed, inter alia, as phosphorescent emitter materials in the emission layer in OLEDs. The iridium compounds shown in Table 3 are used as comparison in accordance with the prior art. The results for the OLEDs are summarised in Table 2.









TABLE 1







Structure of the OLEDs













HTL2
EBL
EML
HBL
ETL


Ex.
Thickness
Thickness
Thickness
Thickness
Thickness










Red OLEDs












D-IrR1
HTM

M7:M8:Ir-R1

ETM1:ETM2



280 nm

(65%:30%:5%)

(50%:50%)





35 nm

40 nm


D-Ir(LB4)3
HTM

M7:M8:Ir(LB4)3

ETM1:ETM2



280 nm

(65%:30%:5%)

(50%:50%)





35 nm

40 nm







Yellow OLEDs












D-Ir-Y2
HTM

M7:M8:Ir-Y2

ETM1:ETM2



250 nm

(62%:30%:8%)

(50%:50%)





25 nm

45 nm


D-Ir(LB3)3
HTM

M7:M8:Ir(LB3)3

ETM1:ETM2



250 nm

(82%:30%:8%)

(50%:50%)





25 nm

45 nm







Green OLEDs












D-Ir-G1
HTM

M7:M8:Ir-G1
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB1)3
HTM

M7:M8:Ir(LB1)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm







Blue OLEDs












D-Ir-B1
HTM
EBM
M1:M4:Ir-B1
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:35%:5%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB55)3
HTM
EBM
M1:M4:Ir(LB55)3
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:35%:5%)
10 nm
(50%:50%)





25 nm

15 nm
















TABLE 2







Results of the vacuum-processed OLEDs












EQE (%)
Voltage (V)
CIE x/y



Ex.
1000 cd/m2
1000 cd/m2
1000 cd/m2












LT80 (h)



1000 cd/m2







Red OLEDs











D-IrR1
13.3
2.9
0.67/0.33
14000


D-Ir(LB4)3
16.0
3.0
0.69/0.30
19000







Yellow OLEDs











D-Ir-Y2
22.3
3.0
0.44/0.55
32000


D-Ir(LB3)3
24.0
3.2
0.48/0.51
36000







Green OLEDs











D-Ir-G1
18.0
3.4
0.32/0.64
8000


D-Ir(LB1)3
23.5
3.4
0.33/0.64
17000









LT50 (h)



1000 cd/m2







Blue OLEDs











D-Ir-B1
16.3
4.8
0.18/0.37
1000


D-Ir(LB55)3
22.8
3.9
0.15/0.32
1200
















TABLE 3





Structural formulae of the materials used









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image









embedded image











Example LB120



embedded image


A mixture of 19.4 g (100 mmol) of 6-aminophenanthridine [832-68-8], 47.6 g (300 mmol) of 3-chlorobicyclo[2.2.2]octan-2-one [23804-48-0], 25.2 g (300 mmol) of sodium hydrogencarbonate, 300 ml of ethylene glycol and 30 ml of water is stirred at 130° C. for 24 h. A further 47.6 g (300 mmol) of 3-chlorobicyclo[2.2.2]octan-2-one [23804-48-0] and 25.2 g (300 mmol) of sodium hydrogencarbonate are then added, and the mixture is stirred at 130° C. for a further 24 h. After cooling, the reaction mixture is diluted with 1000 ml of water, extracted three times with 300 ml of ethyl acetate each time, the combined organic phases are washed with 500 ml of water and 500 ml of saturated sodium chloride solution, and the organic phase is evaporated in vacuo. The residue is chromatographed on silica gel (EA:DCM 9:1), then recrystallised twice from DMF/ethanol and subjected to fractional sublimation twice (T about 200° C., p about 10−4 mbar). Yield: 6.3 g (21 mmol), 21%; purity: about 99.0% according to 1H-NMR.


The following derivatives can be prepared analogously:

















6-Amino-





Ex.
phenanthridine
2-Haloketone
Product
Yield







LB121


embedded image




embedded image




embedded image


20%





LB122


embedded image




embedded image




embedded image


24%





LB123


embedded image




embedded image




embedded image


23%





LB124


embedded image




embedded image




embedded image


25%





LB125


embedded image




embedded image




embedded image


26%





LB126


embedded image




embedded image




embedded image


22%









Example LB127



embedded image


A vigorously stirred mixture of 19.4 g (100 mmol) of 6-aminophenanthridine [832-68-8], 41.1 g (130 mmol) of SB5, 18.0 g (130 mmol) of potassium carbonate, 100 g of glass beads (diameter 3 mm), 2.1 g (8 mmol) of triphenylphosphine and 498 mg (2 mmol) of palladium(II) acetate in 300 ml of o-xylene is heated under reflux for 18 h. After cooling to 80° C., the salts and glass beads are filtered off through a Celite bed with suction, the latter is rinsed with 500 ml of hot o-xylene, and the filtrate is evaporated to dryness in vacuo. The residue is chromatographed on silica gel (EA:DCM 9:1), then recrystallised twice from DMF/ethanol and subjected to fractional sublimation twice (T about 230° C., p about 10−4 mbar). Yield: 11.9 g (34 mmol), 34%; purity: about 99.0% according to 1H-NMR.


The following derivatives can be prepared analogously:


















1,2-Dihalo-




Ex.
Phenanthridine
benzene
Product
Yield







LB128


embedded image




embedded image




embedded image


33%





LB129


embedded image




embedded image




embedded image


28%





LB130


embedded image




embedded image




embedded image


23%









Example LB1
2-Tricyclo[6.2.2.0*2,7*]dodeca-279,3,5-trien-4-yl-pyridine, LB1



embedded image


A mixture of 13.4 g (100 mmol) of 2,3-dimethylenebicyclo[2.2.2]octane [36439-79-9], 12.4 g (120 mmol) of 2-ethynylpyridine [1945-84-2] and 50 ml of chlorobenzene is stirred at 120° C. for 16 h. 26.1 g (300 mmol) of activated manganese(II) oxide are then added, and the mixture is stirred at 120° C. for a further 3 h. After cooling, the mixture is extended with 200 ml of ethyl acetate and filtered through a Celite bed, and the solvent and excess 2-ethynylpyridine are removed in vacuo. The oily residue is distilled twice in a bulb tube (p about 10−4 mbar, T about 190° C.). Yield: 17.2 g (73 mmol), 73%; purity: about 99.0% according to 1H NMR.


The following compounds can be prepared analogously:

















Starting
Starting




Ex.
material
material
Product
Yield







LB131


embedded image




embedded image




embedded image


64%





LB4


embedded image




embedded image




embedded image


68%





LB132


embedded image




embedded image




embedded image


72%





LB133


embedded image




embedded image




embedded image


69%





LB134


embedded image




embedded image




embedded image


61%





LB135


embedded image




embedded image




embedded image


63%





LB136


embedded image




embedded image




embedded image


68%





LB19


embedded image




embedded image




embedded image


70%









C: Synthesis of the Metal Complexes
1) Homoleptic Tris-Facial Iridium Complexes of the Phenylpyridine, Phenylimidazole or Phenylbenzimidazole Type

As described in the above-mentioned chapter, the following metal complexes can be prepared:



















Variant






Reaction medium






Melting aid






Reaction temp.






Reaction time




Ligand

Suspension medium



Ex.
L
Ir complex
Extractant
Yield







Ir(LB120)3
LB120


embedded image


A — 1 ml of hexadecane 290° C. 120 h Acetone Toluene
42%





Ir(LB121)3
LB121
Ir(LB121)3
as for Ir(LB120)3
40%


Ir(LB122)3
LB122
Ir(LB122)3
as for Ir(LB120)3
37%


Ir(LB123)3
LB123
Ir(LB123)3
as for Ir(LB120)3
39%


Ir(LB124)3
LB124
Ir(LB124)3
as for Ir(LB120)3
28%


Ir(LB125)3
LB125
Ir(LB125)3
as for Ir(LB120)3
35%


Ir(LB126)3
LB126
Ir(LB126)3
as for Ir(LB120)3
23%


Ir(LB127)3
LB127
Ir(LB127)3
as for Ir(LB120)3
38%


Ir(LB128)3
LB128
Ir(LB128)3
as for Ir(LB120)3
35%


Ir(LB129)3
LB129
Ir(LB129)3
as for Ir(LB120)3
40%


Ir(LB130)3
LB130
Ir(LB130)3
as for Ir(LB120)3
29%





Ir(LB131)3
LB131


embedded image


A — — 270° C. 24 h EtOH Acetonitrile
46%





Ir(LB132)3
LB132
Ir(LB132)3
as for Ir(LB131)3
48%


Ir(LB133)3
LB133
Ir(LB133)3
as for Ir(LB131)3
37%


Ir(LB134)3
LB134
Ir(LB134)3
as for Ir(LB131)3
45%


Ir(LB135)3
LB135
Ir(LB135)3
as for Ir(LB131)3
39%


Ir(LB136)3
LB136
Ir(LB136)3
as for Ir(LB131)3
34%









Derivatisation of the Metal Complexes


1) Halogenation of the Fac-Iridium Complexes

A ×10.5 mmol of N-halosuccinimide (halogen: Cl, Br, I) are added to a solution or suspension of 10 mmol of a complex carrying A×C—H groups (where A=1, 2 or 3) in the para-position to the iridium in 500 ml of dichloromethane at 30° C. with exclusion of light and air, and the mixture is stirred for 20 h. Complexes which have low solubility in DCM can also be reacted in other solvents (TCE, THF, DMF, etc.) and at elevated temperature. The solvent is subsequently substantially removed in vacuo. The residue is boiled with 100 ml of methanol, the solid is filtered off with suction, washed three times with 30 ml of methanol and then dried in vacuo, giving the fac-iridium complexes which are brominated in the para-position to the iridium


Synthesis of Ir(B74-Br)3



embedded image


5.6 g (31.5 mmol) of N-bromosuccinimide are added in one portion to a suspension, stirred at 30° C., of 8.9 g (10 mmol) of Ir(LB74)3 in 500 ml of DCM, and the mixture is then stirred for a further 20 h. After removal of about 450 ml of the DCM in vacuo, 100 ml of methanol are added to the yellow suspension, the solid is filtered off with suction, washed three times with about 30 ml of methanol and then dried in vacuo. Yield: 10.5 g (9.3 mmol), 953%; purity: >99.0% according to NMR.


The following compounds can be prepared analogously:















Ex.
Complex
Brominated complex
Yield







Ir(LB80- Br)3


embedded image




embedded image


91%





Ir(LB94- Br)3


embedded image




embedded image


95%





Ir(LB95- Br)3


embedded image




embedded image


92%





Ir(LB102- Br)3


embedded image




embedded image


93%





Ir(LB33- Br)3


embedded image




embedded image


92%





Ir(LB55- Br)3


embedded image




embedded image


94%





Ir(LB57- Br)3


embedded image




embedded image


92%





Ir(LB68- Br)3


embedded image




embedded image


94%





fac- Ir(LB48- Br)3


embedded image




embedded image


86%





Ir500-Br2


embedded image




embedded image


87%





Ir502-Br2


embedded image




embedded image


90%





Ir516-Br2


embedded image




embedded image


89%





Ir518-Br


embedded image




embedded image


89%





Ir520-Br


embedded image




embedded image


91%





Ir523-Br


embedded image




embedded image


90%





Ir533-Br


embedded image




embedded image


93%









2) Suzuki Coupling to the Brominated Fac-Iridium Complexes
Variant A, Two-Phase Reaction Mixture

0.6 mmol of tri-o-tolylphosphine and then 0.1 mmol of palladium(II) acetate are added to a suspension of 10 mmol of a brominated complex, 12-20 mmol of the boronic acid or boronic acid ester per Br function and 40-80 mmol of tripotassium phosphate in a mixture of 300 ml of toluene, 100 ml of dioxane and 300 ml of water, and the mixture is heated under reflux for 16 h. After cooling, 500 ml of water and 200 ml of toluene are added, the aqueous phase is separated off, the organic phase is washed three times with 200 ml of water, once with 200 ml of saturated sodium chloride solution and dried over magnesium sulfate. The solid material is filtered off through a Celite bed and rinsed with toluene, the toluene is removed virtually completely in vacuo, 300 ml of methanol are added, the precipitated crude product is filtered off with suction, washed three times with 50 ml of methanol each time and dried in vacuo. The crude product is passed through a silica-gel column twice. The metal complex is finally heated or sublimed. The heating is carried out in a high vacuum (p about 10−6 mbar) in the temperature range from about 200-300° C. The sublimation is carried out in a high vacuum (p about 10−6 mbar) in the temperature range from about 300-400′C, with the sublimation preferably being carried out in the form of a fractional sublimation.


Variant B, One-Phase Reaction Mixture

0.6 mmol of tri-o-tolylphosphine and then 0.1 mmol of palladium(II) acetate are added to a suspension of 10 mmol of a brominated complex, 12-20 mmol of the boronic acid or boronic acid ester per Br function and 60-100 mmol of the base (potassium fluoride, tripotassium phosphate (anhydrous or monohydrate or trihydrate), potassium carbonate, caesium carbonate, etc.) and 100 g of glass beads (diameter 3 mm) in 100 ml-500 ml of an aprotic solvent (THF, dioxane, xylene, mesitylene, dimethylacetamide, NMP, DMSO, etc.), and the mixture is heated under reflux for 1-24 h. Alternatively, other phosphines, such as tri-tert-butylphosphine, SPhos, XPhos, RuPhos, XanthPhos, etc., can be employed, where the preferred phosphine: palladium ratio in the case of these phosphines is 2:1 to 1.2:1. The solvent is removed in vacuo, the product is taken up in a suitable solvent (toluene, dichloromethane, ethyl acetate, etc.) and purified as described under Variant A.


Synthesis of Ir6003



embedded image


Variant A

Use of 11.3 g (10.0 mmol) of Ir(LB74-Br)3 and 4.9 g (40.0 mmol) of phenyl-boronic acid [98-80-6], 17.7 (60 mmol) of tripotassium phosphate (anhydrous), 183 mg (0.6 mmol) of tri-o-tolylphosphine [6163-58-2], 23 mg (0.1 mmol) of palladium(II) acetate, 300 ml of toluene, 100 ml of dioxane and 300 ml of water, 100° C., 12 h. Chromatographic separation on silica gel with toluene/ethyl acetate (90:10, w) twice. Yield: 6.3 g (5.6 mmol), 56%; purity: about 99.9% according to HPLC.


The following compounds can be prepared analogously:
















Complex





Boronic acid




Ex.
Variant
Product
Yield







Ir601
Ir(LB80-Br)3 1233200-59-3 A Chromatographic separation using toluene


embedded image


60%





Ir602
Ir(LB94-Br)3 84110-40-7 B SPhos:Pd(ac)2/2:1 K3PO4 * 3H2O Toluene Chromatographic separation using toluene


embedded image


58%





Ir603
Ir(LB95-Br)3 333432-28-3 A Chromatographic separation using toluene


embedded image


49%





Ir604
Ir(LB102-Br)3 5122-95-2 A Chromatographic separation using toluene


embedded image


66%





Ir605
Ir(LB33-Br)3 84110-40-7 B SPhos:Pd(ac)2/2:1 K3PO4 * 3H2O Toluene Chromatographic separation using toluene


embedded image


60%





Ir606
Ir(LB55-Br)3 1233200-59-3 A Chromatographic separation using toluene


embedded image


62%





Ir607
Ir(LB57-Br)3 1233200-59-3 A Chromatographic separation using toluene


embedded image


57%





Ir608
Ir(LB68-Br)3 4441-56-9 B SPhos:Pd(ac)2/2:1 K3PO4 * 3H2O Toluene Chromatographic separation using toluene


embedded image


52%





Ir609
Ir502-Br2 100379-00-8 B SPhos:Pd(ac)2/2:1 Cs2CO3/dioxane Chromatographic separation using toluene/DCM (95:5 vv)


embedded image


36%





Ir610
Ir516-Br2 1251825-65-6 A Chromatographic separation using n-heptane/EA (90:10)


embedded image


56%





Ir611
Ir533-Br 654664-63-8 A Chromatographic separation using n-heptane/EA (90:10)


embedded image


60%









3) Buchwald Coupling on the Iridium Complexes

0.4 mmol of tri-tert-butylphosphine and then 0.3 mmol of palladium(II) acetate are added to a mixture of 10 mmol of the brominated complex, 12-20 mmol of the diarylamine or carbazole p[er bromine function, 1.1 molar amount of sodium tert-butoxide per amine employed or 80 mmol of tripotassium phosphate (anhydrous) in the case of carbazoles, 100 g of glass beads (diameter 3 mm) and 300-500 ml of toluene or o-xylene in the case of carbazoles, and the mixture is heated under reflux for 16-30 h with vigorous stirring. After cooling, 500 ml of water are added, the aqueous phase is separated off, and the organic phase is washed twice with 200 ml of water and once with 200 ml of saturated sodium chloride solution and dried over magnesium sulfate. The solid material is filtered off through a Celite bed and rinsed with toluene or o-xylene, the solvent is removed virtually completely in vacuo, 300 ml of ethanol are added, the precipitated crude product is filtered off with suction, washed three times with 50 ml of EtOH each time and dried in vacuo. The crude product is purified by chromatography on silica gel twice. The metal complex is finally heated or sublimed. The heating is carried out in a high vacuum (p about 10−6 mbar) in the temperature range from about 200-300° C. The sublimation is carried out in a high vacuum (p about 10−6 mbar) in the temperature range from about 300-400° C., with the sublimation preferably being carried out in the form of a fractional sublimation.


Synthesis of Ir700



embedded image


Use of 11.3 g (10 mmol) of Ir(LB74-Br)3 and 14.5 g (40 mmol) of N-[1,1′-biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-2-amine [897671-69-1]. Heating. Yield: 7.1 g (3.6 mmol), 36%; purity: about 99.8% according to HPLC.


The following compounds can be prepared analogously:















Product




Starting material



Ex.
Amine or carbazole
Yield







Ir701


embedded image


46%





Ir702


embedded image


40%





Ir703


embedded image


44%





Ir704


embedded image


40%









4) Cyanation of the Iridium Complexes

A mixture of 10 mmol of the brominated complex, 13 mmol of copper(I) cyanide per bromine function and 300 ml of NMP is stirred at 200° C. for 20 h. After cooling, the solvent is removed in vacuo, the residue is taken up in 500 ml of dichloromethane, the copper salts are filtered off via Celite, the dichloromethane is evaporated virtually to dryness in vacuo, 100 ml of ethanol are added, the precipitated solid is filtered off with suction, washed twice with 50 ml of ethanol each time and dried in vacuo. Chromatography or hot extraction and fractional sublimation of the crude product as described in C: Synthesis of the metal complexes, 1) Homoleptic tris-facial iridium complexes of the phenylpyridine, phenylimidazole or phenylbenzimidazole type: variant A.


Synthesis of Ir800



embedded image


Use of 11.3 g (10 mmol) of Ir(LB74-Br)3 and 3.5 g (39 mmol) of copper(I) cyanide. Sublimation. Yield: 4.7 g (4.8 mmol), 48%; purity: about 99.8% according to HPLC.


The following compounds can be prepared analogously:















Product



Ex.
Starting material
Yield







Ir801


embedded image


37%





Ir802


embedded image


42%





Ir803


embedded image


35%





Ir804


embedded image


47%





Ir805


embedded image


65%









5) Borylation of the Iridium Complexes

A mixture of 10 mmol of the brominated complex, 12 mmol of bis(pinacolato)diborane [73183-34-3] per bromine function, 30 mmol of potassium acetate, anhydrous, per bromine function, 0.2 mmol of tricyclohexylphosphine, 0.1 mmol of palladium(II) acetate and 300 ml of solvent (dioxane, DMSO, NMP, etc.) is stirred at 80-160° C. for 4-16 h. After removal of the solvent in vacuo, the residue is taken up in 300 ml of dichloromethane, THF or ethyl acetate, filtered through a Celite bed, the filtrate is evaporated in vacuo until crystallisation commences, and finally about 100 ml of methanol are added dropwise in order to complete the crystallisation. The compounds can be recrystallised from dichloromethane, ethyl acetate or THF with addition of methanol or alternatively from cyclohexane.


Synthesis of Ir900



embedded image


Use of 11.3 g (10 mmol) of Ir(LB74-Br) and 9.1 g (36 mmol) of bis(pinacolato)diborane [73183-34-3], DMSO, 120° C., 6 h, taking-up and Celite filtration in THF, recrystallisation from THF:methanol. Yield: 7.5 g (5.7 mmol), 57%; purity: about 99.8% according to HPLC.


The following compounds can be prepared analogously:















Ex.
Starting material
Product
Yield







Ir901


embedded image




embedded image


61%





Ir902


embedded image




embedded image


64%





Ir903


embedded image




embedded image


60%





Ir904


embedded image




embedded image


67%





Ir905


embedded image




embedded image


71%





Ir906


embedded image




embedded image


69%





Ir907


embedded image




embedded image


66%





Ir908


embedded image




embedded image


73%









6) Suzuki Coupling to the Borylated Fac-Iridium Complexes
Variant A, Two-Phase Reaction Mixture

0.6 mmol of tri-o-tolylphosphine and then 0.1 mmol of palladium(II) acetate are added to a suspension of 10 mmol of a borylated complex, 12-20 mmol of aryl bromide per (RO)2B function and 80 mmol of tripotassium phosphate in a mixture of 300 ml of toluene, 100 ml of dioxane and 300 ml of water, and the mixture is heated under reflux for 16 h. After cooling, 500 ml of water and 200 ml of toluene are added, the aqueous phase is separated off, and the organic phase is washed three times with 200 ml of water, once with 200 ml of saturated sodium chloride solution and dried over magnesium sulfate. The mixture is filtered through a Celite bed, the latter is rinsed with toluene, the toluene is removed virtually completely in vacuo, 300 ml of methanol are added, and the crude product which has precipitated out is filtered off with suction, washed three times with 50 ml of methanol each time and dried in vacuo. The crude product is passed through a silica-gel column twice. The metal complex is finally heated or sublimed. The heating is carried out in a high vacuum (p about 10−6 mbar) in the temperature range from about 200-300° C. The sublimation is carried out in a high vacuum (p about 10−6 mbar) in the temperature range from about 300-400° C., where the sublimation is preferably carried out in the form of a fractional sublimation.


Variant B, Single-Phase Reaction Mixture

0.6 mmol of tri-o-tolylphosphine and then 0.1 mmol of palladium(II) acetate are added to a suspension of 10 mmol of a borylated complex, 12-20 mmol of aryl bromide per (RO)2B function and 60-100 mmol of the base (potassium fluoride, tripotassium phosphate (anhydrous, monohydrate or trihydrate), potassium carbonate, caesium carbonate, etc.) and 100 g of glass beads (diameter 3 mm) in 100 ml-500 ml of an aprotic solvent (THF, dioxane, xylene, mesitylene, dimethylacetamide, NMP, DMSO, etc.), and the mixture is heated under reflux for 1-24 h. Alternatively, other phosphines, such as tri-tert-butylphosphine, SPhos, XPhos, RuPhos, XanthPhos, etc., can be employed, where in the case of these phosphines the preferred phosphine: palladium ratio is 2:1 to 1.2:1. The solvent is removed in vacuo, and the product is taken up in a suitable solvent (toluene, dichloromethane, ethyl acetate, etc.) and purified as described under variant A.


Synthesis of Ir600s



embedded image


Variant A

Use of 12.7 g (10.0 mmol) of Ir900 and 4.2 ml (40.0 mmol) of bromobenzene [108-86-1], 17.7 g (60 mmol) of tripotassium phosphate (anhydrous), 183 mg (0.6 mmol) of tri-o-tolylphosphine [6163-58-2], 23 mg (0.1 mmol) of palladium(II) acetate, 300 ml of toluene, 100 ml of dioxane and 300 ml of water, 100° C., 12 h. Chromatographic separation on silica gel using toluene/ethyl acetate (90:10, w) twice. Yield: 6.6 g (5.9 mmol), 59%; purity: about 99.9% according to HPLC.


The following compounds can be prepared analogously:
















Complex





Boronic acid




Ex.
Variant
Product
Yield







Ir612
Ir906 26608-06-0 A Chromatographic separation using toluene


embedded image


62%





Ir613
Ir907 1153-85-1 A Chromatographic separation using toluene


embedded image


65%





Ir614
Ir908 1369587-63-2 A Chromatographic separation using toluene


embedded image


59%









Polymers Containing the Metal Complexes:


General Polymerisation Procedure for the Bromides or Boronic Acid Derivatives as Polymerisable Group, Suzuki Polymerisation


Variant A—Two-Phase Reaction Mixture

The monomers (bromides and boronic acids or boronic acid esters, purity according to HPLC>99.8%) in the composition indicated in the table are dissolved or suspended in a mixture of 2 parts by volume of toluene: 6 parts by volume of dioxane: 1 part by volume of water in a total concentration of about 100 mmol/1.2 mol equivalents of tripotassium phosphate per Br functionality employed are then added, the mixture is stirred for a further 5 min., 0.03 to 0.003 mol equivalent of tri-ortho-tolylphosphine and then 0.005 to 0.0005 mol equivalent of palladium(II) acetate (phosphine to Pd ratio preferably 6:1) per Br functionality employed are then added, and the mixture is heated under reflux for 2-3 h with very vigorous stirring. If the viscosity of the mixture increases excessively, it can be diluted with a mixture of 2 parts by volume of toluene: 3 parts by volume of dioxane. After a total reaction time of 4-6 h, 0.05 mol equivalent per boronic acid functionality employed of a monobromoaromatic compound are added for end capping, and then, 30 min. later, 0.05 mol equivalent per Br functionality employed of a monoboronic acid or a monoboronic acid ester is added, and the mixture is boiled for a further 1 h. After cooling, the mixture is diluted with 300 ml of toluene. The aqueous phase is separated off, the organic phase is washed twice with 300 ml of water each time, dried over magnesium sulfate, filtered through a Celite bed in order to remove palladium and then evaporated to dryness. The crude polymer is dissolved in THF (concentration about 10-30 g/l), and the solution is allowed to run slowly, with very vigorous stirring, into twice the volume of methanol. The polymer is filtered off with suction and washed three times with methanol. The reprecipitation process is repeated five times, the polymer is then dried to constant weight at 30-50° C. in vacuo.


Variant B
One-Phase Reaction Mixture

The monomers (bromides and boronic acids or boronic acid esters, purity according to HPLC>99.8%) in the composition indicated in the table are dissolved or suspended in a solvent (THF, dioxane, xylene, mesitylene, dimethylacetamide, NMP, DMSO, etc.) in a total concentration of about 100 mmol/1.3 mol equivalents of base (potassium fluoride, tripotassium phosphate (anhydrous, monohydrate or trihydrate), potassium carbonate, caesium carbonate, etc., in each case anhydrous) per Br functionality are then added, and the weight equivalent of glass beads (diameter 3 mm) is added, the mixture is stirred for a further 5 min., 0.03 to 0.003 mol equivalent of tri-ortho-tolylphosphine and then 0.005 to 0.0005 mol equivalent of palladium(II) acetate (phosphine to Pd ratio preferably 6:1) per Br functionality are then added, and the mixture is then heated under reflux for 2-3 h with very vigorous stirring. Alternatively, other phosphines, such as tri-tert-butylphosphine, SPhos, XPhos, RuPhos, XanthPhos, etc., can be employed, where the preferred phosphine: palladium ratio in the case of these phosphines is 2:1 to 1.3:1. After a total reaction time of 4-12 h, 0.05 mol equivalent of a monobromoaromatic compound and then, 30 min. later, 0.05 mol equivalent of a monoboronic acid or a monoboronic acid ester is added for end capping, and the mixture is boiled for a further 1 h. The solvent is substantially removed in vacuo, the residue is taken up in toluene, and the polymer is purified as described under variant A.


Monomers M/End Cappers E:




embedded image


embedded image


Polymers:


Composition of the Polymers, mol %


















M1
M2
M3
M4



Polymer
[%]
[%]
[%]
[%]
Ir complex/[%]







P1

30

45
Ir(LB74-Br)3/10


P2
10
10

35
Ir(LB94-Br)3/10


P3

30

40
Ir500-Br2/10


P4

30

40
Ir502-Br2/10


P5
20
30
10
20
Ir904/20









Molecular Weights and Yield of the Polymers According to the Invention:


















Polymer
Mn [gmol−1]
Polydispersity
Yield









P1
190,000
4.5
62%



P2
218,000
5.0
59%



P3
270,000
2.3
60%



P4
245,000
2.2
55%



P5
260,000
2.5
57%










Solubility of the Complexes in Organic Solvents:


The complexes according to the invention have the solubility shown in the table, in the solvents indicated at 25° C. Comparison with the complexes without the bicyclic group according to the invention shows that the solubility of the complexes according to the invention is significantly greater (factor about 10-100).

















Comparative complex
Complex


Ex.
Solvent
Solubility
Solubility [g/ml]







Sol1
Toluene


embedded image




embedded image







Sol2
o-Xylene


embedded image




embedded image







Sol3
3- Phenoxy- toluene


embedded image




embedded image







Sol4
Toluene


embedded image




embedded image







Sol5
Toluene


embedded image




embedded image







Sol6
Toluene


embedded image




embedded image







Sol7
o-Xylene


embedded image




embedded image







Sol8
Toluene


embedded image




embedded image







Sol9
Toluene


embedded image




embedded image







Sol10
Toluene


embedded image




embedded image











Sublimation of the Complexes:


The complexes according to the invention have the sublimation temperature and rate shown in the table at a base pressure of about 10−5 mbar. Comparison with complexes without the bicyclic group according to the invention shows that the sublimation temperature of the complexes according to the invention is lower and the sublimation rate is significantly greater. In addition, the complexes according to the invention are stable under the sublimation conditions.














Ex.
Comparative complex
Complex







Sub1


embedded image




embedded image







Sub2


embedded image




embedded image







Sub3


embedded image




embedded image







Sub4


embedded image




embedded image







Sub5


embedded image




embedded image











Example
Production of OLEDs
2) Further Vacuum-Processed Devices









TABLE 1







Structure of the OLEDs













HTL2
EBL
EML
HBL
ETL


Ex.
Thickness
Thickness
Thickness
Thickness
Thickness










Red OLEDs












D-IrR2
HTM

M7:M8:Ir-R2

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-IrR3
HTM

M7:M8:Ir-R3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir(LB5)3
HTM

M7:M8:Ir(LB5)3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir(LB6)3
HTM

M7:M8:Ir(LB6)3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir(LB12)3
HTM

M7:M8:Ir(LB12)3
HBM2
ETM1:ETM2



280 nm

(30%:60%:10%)
10 nm
(50%:50%)





35 nm

40 nm


D-Ir(LB13)3
HTM

M7:M8:Ir(LB13)3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir(LB19)3
HTM

M7:M8:Ir(LB19)3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir(LB20)3
HTM

M7:M8:Ir(LB20)3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir(LB57)3
HTM

M7:M8:Ir(LB57)3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir(LB68)3
HTM

M7:M8:Ir(LB68)3

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir503
HTM

M7:M8:Ir503

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-507
HTM

M7:M8:Ir507

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-509
HTM

M7:M8:Ir509

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-510
HTM

M7:M8:Ir510

ETM1:ETM2



280 nm

(58%:30%:12%)

(50%:50%)





35 nm

40 nm


D-521
HTM

M7:M8:Ir521

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir540
HTM

M7:M8:Ir540

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir541
HTM

M7:M8:Ir541

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir542
HTM

M7:M8:Ir542

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir543
HTM

M7:M8:Ir543

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir544
HTM

M7:M8:Ir544

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir546
HTM

M7:M8:Ir546

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir548
HTM

M7:M8:Ir548

ETM1:ETM2



280 nm

(60%:30%:10%)

(50%:50%)





35 nm

40 nm


D-Ir551
HTM

M7:M8:Ir551

ETM1:ETM2



280 nm

(60%:35%:5%)

(50%:50%)





35 nm

40 nm


D-Pt002
HTM

M7:M8:Pt002
HBM1
ETM1:ETM2



280 nm

(60%:30%:10%)
5 nm
(50%:50%)





35 nm

40 nm







Yellow OLEDs












D-Ir-Y1
HTM

M7:M8:Ir-Y1

ETM1:ETM2



250 nm

(58%:30%:12%)

(50%:50%)





25 nm

45 nm


D-Ir-Y2
HTM

M7:M8:Ir-Y2

ETM1:ETM2



250 nm

(62%:30%:8%)

(50%:50%)





25 nm

45 nm


D-Ir(LB7)3
HTM

M7:M8:Ir(LB7)3
HBM1
ETM1:ETM2



230 nm

(45%:50%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB94)3
HTM

M7:M8:Ir(LB94)3

ETM1:ETM2



250 nm

(65%:30%:5%)

(50%:50%)





30 nm

40 nm


D-Ir(LB95)3
HTM

M7:M8:Ir(LB95)3

ETM1:ETM2



250 nm

(65%:30%:5%)

(50%:50%)





30 nm

40 nm


D-Ir(LB96)3
HTM

M7:M8:Ir(LB96)3

ETM1:ETM2



250 nm

(65%:30%:5%)

(50%:50%)





30 nm

40 nm


D-Ir(LB102)3
HTM

M7:M8:Ir(LB102)3

ETM1:ETM2



250 nm

(65%:30%:5%)

(50%:50%)





30 nm

40 nm


D-Ir(LB103)3
HTM

M7:M8:Ir(LB103)3

ETM1:ETM2



250 nm

(65%:30%:5%)

(50%:50%)





30 nm

40 nm


D-Ir502
HTM

M7:M8:Ir502

ETM1:ETM2



250 nm

(62%:30%:8%)

(50%:50%)





30 nm

40 nm


D-Ir513
HTM

M7:M8:Ir513

ETM1:ETM2



250 nm

(58%:30%:12%)

(50%:50%)





25 nm

40 nm


D-Ir517
HTM

M7:M8:Ir517

ETM1:ETM2



250 nm

(58%:30%:12%)

(50%:50%)





30 nm

40 nm


D-Ir527
HTM

M7:M8:Ir527

ETM1:ETM2



250 nm

(58%:30%:12%)

(50%:50%)





30 nm

40 nm


D-Ir553
HTM

M7:M8:Ir553

ETM1:ETM2



250 nm

(58%:30%:12%)

(50%:50%)





30 nm

40 nm







Green OLEDs












D-Ir-G2
HTM

M7:M8:Ir-G2
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB8)3
HTM

M7:M8:Ir(LB8)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB10)3
HTM

M7:M8:Ir(LB10)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB15)3
HTM

M7:M8:Ir(LB15)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB18)3
HTM

M7:M8:Ir(LB18)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB74)3
HTM

M7:M8:Ir(LB74)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB75)3
HTM

M7:M8:Ir(LB75)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB84)3
HTM

M7:M8:Ir(LB84)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB85)3
HTM

M7:M8:Ir(LB85)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB86)3
HTM

M7:M8:Ir(LB86)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB87)3
HTM

M7:M8:Ir(LB87)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB88)3
HTM

M7:M8:Ir(LB88)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB104)3
HTM

M7:M8:Ir(LB104)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB105)3
HTM

M7:M8:Ir(LB105)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB106)3
HTM

M7:M8:Ir(LB106)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB116)3
HTM

M7:M8:Ir(LB116)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB131)3
HTM

M7:M8:Ir(LB131)3
HBM2
ETM1:ETM2



230 nm

(60%:30%:10%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB132)3
HTM

M7:M8:Ir(LB132)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB133)3
HTM

M7:M8:Ir(LB133)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB134)3
HTM

M7:M8:Ir(LB134)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB135)3
HTM

M7:M8:Ir(LB135)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir(LB136)3
HTM

M7:M8:Ir(LB136)3
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir500
HTM

M7:M8:Ir500
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir501
HTM

M7:M8:Ir501
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir505
HTM

M7:M8:Ir505
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir508
HTM

M7:M8:Ir508
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir512
HTM

M7:M8:Ir512
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir515
HTM

M7:M8:Ir515
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir516
HTM

M7:M8:Ir516
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir518
HTM

M7:M8:Ir518
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir530
HTM

M7:M8:Ir530
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir533
HTM

M7:M8:Ir533
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir534
HTM

M7:M8:Ir534
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir538
HTM

M7:M8:Ir538
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir800
HTM

M7:M8:Ir800
HBM2
ETM1:ETM2



230 nm

(45%:45%:10%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir804
HTM

M7:M8:Ir804
HBM2
ETM1:ETM2



230 nm

(45%:45%:10%)
10 nm
(50%:50%)





25 nm

35 nm


D-Ir805
HTM

M7:M8:Ir805
HBM2
ETM1:ETM2



230 nm

(45%:45%:10%)
10 nm
(50%:50%)





25 nm

35 nm


D-Pt001
HTM

M7:M8:Pt001
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Pt003
HTM

M7:M8:Pt003
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Pt(LB107)
HTM

M7:M8:Pt(LB107)
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Pt(LB108)
HTM

M7:M8:Pt(LB108)
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Pt(LB109)
HTM

M7:M8:Pt(LB109)
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm


D-Pt(LB110)
HTM

M7:M8:Pt(LB110)
HBM2
ETM1:ETM2



230 nm

(65%:30%:5%)
10 nm
(50%:50%)





25 nm

35 nm







Blue OLEDs












D-Ir-B2
HTM
EBM
M10:M4:Ir-B2
HBM1
ETM1:ETM2



190 nm
10 nm
(45%:45%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB33)3
HTM
EBM
M1:M4:Ir(LB33)3
HBM1
ETM1:ETM2



190 nm
10 nm
(45%:45%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB35)3
HTM
EBM
M1:M4:Ir(LB35)3
HBM1
ETM1:ETM2



190 nm
10 nm
(50%:40%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB42)3
HTM
EBM
M1:M4:Ir(LB42)3
HBM1
ETM1:ETM2



190 nm
10 nm
(50%:40%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB43)3
HTM
EBM
M10:M4:Ir(LB43)3
HBM1
ETM1:ETM2



190 nm
10 nm
(45%:45%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB44)3
HTM
EBM
M10:M4:Ir(LB44)3
HBM1
ETM1:ETM2



190 nm
10 nm
(45%:45%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB52)3
HTM
EBM
M1:M4:Ir(LB52)3
HBM1
ETM1:ETM2



190 nm
10 nm
(50%:40%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB54)3
HTM
EBM
M10:M4:Ir(LB54)3
HBM1
ETM1:ETM2



190 nm
10 nm
(50%:40%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB56)3
HTM
EBM
M10:M4:Ir(LB56)3
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:35%:5%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB83)3
HTM
EBM
M1:M4:Ir(LB83)3
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:35%:5%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB120)3
HTM
EBM
M1:M4:Ir(LB120)3
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:30%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB123)3
HTM
EBM
M1:M4:Ir(LB123)3
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:30%:10%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB127)3
HTM
EBM
M1:M4:Ir(LB127)3
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:35%:5%)
10 nm
(50%:50%)





25 nm

15 nm


D-Ir(LB129)3
HTM
EBM
M1:M4:Ir(LB129)3
HBM1
ETM1:ETM2



190 nm
10 nm
(60%:35%:5%)
10 nm
(50%:50%)





25 nm

15 nm


Ir(535)
HTM
EBM
M1:M4:Ir535
HBM1
ETM1:ETM2



190 nm
10 nm
(50%:40%:10%)
10 nm
(50%:50%)





25 nm

15 nm


Pt004
HTM
EBM
M1:M4:Pt004
HBM1
ETM1:ETM2



190 nm
10 nm
(50%:40%:10%)
10 nm
(50%:50%)





25 nm

15 nm


Pt(LB111)
HTM
EBM
M10:M4:Pt(LB111)
HBM1
ETM1:ETM2



190 nm
10 nm
(45%:45%:10%)
10 nm
(50%:50%)





25 nm

15 nm


Pt(LB112)
HTM
EBM
M10:M4:Pt(LB112)
HBM1
ETM1:ETM2



190 nm
10 nm
(45%:45%:10%)
10 nm
(50%:50%)





25 nm

15 nm
















TABLE 2







Results of the vacuum-processed OLEDs












EQE (%)
Voltage (V)
CIE x/y



Ex.
1000 cd/m2
1000 cd/m2
1000 cd/m2












LT80 (h)



1000 cd/m2







Red OLEDs











D-IrR2
19.0
3.2
0.66/0.34
25000


D-IrR3
16.5
3.1
0.63/0.37
19000


D-Ir(LB5)3
19.5
2.9
0.65/0.34
15000


D-Ir(LB6)3
18.6
3.0
0.70/0.30



D-Ir(LB12)3
16.3
3.5
0.68/0.31



D-Ir(LB13)3
19.3
3.0
0.65/0.35
18000


D-Ir(LB19)3
18.4
3.2
0.69/0.30
12000


D-Ir(LB20)3
19.4
3.1
0.65/0.35
19000


D-Ir(LB57)3
17.8
3.1
0.66/0.34
10000


D-Ir(LB68)3
18.8
3.2
0.63/0.35
13000


D-Ir503
19.4
3.1
0.64/0.35
23000


D-Ir507
16.8
3.2
0.63/0.36



D-Ir509
16.6
3.2
0.62/0.38



D-Ir510
19.2
3.1
0.63/0.35
26000


D-Ir521
19.0
3.0
0.64/0.35



D-Ir540
17.0
3.0
0.67/0.32



D-Ir541
19.8
3.1
0.67/0.33
30000


D-Ir542
19.3
2.9
0.66/0.34



D-Ir543
19.5
3.0
0.67/0.33
27000


D-Ir544
19.7
3.0
0.65/0.34



D-Ir546
18.9
3.1
0.64/0.36



D-Ir548
20.0
3.3
0.66/0.34
29500


D-Ir551
17.4
3.0
0.65/0.34
19500


D-Pt002
16.9
3.4
0.67/0.32








Yellow OLEDs











D-Ir-Y1
19.7
3.0
0.39/0.61
32000


D-Ir(LB7)3
21.3
3.2
0.41/0.58



D-Ir(LB94)3
20.0
3.1
0.43/0.55
40000


D-Ir(LB95)3
19.8
3.0
0.43/0.56
45000


D-Ir(LB96)3
20.5
3.0
0.43/0.56
38000


D-Ir(LB102)3
20.2
3.1
0.43/0.56
35000


D-Ir(LB103)3
20.1
3.3
0.41/0.58
32000


D-Ir502
24.2
2.8
0.44/0.55
40000


D-Ir513
22.0
3.0
0.41/0.57
38000


D-Ir517
21.1
3.2
0.39/0.60
33000


D-Ir527
24.6
2.9
0.46/0.54
44000


D-Ir553
19.9
3.2
0.48/0.52
35000







Green OLEDs











D-Ir-G2
19.1
3.2
0.35/0.61
19000


D-Ir(LB8)3
24.5
3.3
0.35/0.62
25000


D-Ir(LB10)3
23.9
3.3
0.33/0.64
22000


D-Ir(LB15)3
24.6
3.3
0.35/0.62
27000


D-Ir(LB18)3
24.5
3.3
0.35/0.62
22000


D-Ir(LB74)3
22.3
3.1
0.33/0.63
24000


D-Ir(LB75)3
22.8
3.1
0.33/0.64
26000


D-Ir(LB84)3
24.3
3.3
0.34/0.62
24000


D-Ir(LB85)3
24.4
3.3
0.34/0.62
24000


D-Ir(LB86)3
24.0
3.4
0.30/0.63
19000


D-Ir(LB87)3
24.5
3.3
0.34/0.62
25000


D-Ir(LB88)3
24.2
3.2
0.34/0.62



D-Ir(LB104)3
20.7
3.4
0.38/0.60
20000


D-Ir(LB105)3
18.7
3.5
0.37/0.60



D-Ir(LB106)3
19.6
3.5
0.39/0.58



D-Ir(LB116)3
20.1
3.4
0.41/0.56



D-Ir(LB131)3
21.8
3.3
0.35/0.62



D-Ir(LB132)3
23.0
3.3
0.34/0.64
26000


D-Ir(LB133)3
22.8
3.4
0.33/0.62
24000


D-Ir(LB134)3
23.3
3.3
0.36/0.61
24000


D-Ir(LB135)3
22.8
3.2
0.35/0.62



D-Ir(LB136)3
21.0
3.3
0.39/0.58



D-Ir500
23.5
3.1
0.33/0.64
22000


D-Ir501
24.5
3.1
0.36/0.62
28000


D-Ir505
24.6
3.1
0.36/0.62
30000


D-Ir508
23.0
3.4
0.18/0.54



D-Ir512
24.1
3.1
0.34/0.63
23000


D-Ir515
24.3
3.3
0.33/0.63
25000


D-Ir516
24.1
3.2
0.33/0.63



D-Ir518
24.2
3.3
0.34/0.63
24000


D-Ir530
24.4
3.3
0.34/0.63
24000


D-Ir533
24.0
3.2
0.34/0.63
26000


D-Ir534
24.2
3.4
0.33/0.63
26000


D-Ir538
22.2
3.2
0.39/0.59



D-Ir800
22.3
3.5
0.16/0.40



D-Ir804
22.7
3.4
0.18/0.52



D-Ir805
22.5
3.4
0.18/0.55



D-Pt001
17.1
3.2
0.31/0.60



D-Pt003
18.0
3.3
0.31/0.62



D-Pt(LB107)
18.9
3.1
0.35/0.62
13000


D-Pt(LB108)
19.7
3.1
0.36/0.62



D-Pt(LB109)
20.4
3.2
0.35/0.62



D-Pt(LB110)
20.7
3.2
0.36/0.62
18000









LT50 (h)



1000 cd/m2







Blue OLEDs











D-Ir-B2
3.1
5.1
0.16/0.07
  50


D-Ir(LB33)3
21.5
3.9
0.17/0.40
 1800


D-Ir(LB35)3
20.6
4.6
0.17/0.36



D-Ir(LB42)3
20.8
4.1
0.17/0.38



D-Ir(LB43)3
9.1
5.4
0.15/0.12
 100


D-Ir(LB44)3
9.3
5.3
0.15/0.15



D-Ir(LB52)3
7.2
6.0
0.15/0.10



D-Ir(LB54)3
6.9
6.0
0.15/0.09



D-Ir(LB56)3
23.0
3.8
0.15/0.33
 1100


D-Ir(LB83)3
22.1
3.9
0.15/0.27
 800


D-Ir(LB120)3
19.1
4.5
0.16/0.31
 500


D-Ir(LB123)3
19.4
4.6
0.16/0.32



D-Ir(LB127)3
21.3
4.4
0.23/0.60



D-Ir(LB129)3
21.6
4.6
0.22/0.61
10000


Ir535
19.8
4.4
0.16/0.37



Pt004
17.5
4.0
0.18/0.43



Pt(LB111)
10.1
5.1
0.15/0.17



Pt(LB112)
12.1
5.0
0.15/0.23










3) Solution-Processed Devices
A: From Soluble Functional Materials

The iridium complexes according to the invention can also be processed from solution, where they result in OLEDs which are significantly simpler as far as the process is concerned, compared with the vacuum-processed OLEDs, with nevertheless good properties. The production of components of this type is based on the production of polymeric light-emitting diodes (PLEDs), which has already been described many times in the literature (for example in WO 2004/037887). The structure is composed of substrate/ITO/PEDOT (80 nm)/interlayer (80 nm)/emission layer (80 nm)/cathode. To this end, use is made of substrates from Technoprint (soda-lime glass), to which the ITO structure (indium tin oxide, a transparent, conductive anode) is applied. The substrates are cleaned with DI water and a detergent (Deconex 15 PF) in a clean room and then activated by a UV/ozone plasma treatment. An 80 nm layer of PEDOT (PEDOT is a polythiophene derivative (Baytron P VAI 4083sp.) from H. C. Starck, Goslar, which is supplied as an aqueous dispersion) is then applied as buffer layer by spin coating, likewise in the clean room. The spin rate required depends on the degree of dilution and the specific spin coater geometry (typically for 80 nm: 4500 rpm). In order to remove residual water from the layer, the substrates are dried by heating on a hotplate at 180° C. for 10 minutes. The interlayer used serves for hole injection, in this case HIL-012 from Merck is used. The interlayer may alternatively also be replaced by one or more layers, which merely have to satisfy the condition of not being detached again by the subsequent processing step of EML deposition from solution. In order to produce the emission layer, the emitters according to the invention are dissolved in toluene together with the matrix materials. The typical solids content of such solutions is between 16 and 25 g/l if, as here, the typical layer thickness of 80 nm for a device is to be achieved by means of spin coating. The solution-processed devices of type 1 comprise an emission layer comprising (polystyrene):M5:M6:Ir(L)3 (20%:30%:40%:10%) and those of type 2 comprise an emission layer comprising (polystyrene): M5:M6:Ir(LB3)3:Ir(L)3 (20%:20%:40%:15%: 5%). The emission layer is applied by spin coating in an inert-gas atmosphere, in the present case argon, and dried by heating at 130° C. for 30 min. Finally, a cathode is applied by vapour deposition from barium (5 nm) and then aluminium (100 nm) (high-purity metals from Aldrich, particularly barium 99.99% (Order No. 474711); vapour-deposition equipment from Lesker, inter alia, typical vapour-deposition pressure 5×10−6 mbar). Optionally, firstly a hole-blocking layer and then an electron-transport layer and only then the cathode (for example Al or LiF/Al) can be applied by vacuum vapour deposition. In order to protect the device against air and atmospheric moisture, the device is finally encapsulated and then characterised. The OLED examples given have not yet been optimised, Table 4 summarises the data obtained.









TABLE 4







Results with solution-processed materials















CIE x/y



Emitter
EQE (%)
Voltage (V)
1000


Ex.
Device
1000 cd/m2
1000 cd/m2
cd/m2










Red OLEDs











Sol-D-Ir-R2
Ir-R2
18.0
3.8
0.66/0.34



Type 2


Sol-D-Ir(LB14)3
Ir(LB14)3
19.2
3.9
0.65/0.35



Type 1


Sol-D-Ir(LB69)3
Ir(LB69)3
19.5
3.6
0.67/0.33



Type 1


Sol-D-Ir(LB71)3
Ir(LB71)3
19.0
3.8
0.65/0.35



Type 1


Sol-D-Ir511
Ir511
21.3
3.7
0.62/0.37



Type 1


Sol-D-Ir525
Ir525
20.1
3.9
0.66/0.34



Type 1


Sol-D-Ir545
Ir545
18.8
3.9
0.66/0.34



Type 2


Sol-D-Ir547
Ir547
17.5
3.5
0.68/0.32



Type 2


Sol-D-Ir549
Ir549
19.3
4.0
0.65/0.35



Type 2


Sol-D-Ir550
Ir550
19.5
4.0
0.66/0.34



Type 2


Sol-D-Ir552
Ir552
17.9
3.9
0.69/0.31



Type 2


Sol-D-Ir607
Ir607
16.8
3.9
0.67/0.32



Type 2


Sol-D-Ir608
Ir608
18.6
3.7
0.65/0.35



Type 2







Yellow OLEDs of type 1











Sol-D-Ir-Y3
Ir-Y3
19.3
4.0
0.48/0.49


Sol-D-Ir(LB3)3
Ir(LB3)3
22.1
4.1
0.49/0.50


Sol-D-Ir(LB9)3
Ir(LB9)3
21.8
4.1
0.48/0.52


Sol-D-Ir(LB76)3
Ir(LB76)3
20.8
4.0
0.55/0.44


Sol-D-Ir(LB77)3
Ir(LB77)3
22.0
4.1
0.51/0.48


Sol-D-Ir(LB78)3
Ir(LB78)3
22.5
4.3
0.51/0.48


Sol-D-Ir(LB79)3
Ir(LB79)3
20.9
3.9
0.48/0.48


Sol-D-Ir(LB81)3
Ir(LB81)3
21.3
4.2
0.47/0.52


Sol-D-Ir504
Ir504
21.3
4.0
0.46/0.53


Sol-D-Ir514
Ir514
20.7
4.2
0.49/0.50


Sol-D-Ir520
Ir520
21.3
4.0
0.47/0.52


Sol-D-Ir522
Ir522
21.0
4.0
0.47/0.53


Sol-D-Ir528
Ir528
20.9
4.2
0.47/0.53


Sol-D-Ir529
Ir529
19.8
4.4
0.40/0.56


Sol-D-Ir531
Ir531
20.3
4.2
0.49/0.50


Sol-D-Ir602
Ir602
20.9
3.9
0.43/0.56


Sol-D-Ir603
Ir603
20.7
4.1
0.45/0.55


Sol-D-Ir604
Ir604
21.0
4.0
0.45/0.55


Sol-D-Ir609
Ir609
20.7
4.0
0.46/0.53


Sol-D-Ir612
Ir612
20.5
4.1
0.47/0.52







Green OLEDs of type 1











Sol-D-Ir-G3
Ir-G3
18.5
4.3
0.34/0.62


Sol-D-Ir(LB1)3
Ir(LB1)3
20.7
4.5
0.38/0.59


Sol-D-Ir(LB11)3
Ir(LB11)3
21.0
4.5
0.36/0.62


Sol-D-Ir(LB18)3
Ir(LB18)3
20.9
4.6
0.38/0.59


Sol-D-Ir(LB80)3
Ir(LB80)3
20.2
4.5
0.37/0.60


Sol-D-Ir(LB90)3
Ir(LB90)3
20.5
4.6
0.34/0.62


Sol-D-Ir(LB91)3
Ir(LB91)3
21.2
4.5
0.34/0.64


Sol-D-Ir(LB92)3
Ir(LB92)3
21.2
4.6
0.34/0.64


Sol-D-Ir(LB93)3
Ir(LB93)3
21.7
4.7
0.34/0.64


Sol-D-Ir(LB128)3
Ir(LB128)3
13.8
4.6
0.23/0.60


Sol-D-Ir(LB132)3
Ir(LB132)3
21.0
4.6
0.35/0.63


Sol-D-Ir506
Ir506
20.3
4.5
0.34/0.63


Sol-D-Ir519
Ir519
20.0
4.6
0.36/0.61


Sol-D-Ir523
Ir523
20.9
4.6
0.34/0.63


Sol-D-Ir524
Ir524
14.6
4.8
0.24/0.58


Sol-D-Ir532
Ir532
20.7
4.6
0.36/0.61


Sol-D-Ir539
Ir539
19.7
4.5
0.33/0.65


Sol-D-Ir600
Ir600
20.0
4.5
0.36/0.64


Sol-D-Ir610
Ir610
20.5
4.4
0.32/0.64


Sol-D-Ir611
Ir611
20.4
4.5
0.33/0.65


Sol-D-Ir613
Ir613
20.7
4.5
0.36/0.62


Sol-D-Ir614
Ir614
20.3
4.5
0.34/0.64


Sol-D-Ir701
Ir701
19.9
4.4
0.33/0.65


Sol-D-Ir703
Ir703
21.0
4.4
0.34/0.64









B: From Polymeric Functional Materials

Production of the OLEDs as described under A:. For the production of the emission layer, the polymers according to the invention are dissolved in toluene. The typical solids content of such solutions is between 10 and 15 g/l if, as here, the typical layer thickness of 80 nm for a device is to be achieved by means of spin coating. The said OLED examples have not yet been optimised, Table 5 summarises the data obtained.









TABLE 5







Results with solution-processed materials













EQE (%)
Voltage (V)
CIE x/y


Ex.
Polymer
1000 cd/m2
1000 cd/m2
1000 cd/m2










Yellow OLEDs











D-P2
P2
19.4
3.6
0.43/0.57


D-P4
P4
21.4
3.7
0.46/0.53







Green OLEDs











D-P1
P1
19.8
4.1
0.34/0.61


D-P3
P3
20.1
4.3
0.32/0.63


D-P5
P5
21.6
4.3
0.33/0.64









4) White-Emitting OLED9

A white-emitting OLED having the following layer structure is produced in accordance with the general processes from 1):









TABLE 6







Structure of the white OLEDs

















EML





HTL2
EML
EML
Green
HBL



Ex.
Thickness
Red Thickness
Blue Thickness
Thickness
Thickness
ETL





D-W1
HTM
EBM:Ir541
M1:M3:Ir(LB55)3
M3:Ir(LB74)3
M3
ETM1:ETM2



230 nm
(97%:3%)
(45%:50%:5%)
(95%:5%)
10 nm
(50%:50%)




9 nm
8 nm
7 nm

30 nm
















TABLE 7







Device results












EQE (%)
Voltage (V)
CIE x/y
LT50 (h)


Ex.
1000 cd/m2
1000 cd/m2
1000 cd/m2
1000 cd/m2





D-W1
21.8
5.8
0.41/0.39
5500








Claims
  • 1-20. (canceled)
  • 21. A compound of formula (1): M(L)n(L′)m  (1)comprising a moiety M(L)n of formula (2):
  • 22. The compound of claim 21, wherein M is iridium(III), n is 1, and four monodentate or two bidentate or one bidentate and two monodentate or one tridentate and one monodentate or one tetradentate ligand L′ is coordinated to the iridium, or wherein n is 2 and one bidentate or two monodentate ligands L′ are coordinated to the iridium, or wherein n is 3 and m is 0, or wherein M is platinum(II) and n is 1 and one bidentate or two monodentate ligands L′ are coordinated to the platinum, or wherein that n is 2 and m is 0.
  • 23. The compound of claim 21, wherein CyC is selected from the group consisting of structures of formulae (CyC-1) through (CyC-19), wherein the group CyC is in each case bonded to CyD at the position denoted by # and is coordinated to M at the position denoted by *:
  • 24. The compound of claim 23, wherein CyC is selected from the group consisting of structures of formulae (CyC-1a) through (CyC-19a):
  • 25. The compound of claim 21, wherein CyD is selected from the group consisting of structures of formulae (CyD-1) through (CyD-10), wherein the group CyD is in each case bonded to CyC at the position denoted by # and is coordinated to M at the position denoted by *:
  • 26. The compound of claim 25, wherein CyD is selected from the group consisting of structures of formulae (CyD-1a) through (CyD-10a):
  • 27. The compound of claim 21, wherein the radicals R on CyC and CyD together define a ring and the ligands L are selected from the group consisting of ligands (L1) through (L6):
  • 28. The compound of claim 21, wherein CyC is selected from the group consisting of structures of formulae (CyC-1-1) through (CyC-19-1) and CyD is selected from the group consisting of structures of formulae (CyD1-1) through (CyD-10-1) or wherein the ligands L are selected from the group consisting of ligands (L1-1) through (L5-6):
  • 29. The compound of claim 21, wherein A1 and A2 in formula (3) are both, identically or differently, CR2 or wherein A1 and A2 are both N.
  • 30. The compound of claim 21, wherein A3 and A4 are, identically or differently on each occurrence, an alkylene group having 2 or 3 carbon atoms, wherein the alkylene group is optionally substituted by one or more radicals R3.
  • 31. The compound of claim 21, wherein R2 and R3 are selected, independently of one another, identically or differently on each occurrence, from the group consisting of H, D, F, a straight-chain alkyl group having 1 to 10 C atoms, which is optionally substituted by one or more radicals R4, a branched or cyclic alkyl group having 3 to 10 C atoms, which is optionally substituted by one or more radicals R4, and an aromatic or heteroaromatic ring system having 5 to 12 aromatic ring atoms, which is optionally substituted by one or more radicals R4; wherein two radicals R3 optionally define a ring a polycyclic, aliphatic ring system with one another, wherein a radical R3 may be bonded to A3 and a radical R may be bonded to A4.
  • 32. The compound of claim 21, wherein the structure of formula (3) is selected from the group consisting of structures of formulae (4), (5), and (6):
  • 33. The compound of claim 21, wherein the structure of formula (3) is selected from the group consisting of structures of formulae (4a), (5a), (6a), (4b), and (6b):
  • 34. The compound of claim 21, wherein L′ is selected, identically or differently on each occurrence, from the group consisting of carbon monoxide, nitrogen monoxide, alkyl cyanides, aryl cyanides, alkyl isocyanides, aryl isocyanides, amines, phosphines, phosphites, arsines, stibines, nitrogen-containing heterocycles, carbenes, hydride, deuteride, halides, alkylacetylides, arylacetylides, cyanide, cyanate, isocyanate, thiocyanate, isothiocyanate, aliphatic alcoholates, aromatic alcoholates, aliphatic thioalcoholates, aromatic thioalcoholates, amides, carboxylates, aryl groups, O2−, S2−, carbides, nitrenes, imines, 1,3-diketonates derived from 1,3-diketones, 3-ketonates derived from 3-ketoesters, salicyliminates, borates of nitrogen-containing heterocycles, and monoanionic ligands which form a cyclometallated five-membered ring or six-membered ring having at least one metal-carbon bond with M.
  • 35. A process for preparing a compound of claim 21 comprising reacting a free ligand L and optionally L′ with a metal alkoxide of formula (69), a metal ketoketonate of formula (70), a metal halide of the formula (71), a dimeric metal complex of formula (72), a metal complex of formula (73), or an iridium compound which carries both alkoxide and/or halide and/or hydroxyl and also ketoketonate radicals:
  • 36. An oligomer, polymer, or dendrimer comprising one or more compounds of claim 21, wherein one or more bonds are present from the compound to the polymer, oligomer, or dendrimer.
  • 37. A formulation comprising at least one compound of claim 21 or an oligomer, polymer, or dendrimer comprising one or more of said compounds, wherein one or more bonds are present from the compound to the polymer, oligomer, or dendrimer, and at least one further compound and/or at least one solvent.
  • 38. An electronic device comprising at least one compound of claim 21 or an oligomer, polymer, or dendrimer comprising one or more of said compounds, wherein one or more bonds are present from the compound to the polymer, oligomer, or dendrimer, wherein the electronic device is selected from the group consisting of organic electroluminescent devices, organic integrated circuits, organic field-effect transistors, organic thin-film transistors, organic light-emitting transistors, organic solar cells, organic optical detectors, organic photoreceptors, organic field-quench devices, light-emitting electrochemical cells, and organic laser diodes.
  • 39. The electronic device of claim 38, wherein the electronic device is an organic electroluminescent device and wherein the compound is employed as an emitting compound in one or more emitting layers.
Priority Claims (2)
Number Date Country Kind
14000105.8 Jan 2014 EP regional
14000345.0 Jan 2014 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2014/003398 12/17/2014 WO 00